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Sec61 interactor analysis by chemical crosslinking
Abstract
The Sec61 complex is a heterotrimeric complex responsible for the translocation
of secretory proteins through the endoplasmic reticulum (ER) membrane. Sec61,
the pore forming subunit of the channel, is a transmembrane protein with 10 trans-
membrane domains. Its lumenal loops are mostly short, with the exception of L5,
which is the hinge that allows channel opening, and a large luminal loop (L7). Pro-
teins that misfold in the endoplasmic reticulum are transported back to the cytosol for
ER-associated degradation (ERAD). The Sec61 channel is also one of the candidates
for the retrograde transport conduit.
In this work I developed and optimized a chemical crosslinking setup using ER
membranes. Upon purification and mass spectrometry analysis of crosslinked sam-
ples I was able to identify new Sec61 interactors. In addition to known interactors I
detected new interactions with ERAD factors including Cue1, Ubc6, Ubc7, Asi3, and
Mpd1. I show that a substrate dependent on Asi3 for degradation (Erg11), is also
Sec61 dependent. Moreover, I show that the CPY* ERAD factor Mpd1 binds to the
lumenal Sec61 hinge region. Deletion of the Mpd1 binding site reduced the interac-
tion between both proteins and caused an ERAD defect specific for CPY* without af-
fecting protein import into the ER or ERAD of other substrates. My data suggest that
Mpd1 binding to Sec61 is a prerequisite for CPY* ERAD and confirm a role of Sec61
in ERAD of misfolded secretory proteins
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Zusammenfassung
Der Sec61-Komplex ist ein heterotrimerer Proteinkomplex, der sekretorische Pro-
teine ins Endoplasmatische Retikulum (ER) transloziert. Die porenbildende Unterein-
heit des Komplexes, Sec61, hat 10 Transmembrandomänen. Die meisten ER-lumenalen
Loops von Sec61 sind kurz, bis auf L5, das die Verbindung oder Angel zwischen der
N- und der C-terminalen Hälfte des Kanals bildet, um die sich die N-terminale Hälfte
bei der Kanalöffnung bewegt, und den langen L7. Proteine, die im ER fehlfalten, wer-
den zum Abbau zurück ins Zytosol transportiert (ER-assoziierte Degradation, ERAD).
Der Sec61 Kanal ist einer der Kanal-Kandidaten für den retrograden Proteintransport.
In meiner Arbeit habe ich eine chemische Crosslinking-Methode für Sec61-Interaktoren
ausgearbeitet und optimiert für Mikrosomen. Ich reinigte die Sec61-Komplexe und
analysierte ihre Komponenten durch Massenspektrometrie. Es gelang mir, neue ER-
lumenale Interaktionspartner von Sec61 zu identifizieren. Zusätzlich zu bekannten
Sec61-bindenden Proteinen detektierte ich ERAD-Faktoren in den Sec61-Komplexen
wie Cue1, Ubc6, Ubc7, Asi3 und Mpd1. Ich habe gezeigt, dass der Ubiquitinligase
Asi3-abhängige Abbau von Erg11 ebenfalls abhängig ist von Sec61. Weiterhin habe
ich gezeigt, dass der CPY*-spezifische ERAD-Faktor Mpd1 an den lumenalen L5 von
Sec61 bindet. Deletion der Mpd1-Bindestelle in L5 reduzierte die Interaktion zwis-
chen Sec61 und Mpd1 und führte zu einem ERAD-Defekt für CPY* ohne ER-Import
oder ERAD anderer Substrate zu beeinträchtigen. Meine Daten zeigen, dass Mpd1-
Interaktion mit Sec61 eine Voraussetzung für CPY*-ERAD ist, und bestätigen eine
Beteiligung von Sec61 am ERAD fehlgefalteter sekretorischer Proteine.
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Introduction
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0.1 Secretory Pathway
Figure 1: Overview of the secretorymachinery. Figure fromHou et al. [165]. The nascent peptide is folded andmodiﬁed through
different mechanisms until it reaches an appropriate structure to perform its functions as a protein. SRP, signal recognition particle;
SPC, signal peptidase complex; PMT, protein O-mannosyl transferase; OST, oligosaccharyl transferase; Ubiq, ubiquitin; Lect, Lectin;
ALP, arginine transporter pathway; CPY, carboxypeptidase Y pathway.
Protein secretion is an essential process in both prokaryotes and eukaryotes. Unlike
prokaryotes that only secrete proteins into the periplasmic space or exterior of the
cell, eukaryotic cells possess a complex endomembrane system (i.e organelles) that
is functionally interconnected [414]. This means that in practice the cell is compart-
mentalized into multiple organelles, with different structures and local environments
that are associated with different functions, protein contents and redox conditions [91].
Loosely speaking a cell might be compared to a factory. As any factory, it possesses
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different departments (i.e organelles) that communicate between each other and that
posses their unique machinery and function (e.g proteins).
Although this compartmentalization brings numerous advantages, it also creates
the necessity for a shuttling system of products and effectors between compartments,
as well as with the exterior. The pathway responsible for this process is the Secretory
Pathway. It is estimated that in an eukaryotic cell approximately 30 % of all protein
produced go through at least one step of this pathway [76].
The scheme depicted in Figure 1 shows the general structure of the secretory path-
way and its main checkpoints and events, where vertical dotted lines represent mem-
brane barriers that have be transposed either by translocation (cytosol to ER; Figure
1, step 1) or vesicle budding and fusion events (ER to Golgi and Golgi to downstream;
Figure 1, step 2 and 3, respectively).
The secretory pathway starts with protein translocation into the endoplasmic reticu-
lum (ER), either co- or post-translationally (Figure 1, step 1). In S. cerevisiae, the ER
presents two morphologies: the perinuclear ER or nuclear envelope and the periph-
eral or cortical ER. Perinuclear ER is formed by membrane sheets that enclose the
nucleus, while the cortical ER is a highly dynamic network of interconnected tubules
that lines the cell periphery [300]. Protein translocation across the ER membrane is
mediated mainly by the Sec61 channel, either the Sec61 trimeric complex (Sec61,
Sbh1 and Sss1) when done co-translationally or by the heptameric Sec complex
(Sec61 trimeric complex plus Sec63 heptameric complex -Sec62, Sec63, Sec71 and
Sec72) when done post-translationally. In both cases the the pore forming sub-unit
of the complex is Sec61 [469, 258]. This subject will be addressed more thoroughly
further ahead (Section 0.2).
After translocation into the ER lumen, proteins are targeted by a series of chaper-
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ones that facilitate folding, like Kar2, or processed by glycosilation (oligosaccharyl-
transferase (OST) complex) and dissulfide bond formation (Pdi1) [76] (Figure 1, stage
A) . The matter will be discussed in more detail in Section 0.3.2. At this stage, pro-
teins enter a long process of processing and quality control (QC) steps that ensures
correct folding as misfolded proteins have an extremely toxic effect [80, 392]. In fact,
many of the chaperones involved in protein maturation serve themselves as check-
points where any signal of misfolding, like delay in processing, ensues either remedi-
ation or degradation of the misfolded form [449]. If proteins are deemed irreversibly
incorrectly folded, they must be degraded. This degradation is done by a process
called endoplasmic reticulum associated degradation (ERAD) that recognizes and
retrotranslocates this misfolded protein to the cytoplasm for proteasome-dependent
degradation [296] (subject delft in more detail in Section 0.4).
Some proteins are ER resident, and after translocation and processing they do not
need to go any further. Soluble or membrane proteins targeted for other cellular com-
partments or for secretion, however, must continue further through this pathway and
enter the Golgi apparatus (Figure 1; step 2). Once deemed correctly processed by
ER QC, they became available for further traffic through the secretory pathway (Fig-
ure 2, step 2). In ER to Golgi transport, proteins meant for transport accumulate at
discrete sites called transitional ER (tER) or ER exit sites (ERES) [324, 359]. Saccha-
romyces cerevisiae lacks discrete tER sites and cargo proteins leave the ER mem-
brane from many small tER which are distributed all over the ER [324, 57].
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Figure 2: ER to Golgi and Golgi to ER system representation. Figure extracted fromDancourt & Barlowe [71]. Model depicting
bidirectional transport between the endoplasmic reticulum (ER) and Golgi compartments. COPI and COPII- coat protein complex I
and II. R- ER resident proteins.
Transport is then done by means of a vesicle-shuttling system. These vesicles
are responsible for moving secretory proteins forward in the secretory pathway with-
out perturbing the functional segregation conferred by organelles [129, 414] (Fig-
ure 2). In anterogade transport, COPII-coated vesicles are responsible for transport.
COPII coat comprises five subunits: Sar1–GTP, dimeric Sec23/Sec24, and tetrameric
Sec13/Sec31 [13, 378]. This complex is responsible not only for the budding of the
cargo vesicle but also by the selective incorporation of correctly folded and assem-
bled secretory and membrane proteins into the formed vesicles [13, 27, 93].
After ER-budding, vesicles must fuse with the target downstream organelle, the
Golgi. In mammalian cells, an intermediary structure called ERGIC is formed between
ER and the cis-Golgi [167]. This structure results from the fusion of multiple COPII
vesicles [167, 414]. In yeast, however, COPII vesicles fuse directly with the cis-Golgi
cisternae [414]. Vesicle fusion with the membranes depends on a set of membrane-
bound Soluble NSF Attachment Protein Receptor (SNARE) proteins [373, 53]. When
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SNARE proteins associate into a complex, they form elongated four-helical bundles
with a high degree of stability that mechanically pull the membranes closer together
and results in the formation of a fusion pore (Figure 3)[174, 98].
Figure 3: SNAREmediated Vesicle Fusion. Based on ﬁgure from Ferro-Novick & Brose [98]. Illustration of SNAREmediated vesicle
fusion.
Unlike most eukaryotic cell types, S. cerevisiae’s Golgi complex is not arranged in
coherent stacks. Instead, its composed of a collection of single, isolated cisternae
scattered throughout the cytoplasm that can only occasionally associate with one
another [300, 323]. Based on protein content, these cisternae can be classified as
cis, medial, trans or trans-Golgi Network (TGN) [360, 228]. In the different Golgi cis-
ternae, secretory proteins undergo processing in compartment-specific manner (e.g
outer-chain carbohydrate modifications, proteolytic processing) (Figure 1, stage B).
For glycoproteins, for example, the core carbohydrate is extended by addition of Ⱦ-
1,6-mannose in the cis-Golgi and of Ⱦ-1,2- and Ⱦ-1,3-mannose in the medial compart-
ment [76]. Once the trans-Golgi cisternae are reached, and secretory proteins are
deemed correctly folded, the Golgi is also responsible for sorting them to their correct
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location by vesiculation (Figure 1, stage C) [414] .
This vesicle-shuttling system, however, is characterized by its bidirectionality, mean-
ing that not only vesicles migrate in the ER-Golgi direction in COPII-coated vesicles
(i.e anterogade transport) for further processing and secretion, but also in the Golgi-
ER direction (i.e retrogade transport) by COPI-coated vesicles (Figure 2) [129, 414].
The COPI complex, or coatomer, is composed by seven subunits (Ⱦ , ˳ , ˳′ , ɀ , Ɂ , ε
, and Ƀ-COP), which are recruited as an intact complex to membranes [143]. One of
the main roles of the COPI-coated vesicles is the retrieval to the ER or to previous
Golgi cisternae (trans to cis transport) of transport machinery and escaped ER resi-
dents [129, 414, 87]. The COPI-mediated retrieval of ER resident proteins uses spe-
cific sorting signals, namely the retrieval motifs HDEL (His-Asp-Glu-Leu) for lumenal
cargo and K(X)KXX for membrane proteins [64].
Ultimately, the cell maintains its organelle structure, function, and homeostasis by
modulating early secretory pathway flux of proteins and lipids [14].
0.2 Protein Translocation
0.2.1 Sec61 channel
As mentioned in the previous section, about one third of the eukaryotic proteome,
namely secretory and transmembrane proteins, reside within the endomembrane
system [59], and thus cycle through the ER. For this purpose, proteins have to either
cross or integrate into the ER membrane [353, 270]. This is achieved in either a co-
or postranslational manner, mainly, with the help of a proteinaceous aqueous chan-
nel, the Sec61 channel [281].
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Figure 4: Sec61 Structure. A) Cutaway side view of a space-ﬁllingmodel of the idle SecYEβ channel fromMethanocaldococcus jan-
naschii (PDB code 1RH5) in themembrane. Pore ring in green and Plug domain in yellow. TM7/TM8 and TM2/TM3 in red and
blue, respectively. Figure fromRapoport et al. [310] B) Crystal structure of the idle SecY channel fromMethanocaldococcus jan-
naschii (PDB code 1RH5) as seen from above. Same coulor code as in A. SecE (brown) and Secβ (purple) are also visible. Figure from
Rapoport et al. [310]. C) Schematic representation of the channel as seen from the side (left) and from above (right). Same colour
code as A and Bwith the addition of TM10 being represented inMagenta. Figure fromGogala et al. [127].
A breakthrough on the mechanistic insights into the Sec complex function were
obtained by the resolution of the x-ray structure of the archaeal-bacterial SecY com-
plex which revealed that SecY (Sec61 in yeast and SecȾ in mammals) is divided
into two bundles of five transmembrane domains (TMD). These two bundles form
an hourglass-shaped pore, in which the loop between TMD5 and TMD6 serves as
a hinge [404, 400, 84] (Figure 4 A).
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The middle constriction, called the pore ring (Figure 4 A; green), consists of con-
served hydrophobic residues. On the lumenal side the pore is sealed by a short he-
lical plug domain (TMD2a) (Figure 4 A; yellow) [313, 310]. This two structures (the
pore ring and plug) guarantee that the channel is sealed, preventing ion and metabo-
lite leakage, thus mantaining membrane integrity [280]. The plug was also shown to
be important for efficient protein translocation, signal anchor protein orientation, and
Sec61 complex stability [184, 183].
Another interesting structure of the channel is its lateral gate, located opposite to
the hinge, and formed by TMD2b and TMD7. It is bordered by segments of TMD2
and TMD3 on one side and by segments of TMD7 and TMD8 on the other (Figure
4 B and C; blue and red, respectively) [404, 234]. This lateral gate serves as signal
peptide binding site during translocation early stages and allows TMDs of nascent
chains to partition into the lipid bilayer [292, 149, 127].
Translocation through the Sec61 channel can happen either co-translationally (i.e
concomitant with protein synthesis) or post-translationally (i.e after termination of pro-
tein synthesis).
Figure 5: Sec61 trimeric complex. Schematic representation of the Sec trimeric complex. Figure fromCross et al. [69].
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For co-translational translocation, Sec61 associates in a trimeric complex with
Sbh1 (Sec61ȿ in mammals) and Sss1 (SecE in bacteria, Sec61ɀ in mammals) [278,
442, 188, 153]. Sss1 contains an amphipathic helix that lies flat on the cytosolic sur-
face of the ER membrane, and a TMD that diagonally crosses the membrane, holding
the two halves of the Sec61 together (Figure 4 B and C, and 5; brown). It has been
proposed to act as a “clamp” that holds both halves of the SecY/Sec61 together, thus
stabilizing the open or closed state [90, 404]. Sbh1 is a tail anchored protein with an
unstructured cytosolic domain (Figure 4 B and 5; purple) [404, 424]. Both its trans-
membrane helix and its cytosolic domain interact with Sec61 [424, 465].
Figure 6: Sec heptameric complex. Schematic representation of the Sec complex during both post-translational (heptameric com-
plex; left) and co-translational (trimeric complex; right) translocation. Figure fromDelic et al. [76].
In eukaryotes, a requirement for post-translational transport is the association of
the Sec61 complex with the Sec63 complex [248, 277], which consists of Sec63,
Sec62, Sec71, and Sec72 [79, 44], forming the heptameric Sec complex (Figure 6,
left). Indeed, gating of the Sec61 translocon by Sec63 in a precursor dependent fash-
ion is hypothesized [214]. Also, over-expression of Sec63 decreases steady-state
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levels of multi-spanning membrane proteins, pointing to a potential regulatory function
[232].
0.2.2 Targeting
The first step of protein translocation, either co- or post-translational, is the recogni-
tion of the to-be translocated peptide and its targeting to the translocon (Figure 7).
Both processes depend on the recognition of a N-terminal signal peptide (SP) com-
posed by three domains: a net positive charge in the N-terminal region; a central hy-
drophobic H-region; and a polar C-terminal region defining the signal peptidase cleav-
age site [417, 147]. The general architecture of signal peptides is conserved [416].
Their primary sequence and length, however, vary substantially [418]. After transloca-
tion the signal peptide is removed by signal peptidase.
For the movement of signal peptides into the phospholipid bilayer, the hydrophobic-
ity of the H region is recognized by a hydrophobic patch of the lateral gate [423].
Figure 7: Steps of translocation. Schmeatic representation of the steps necessary for co-translational translocation. SRP - Signal
Recognition Particle. TMD - TransmembraneDomain. Figure from Shao &Hegde [353].
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The targeting for the co-translational translocation route begins in the cytosol when
the first hydrophobic element in the nascent polypeptide, either an N-terminal signal
peptide or the first TMD is recognized by the signal recognition particle (SRP) (Fig-
ure 7; Recognition) [426, 352, 136]. This recognition causes high affinity binding of
SRP to the ribosome and an arrest of chain elongation, increasing the time during
which the nascent chain remains competent for translocation [426, 447]. Targeting
of the ribosome/nascent-chain/SRP complex to the translocon occurs via an initial
interaction between SRP and the ER-localized SRP receptor (SR) (Figure 7; Tar-
geting) [123, 247] encoded by SRP101 and SRP102 in yeast [271]. This interaction
causes SRP displacement from the signal peptide and a concomitant release of the
elongation arrest [121]. The ribosome-SR complex then transfers the nascent chain
to Sec61 and translation resumes (Figure 7; Transfer and Recognition) [440]. Sup-
porting this hypothesis, is the biochemical and genetic evidence showing that the SR
directly interacts with the Sec61 complex [180, 376].
In this model, the Sec61 complex acts as a receptor for the ribosome via its cytoso-
lic loops [60] and the alignment of the ribosomal tunnel with the central pore of the
translocon allows direct movement of the nascent chain from the ribosomal tunnel
exit across or into the membrane (Figure 7; Recognition and Integration) [18, 19]
Generally speaking, membrane proteins and SP preferentially engage the SRP-
dependent pathway due to their high hydrophobicity. SP of lower hydrophobicity, how-
ever, depend on a Sec complex-mediated post-translational translocation [258].
The targeting of proteins for post-translational translocation is less well understood.
They escape recognition by SRP, either because they are to short to engage SRP
before their synthesis is completed, or due to less hydrophobic signal peptides [310].
Indeed, the heptameric Sec complex subunit Sec62 has been suggested to act as
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a targeting receptor for small presecretory proteins with comparatively short and ap-
olar signal peptides [212, 214]. Likewise, the Sec72 component, which possesses
a tetratricopeptide repeat (TPR) domain, was also shown to interact with an Hsp70,
suggesting it may act as a target receptor [398].
However, signal peptides have a dual function: they do not only target pre-secretory
proteins to the Sec61 complex; they also trigger the opening of the Sec61 pore form-
ing subunit for passage of the nascent polypeptide [445, 404, 63].
0.2.3 Translocation
In the quiescent state, the Sec channel is closed both axially across the membrane
and laterally toward the lipid bilayer [422, 423]. Nevertheless, for both co- and post-
translational import the channel must open longitudinally.
0.2.3.1 Co-translational Translocation
During co-translational import the initial trigger for channel priming is ribosome arrival.
The cytosolic loops 6 and 8 of Sec61 interact with the RNC at the polypeptide exit site
on the large ribosomal subunit [60, 17, 422]. Ribosomal interaction induces shifting of
these transmembrane helices, resulting in a cracking of the cytosolic half of the lateral
gate. This both destabilizes the interaction between helices 2 and 7 (responsible for
the closed state of the lateral gate) and exposes a seam of hydrophilic residues to the
hydrophobic bilayer. Thus, ribosome binding, constrains Sec61 in a destabilized state
relative to the quiescent channel [424]. Structural analysis of the mammalian translo-
con also suggested that simple ribosome binding was sufficient to induce lateral gate
opening [284]. Alternative data, however, showed that in the SecY channel ribosome
binding causes only minor alterations, and that it is the SP binding that causes struc-
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tural modifications [279, 215].
Figure 8: Translocation process. Schematic representation of the stages of protein translocation through the Sec61 channel. Based
on ﬁgure fromRapoport et al. [310].
As the hydrophobic signal peptide approaches the channel, it is faced with a pre-
dominantly hydrophilic environment: the aqueous pore of Sec61 and the polar head-
groups of the lipid bilayer [423]. Due to the conformational changes caused by the
ribosome binding, the hydrophobic patch belonging to TMD2 and TMD7, is also ex-
posed, creating thus a binding site for the hydrophobic H region of the signal pep-
tide [292, 423]. After SP binding, translocation is initiated by insertion of the nascent-
chain into the channel in loop-like manner. While the SP remains bound to the chan-
nel hydrophobic patch, the downstream section resides in the pore (Figure 8, left)
[354, 292, 310].
If the signal is sufficiently hydrophobic, it displaces TMD2, destabilizing further the
lateral gate, while simultaneously widening the central pore to dislodge the plug by
movement of TMD7 towards TMD10 [423, 160, 279]. This allows the intercalation of
the hydrophobic signal (or TMD) into the lipidic bilayer in an energetically favorable
fashion (Figure 8, middle) [42, 241, 423].
The Sec61 channel is a passive pore with an aqueous interior; a polypeptide chain
14
located in the channel can slide in either direction. To achieve unidirectional transport
(i.e., export from the cytosol into the ER lumen or extracellular space), the channel as-
sociates with partners that provide a driving force. In cotranslational translocation, the
channel partners with the translating ribosome, which feeds the growing polypeptide
into the channel [310]. In post-translational translocation in eukaryotes, the Sec61
channel partners with the Sec63 complex and the luminal chaperone Kar2 (Bip in
mammals), a member of the Hsp70 family of ATPases [310, 235]
During the entire process, the SP is thought to remain bound to the Sec61 complex
until a translocon associated signal peptidase cleaves it, releasing the translocated
peptide into the ER lumen (Figure 8, right) [181, 5, 145].
Most membrane proteins, however, lack a SP and their highly hydrophobic N-terminal
TMDs serve as a recognition signal instead [419]. Nevertheless, most of them use
the cotranslational pathway for their integration [258, 8, 335].
Translocation of hydrophilic peptides requires only slightly rearrangement of the
channel, where the lateral gate displays an essentially closed state. Membrane inser-
tion of a hydrophobic domain, on the other hand, requires Sec61 lateral gate to open
and a rearrangement of its plug to guarantee maintenance of ion permeability barrier
[127]. Structural rearrangements of helices 2b and 3 on one side and 7 and 8 on the
other, allow partition of the TMDs into the lipid bilayer [160, 313]. This partioning is
mainly determined by the TMD hydrophobicity [156] and follows the ‘‘positive-inside
rule’’ [420] (Figure 9). Depending on the peptide sequence, this might happen only
once (Figure 9 A and B) or multiple times (Figure 9 C) until all TMDs have been in-
serted into the membrane [353].
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Figure 9: Trans-membrane segmentsmembrane insertion scheme.Models of transmembrane domain (TMD) insertion.A) Generic
model for TMD-translocon interactions. B) Depending on any of various parameters, the sequence of events in panel a can be biased
toward one or the other outcome. Lengthy N-terminal domains strongly disfavor their translocation into the lumen. Consequently,
type II orientation is the favored. C) Example of non-sequential insertion of TMDs in a polytopic integral membrane protein (IMP).
Figure from Shao &Hegde [353].
0.2.3.2 Post-translational Translocation
Although alternate post-translational pathways to the ER are used by specialized sub-
classes of proteins [353, 148, 8], most post-translational translocation is done by the
heptameric Sec complex (Figure 10).
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Figure 10: Pos-translational translocation scheme.Model of pos-translational translocation in eukaryotes. The scheme shows
different steps in the pos-translational translocation of a eukaryotic secretory protein. Figure from Park & Rapoport [280].
Current models for post-translational translocation suggest that the Sec63 complex
recognizes and binds the SP of soluble, fully translated substrates. Through confor-
mational changes, it then transmits information to the translocon and Kar2, which is
lumenally associated [14, 145, 280]. As in co-translational translocation, SP binds to
the channel near the lateral gate and induces pore opening, allowing the hydrophilic
polypeptide to transverse the membrane (Figure 10, step 1) [292, 423]. The secretory
protein then associates with Kar2 which promotes directed movement of the polypep-
tide (Figure 10, steps 2 and 3) [235, 277]. In fact, the Kar2/Sec63 (through its J do-
main) interaction is responsible for the coordinated and directed anterogade peptide
movement [94, 250]. Additional data suggests that this interaction might also play a
role in co-translational translocation [43, 309, 411]. It has been suggested that the
Kar2 drives import by promoting folding, which serves as the driving force [130, 307].
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0.3 Protein Folding and ER Quality Control
0.3.1 Folding
As polypeptides emerge from the translocon, they are unfolded. They must, therefore,
undergo a folding process until their native conformation is achieved. Since the ER lu-
men is an aqueous environment, hydrophobic peptides and protein domains would be
bound to aggregate if left in a free, unstructured form. To tackle this problem, molecu-
lar chaperones immediately engage the nascent polypeptides at the pore exit. Chap-
erones can help in the actual translocation, like Kar2 [309, 43], and promote protein
folding [116, 37, 7]. Moreover, chaperone interaction guarantees that any given pro-
tein stays in the ER until it is correctly folded [456].
In fact, the ER provides an optimized environment for protein folding and matura-
tion. This is mainly due to the high concentration of ER-resident chaperones [85].
With their help both soluble and membrane proteins can acquire their native confor-
mations [461].
Chaperones perform their functions by non covalently binding to the surface-exposed
hydrophobic patches of the unfolded or misfolded peptides, thus preventing protein
aggregation. In some cases they even provide secure (i.e protected) environment for
protein folding [329, 47].
One of the main families of chaperones is the heat shock proteins of 70 kDa (Hsp70s)
family [236, 73]. This family is quite prolific and versatile. They are not only present in
nearly every cellular compartment in eukaryotes and in most prokaryotes, as their
functions span protein folding, transport, and degradation [411]. In general, Hsp70
proteins, like BiP (Figure 11, top, in purple), catalyze ATP hydrolysis when binding
to exposed hydrophobic segments of unfolded proteins (Figure 11, top) , remaining
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bound until ADP is released, thus facilitating protein folding. Due to a weak ATPase
activity, Hsp70s need DNAJ/Hsp40 co-chaperones (ERdj: ER-resident DNAJ pro-
tein) to accelerate ATP hydrolysis and promote maximal chaperone activity (Figure
11, bottom, in brown) [245, 154, 425, 68]. For ADP and ATP realease and re-fuelling,
respectively, nucleotide-exchange factors (NEFs) are necessary (Figure 11, top, in
red)[144, 46, 20].
In yeast, one of the most prominent Hsp70 is the already mentioned Kar2, having
an important role in ER folding besides its role in translocation. For Kar2, the known
co-chaperones are Sec63, Scj1, and Jem1 [337, 266]. Sec63 is transmembrane (3
TMDs) with a lumenal J-domain, Jem1 is ER membrane-associated, and Scj1 is a
soluble ER-lumenal protein [366, 266, 94]. Although Kar2 interacts with Sec63 also
during translocation, its interaction with Jem1 and Scj1 seems to be exclusively to
maintain aberrant proteins soluble [267]. As for its nucleotide exchange factors, Kar2
seem to partner with the Hsp70 Lhs1, as well as with Sil1, a GrpE family member [15,
379, 135]. Additionally, Kar2 has also been described has having prominent roles in
protein degradation via ERAD and UPR regulation [267, 239].
Due to its roles in recognizing and binding of unfolded proteins and in maintaining
said protein in the ER, Kar2 activity represents a major ER quality control (ERQC)
stage.
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Figure 11: Nascent chain interactionwith lumenal chaperones.Model of protein folding andmisfolding at the ER. Co-translational
glycosilationmediated byOST catalyses followed by chaperone action. BiP binds nascent chains in an ATP-dependentmanner
assisted ERdjs andNEFs. Pdi1 promotes disulﬁde-bond formation oxidizing cysteine residues, being kept oxidized by Ero1 and ER
peroxidases PrxIV and Gpx7/8. Based on ﬁgure fromMcCaffrey & Braakman [239].
Another essential folding catalyst and chaperone of the ER is Pdi1, the better known
member of the PDI family [119, 104]. Pdi1 has a dual role. It serves as a chaperone,
interacting with portions of the substrate that would normally self-associate, and thus
inhibiting the aggregation of misfolded proteins [301, 51], and is responsible for disul-
fide bond formation (Figure 11, bottom, in dark blue). Disulfide bonds are crucial for
protein folding, function and stability [6]. Since the ER lumen possesses an oxidizing
environment, protein disulfide isomerases, with their thioredoxin-like domains, can
catalyze the formation, isomerization, and reduction of disulfide bonds [14, 239]. Pdi1
is one of such proteins. Besides Pdi1, four other ER-resident PDI homologs have
been identified: Mpd1, Mpd2, Eug1, and Eps1 [269].
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Pdi1 has five domains: a, b, b’, a’, and c [72]. The a and a’ domains are those con-
taining the thioredoxin-like active sites and responsible for its oxidative role [97]. The
b and b’ domains have a fold similar to a and a’ domains but do not contain active
sites [193]. The c domain represent a highly negatively charged sequence that was
related to its low affinity, high capacity calcium-binding properties [231, 403]. The
presence of these activity devoided domains confers Pdi1 the capacity to bind pep-
tides or proteins [268, 200], leading to its chaperone role [401]. Some data seems to
suggest that the critical function of Pdi1 may be the isomerization of non-native disul-
fide bonds [133], and its chaperone activity is thought to depend on this isomerase
function [190, 441, 346]. Indeed, Pdi1 is involved in the folding of even proteins that
lack disulfide bonds [427, 51, 375]. Moreover, recent reports show that members of
the PDI family (including Pdi1) interact with components of the ER folding machinery
(e.g calnexin and Kar2) [120, 199], as well as with Htm1, a QC mannosidase enzyme
[112].
Interestingly, only a subset of members of the PDI family are able to catalyse disul-
fide bond isomerization efficiently, whereas others are probably not directly involved
in native disulfide bond formation [86]. Growing evidence suggests that the variation
of domain architectures in the PDI family [415] might account for their different affinity
for specific chaperones, which would allow shepherding of a broad range of proteins
into either their folded forms or into ERAD pathways [14].
Together, Kar2 and Pdi1 represent preponderant QC sensors. Any incomplete fold-
ing or misfolding ensues binding of one or more of this factors promoting ER retention
[103, 151, 152].
Of all the post-translational modifications (PTMs) happening in the ER, the most
prevalent is the attachment of carbohydrates, which is essential for the maturation
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of many proteins [150]. Attachment of oligosaccharides to newly synthesized polypep-
tides not only increases their solubility but also their processing serves as ER-resident
lectin chaperone recruitment signals, regulating glycopolypeptide folding and turnover
[430, 448, 189]. Although the mechanism for protein glycosilation is well studied, its
direct role in folding and quality control was only recently understood. To the moment,
only two forms of glycosylation capable of serving this role were identified: N-linked
glycosylation and O-mannosylation [456].
In case of N-linked glycosylation, oligosaccharides are added to consensus Asn-X-
Ser/Thr sites (sometimes NXC, NXV or NG) where X is any amino acid except proline
[468]. This addition, which can be concommitant with polypeptide translocation, is
catalyzed by the oligosaccharyl transferase (OST) enzyme using a lipid-linked gly-
can donor. The OST complex is composed by Ost1, Ost2, Ost3 or Ost6, Ost4, Ost5,
Wbp1, Swp1, and Stt3, all of which are integral membrane proteins [192], and was
described as directly interacting with the Sec61 translocon [334, 192, 226].
Besides N-linked glycosylation, there are proteins that undergo O-linked mannosy-
lation. This happens by attachment of residues of mannose to serines or threonines
by protein O-mannosyltransferases (Pmts) [383, 226]. S.cerevisiae expresses seven
integral membrane mannosyltranferases (Pmt1–Pmt7) that are able to link mannose
residues to proteins using a lipidic-linked mannose donor [383, 444]. A recent study
also reported that the O-mannosyltransferase associates with the Sec61 translocon,
allowing co-translational O-mannosylation [226].
This initial glycosilation, which was attached en bloc to nascent polypeptides, will
then help protein folding and ER QC as it is sequentially processed by glycosylhydro-
lases in a protein conformation-dependent manner [150, 7].
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0.3.2 Quality control
Figure 12: Quality control in the ER. Schematic representation of the different pathways involved in ER quality control from en-
trance in the ER until ER exit. Figure fromCyr &Hebert [70].
It has long been known that many eukaryotic newly synthesized proteins misfold dur-
ing biogenesis [344]. Although estimations about protein biogenesis efficiency vary,
it represents a high-fidelity process [82, 128]. Nonetheless, due to mutations, tran-
scription and translation errors, cell stress, etc., a small proportion of proteins always
misfold [225, 400]. The accumulation of aberrant proteins, without countermeasures,
can seriously compromise cell function [205, 80, 320]. In order to circumvent this is-
sue, the cell possesses sophisticated QC mechanisms that recognize, segregate,
and degrade misfolded proteins (Figure 12. Therefore, proteins are subject to strin-
gent quality control. For secretory proteins, such quality control begins at their site of
biogenesis, the ER, which possesses perhaps the most elaborated QC environment.
High concentration of chaperones and protein-modifying enzymes ensures that only
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mature proteins exit the ER [399, 85, 7, 456].
At its essence, ER QC encompasses a series of pathways that integrate folding,
traffic control, sorting and disposal of misfolded proteins (Figure 12). Understanding
the system requires the characterization of individual pathways, the identification of
components and their organization, the precise dissection of the sequential events,
and how individual factors fit into each step. [189]
Proteins that do not fold properly must be retained and targeted to ERAD for turnover
[391, 274, 328]
For the purpose of maintaining a tight QC system, the cell uses intrinsic structural
signals to detect unfolding or misfolding. Many of these are PTMs, as mentioned in
Section 0.3.1, as any lack or delay in the acquisition of said modification may serve
as a signal of misfolding.
The cell distinguishes native from non-native protein conformations by using vari-
ous sensor molecules, mainly molecular chaperones, since these inherently interact
with incompletely folded proteins. Besides assisting in protein folding, chaperones are
often involved in the recoginition and dispatching of misfolded proteins for degrada-
tion [85, 36, 239, 381]. The conformation-sensing system depends on selective and
covalent ”tagging” of misfolded proteins, allowing their recognition by the machinery
responsible for folding and degradation. The best described tags are ubiquitin and
glucose. Ubiquitin, a small protein, is cytosolically attached to lysines as a signal for
degradation [125]. Glucose, in turn, is attached at the ER lumen to the N-glycans of
glycoproteins, functioning as a retention signal (Figure 13) [137, 283]. By preventing
exit from the ER of folding intermediates, it extends their exposure to the ER folding
machinery, thus improving the chance of correct maturation [249].
In both mammals and yeast, the rapid removal of terminal glucose and mannose
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residues from protein-bound oligosaccharides and the regulated addition of a specific
glucose residue dictates the sequential schedule of events occurring during matura-
tion and selection for degradation (Figure 13) [388]. A series of carbohydrate trim-
ming events begin with the removal of the terminal glucose residue by glucosidase I
(Gls1/ Cwh41). Glucosidase II (Gls2/Rot2) removes the next two progressively (Fig-
ure 13, top panel, left). This process, which is quick in S.cerevisiae, can be slowed in
other organisms for the calnexin folding cycle [150, 7].
Figure 13: Glycan trimming. Upper panel depicts yeast pathway of glycan trimming, and the lower panel depicts themammalian
pathway. The blue sphere outlined in red (Man7GlcNAc2 glycan; right) indicates the terminal α-1,6￿linkedmannose ligand of the
yeast Yos9 (OS-9 and XTP3-B inmammals), an ERAD receptor. Glc, glucose; GlcNAc, N-acetylglucosamine; Gls, glucan synthase of
cerevisiae protein; Man, mannose;Mns1, mannosidase I; Pdi1, protein disulﬁde isomerase. Figure fromXu&Ng [456].
One of such primary QC systems, the mammalian calnexin/calreticulin cycle, is
particularly well-characterized (Figure 14). This system retains in the ER non-native
glycoproteins, thus promoting their folding or, in some cases, targeting misfolded gly-
coproteins for degradation [275, 432, 223, 409]. Calnexin and calreticulin interact with
the intermediates of the N-linked core glycans trimming pathway of newly synthesized
glycoproteins (Figure 14, middle) [137, 432, 146]. Both calnexin and calreticulin inter-
act also with ERp57, a thiol-disulphide oxidoreductase [273, 272], forming a protected
space where the substrate can bind. Glucosidase II hydrolyses a glucose from the
core glycan of the substrate glycoprotein, promoting its dissociation from calnexin or
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calreticulin. The UDP-glucose:glycoprotein glucosyltransferase (UGGT), however,
catalyzes the inverse reaction, re-glucosylating the substrate and promoting reasso-
ciation with calnexin or calreticulin. UGGT works as a folding and re-glucosylation
sensor only if the glycoprotein is incompletely folded [283]. Only when UGGT fails to
re-glucosylate it, does a protein exit the cycle. In this way, glucose acts as a selec-
tive tag for incomplete folding. Cycles of glucosylation and de-glucosylation end when
the glycoprotein either reached its native conformation or is targeted for degradation
(Figure 14, right and top, respectively) [85].
Figure 14: Calnexin/calreticulin cycle. N-linked glycosylation and the degradation of glycosylated proteins. After co-translational
glycosilation, glycan is sequentially trimmed by glucosidase-I and glucosidase-II enabling substrate recognition by calnexin and
calreticulin, which facilitate folding. ERP57 (disulphide isomerase homologue) catalyses disulphide bond formation. If glycoproteins
have adopted their native conformations, they can be de-mannosylated (denoted by the use of parentheses around themannoses)
by ERmannosidases I and II (ERman-I andman-II) and exit the ER. If not, proteins are reglucosylated by UGGT, which promotes re-
entry into the folding cycle. Terminally misfolded glycoproteins might also be targeted for ER-associated degradation (ERAD). Based
on ﬁgure fromVembar & Brodsky [409].
In S.cerevisiae, however, there is no UGGT and a role for calnexin in protein fold-
ing remains to be determined (Figure 13, top versus lower panel) [240].
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Yeast also possesses two additional ER mannosidases (Mns1 and Htm1) that trimm
mannose residues from the glycan moiety (Figure 13, middle and right) [49, 189].
Mns1 and Htm1, two related enzymes, have distinct specificities. Mns1 removes the
terminal mannosyl residue of Man9GlcNAc2 processing it into Man8GlcNAc2, which
is the typical glycan of exported proteins (i.e fully folded glycoproteins) [176]. Htm1 is
thought to interact with terminally misfolded proteins, after Mns1 [62]. The resulting
Man7GlcNAc2 glycan is recognized by Yos9, an ER lectin that targets the protein for
ERAD (Figure 13, right, circled in red) [55, 77].
0.3.3 UPR
Retention of unfolded or misfolded proteins in the ER as a result of the action of the
ER QC machinery activity can cause ER-proteostasis stress. In yeast, ER proteosta-
sis stress elicits the unfolded protein response (UPR) [24, 107]. Use of ER protein
folding inhibitors (e.g., tunicamycin, dithiothreitol) or overexpression of misfolded pro-
teins can also experimentally induce UPR [24].
The UPR triggers an adaptive response to restore ER homeostasis by coordinat-
ing a reduction in the quantity of protein produced, increased synthesis of molecular
chaperones to deal with buildup of misfolded protein, as well as an increase in ERAD
to remove misfolded proteins [396, 343]. In fact, much of the folding and biogenesis
machinery in the ER was found to be under the transcriptional control of the UPR. By
genetic screening IRE1, HAC1, and RLG1 were found to be essential for robust UPR
[67, 363].
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Figure 15: UPR in yeast. General yeast UPR schematic. Under unstressed conditions, BiP binds to Ire1maintaining it inactive. When
the ER is stressed, BiP can be titrated away to bind tomisfolded substrates, in turn inducing Ire1 dimerization and activation. Ire1
activation triggers its endoribonuclease activity which in turn causes HAC1 (a dedicated UPR transcriptional activator) mRNA
splicing. After re-ligated and translated, Hac1 translocates into the nucleus, binds to UPR elements (UPREs) upregulation target-
genes expression. Figure fromVembar & Brodsky [409].
Posterior studies revealed that IRE1 encodes an ER transmembrane protein that
has a cytosolic domain with kinase/ribonuclease activity and a lumenal domain that
senses and transduces unfolded protein levels. HAC1 encodes a transcription factor
with a leucine zipper that binds to specific unfolded protein response element (UPRE)
sequences, typically 22bp long, inducing their expression. RLG1 encodes a tRNA lig-
ase that is required for the ligation of the Ire1-spliced HAC1 pre-mRNA [67]. Current
models indicate that the lumenal domain of Ire1 interacts with Kar2 and unfolded pro-
teins, thus sensing the protein folding status (Figure 15, step 1) [25, 290, 108]. When
unfolded proteins accumulate in the ER, Kar2 interaction is compromised and Ire1
oligomerizes, thus activating its cytoplasmic kinase and ribonuclease domains (Figure
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15, step 2). Activated Ire1 ribonuclease splices HAC1 pre-mRNA and the the Rlg1
ligates the intermediate product, producing mature HAC1 mRNA (Figure 15, step 3).
Hac1 protein will then act as a potent transcriptional activator of UPR target genes
(i.e UPRE-containing) (Figure 15, step 4) [24, 364, 191]. Besides Kar2, other ER fold-
ing key components are under UPR induction, like Pdi1 and Eug1 [66, 252]. Inter-
estingly, Ire1 has been shown to form a complex with the Sec61 translocon, which it
needs to efficiently cleave its mRNA substrates [298].
The mechanism of Ire1 activation and signal transduction is conserved from yeast
to mammals [431, 356, 220]. However, while in yeast the only mechanism for UPR in-
duction is the one mediated by Ire1, in mammals there are three classes of ER stress
sensors: inositol-requiring enzyme 1Ⱦ (IRE1Ⱦ) and IRE1ȿ ; protein kinase RNA-like
ER kinase (PERK); and activating transcription factor 6 (ATF6; both Ⱦ and ȿ isoforms)
[157, 70].
When a protein has attained its native conformation, it is targeted to its final desti-
nation. If an aberrant conformation arises or folding is delayed, the substrate is sub-
jected to additional folding cycles, or if deemed terminally misfolded, shepherd for
ERAD [47, 240].
0.4 ERAD
ER-associated degradation (ERAD) is the process by which misfolded ER proteins
are detected by ER-resident factors and directed for retro-translocation into the cy-
tosol, where they undergo ubiquitin- and proteasome-dependent degradation (Figure
16) [430, 409]. This highly conserved process prevents accumulation and eventual
aggregation of defective secretory proteins, thus promoting ER homeostasis and a
normal cellular physiology [159, 45, 370].
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Figure 16: ERAD pathway scheme. Step-by-step illustration of endoplasmic reticulum-associated degradation. Based on ﬁgure
fromVembar & Brodsky [409].
0.4.1 Recognition and Targeting
The first step in ERAD of misfolded proteins it is their recognition by the cell (Figure
16, step A). ERAD substrate recognition and targeting (Figure 16, step B) can be-
come indistinguishable as growing evidence suggests that the recognition factors
belong to multiprotein complexes that are required for targeting as well [409].
The association of ER chaperones with unfolded and misfolded proteins suggests
dual function in protein folding and quality control. While chaperones transiently bind
unfolded polypeptides to aid folding in the ER [114, 260, 137, 291], irreversibly mis-
folded proteins seem to exhibit stable interactions with ER chaperones [169, 259].
This dynamic is best understood in the well characterized mammalian calnexin/calreticulin
cycle [150]. Indeed in the ER lumen, the chaperones Kar2, Pdi1 and its homologue
Eps1, and the semi-redundant J-domain containing proteins Scj1 and Jem1 proteins
are required for ERAD [267, 366, 120, 185, 429]. This process seems logical as, in
order to be translocated across the ER membrane to the cytosol, ERAD substrates
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need to be soluble and dissociated from oligomeric complexes, and their disulfide
bonds need to be reduced [393, 120, 92, 267, 350]. Substrates that present mis-
folded cytosolic domains and contain short or folded luminal segments seem to de-
pend on the cytoplasmic Hsp42, Hsp26, Hsp70 and its co-chaperones Ydj1 and Hlj1
for ERAD in a way that can be substrate-specific [172, 2, 282, 410, 460].
Prolonged chaperone association, however, does not appear to be a sufficient trig-
ger for ERAD. There are numerous examples of misfolded proteins stably retained
in the ER [224, 208, 202, 377]. Indeed the actual targeting into the ERAD pathway
may be mediated by chaperones that do not interact with normal folding intermedi-
ates [321]. Furthermore, recent studies indicate specific “signals” must be displayed
to activate degradation [454].
One of this signals is de-mannosylation, which has been identified as a require-
ment for degradation of misfolded N-glycosylated proteins (Figure 17) [150, 452]. Af-
ter trimming by Gls1, Gls2 and Mns1, the resulting Man8-GlcNAc2 is indicative of a
protein ready for export (Figure 17, number 1). Delay in this stage, allows this struc-
ture to be processed by a mannnosidase-related lectin in the ER (Htm1/Mnl1 in yeast;
EDEM in mammalian cells) [150] whose action seems to be determinant for ERAD
(Figure 17, number 2) [175, 251]. Work with CPY* and PrA* (standard glycosilated
substrates) suggested that formation of a local structure adjacent to the glycan is de-
pendent on the overall folding of the polypeptide and that the full determinant is as
simple as a Man7GlcNAc2 glycan attached to an unfolded/disordered structure. Its
positioning seems to effectively generates an intrinsic sensor for the overall folding of
the polypeptide [453, 454]. Presently, an elegant mechanism where a protein-linked
carbohydrate chain is transformed into an intrinsic timer for folding is widely accepted
[303, 62, 454].
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Figure 17: De-manosilation as folding signal. Schematic representation of the glycanmoyety of glycoproteins and of how its length
serves as signal for protein fate. Enzymes responsible for each of the trimming steps are represented at the proper steps. Red circle
highlights the α1,6-linkedmannose residue that serves has the Yos9 ligand. Based on ﬁgure from Thibault &Ng [391] and Ellgaard &
Helenius [85] .
In both yeast and mammals, multiple glycoprotein-recognizing ER-resident fac-
tors were characterized recently. These include the ER degradation-enhancing α-
mannosidase-like (EDEMs) and the mannose-6-phosphatereceptor-like domain con-
taining (Yos9 in yeast, OS9 in mammals) lectins. These factors are thought to be
responsible for ERAD-substrate delivery to the retrotranslocon [189]. Suggesting a
chaperone like activity, Yos9 was shown to bind even unglycosylated misfolded sub-
strates. Moreover, Yos9 associates with BiP and the Hrd1 complex, where it may reg-
ulate Hrd1 selectivity for misfolded substrates [77, 55, 111]
Work in Saccharomyces cerevisiae resulted in a simple model of three core ERAD
pathways depending on the localization of the misfolded domain. They were named
ERAD-L, -M, or -C depending if the substrate lesion was in the ER lumen, within the
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membrane, or on the cytosolic side of the ER membrane, respectively (Figure 18)
[77, 55, 407, 172, 113]. These pathways involve distinct ubiquitin ligases (Hrd1 and
Doa10) which associate with specific adapter molecules to form hetero oligomeric
complexes that associate with misfolded proteins [96, 159].
Figure 18: ERAD L-,M- and C scheme. Schematic depiction of the different ERAD pathways. Figure from Stevenson et al. [381].
ERAD-L substrates (Figure 18, number 1) use the Hrd1 complex [34, 55], being
recognized by Kar2, Jem1 and Scj1. These chaperones, assisted by Pdi1 and Yos9,
associate with Hrd3 and thus recruit substrates to the Hrd1 complex [111]. Substrates
of ERAD-M and ERAD-C (Figure 18, numbers 2 and 3, respectively) are directly rec-
ognized by Hrd1 and Doa10, respectively, with the latter acting together with Ssa1,
Ydj1 and Hlj1 [254]. Doa10, however, also recognizes some ERAD-M substrates
[134]. In this model, ERAD specificity is maninly assured by the ubiquitin-ligase com-
plexes accessory proteins, that function as substrate-recruitment factors.They bind
misfolded proteins selectively, and promote their targeting for downstream processing
[101, 246].
Besides this well established pathways, a fourth pathway responsible for the degra-
dation of misfolded inner nuclear membrane proteins was recently identified [102]. It
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instead utilizes a ubiquitin ligase-complex consisting of three proteins, Asi1, Asi2, and
Asi3 [102, 194].
The ERAD-C, ERAD-L and ERAD-M pathways, however, have been defined only
in yeast. In mammals, the bigger assortment of ERAD-requiring components, led to
an increased complexity of the evolved secretory-pathway residents, which may have
caused a blurring of the distinctions between pathways. Even in yeast the ERAD-C
and ERAD-L pathways can overlap, as certain membrane substrates require both
the Doa10 and Hrd1 ubiquitin ligases for degradation [172, 207, 255]. This probably
increases degradation efficiency and allows for compensation in case of substrate
overload of one or the other pathway [409].
Rather surprisingly, soluble substrates (but not transmembrane ERAD substrates)
also rely on genes required for ER-Golgi vesicle budding and anterograde transport
(SEC12, SEC18, ERV29, ERV14, SEC23, SEC13, UFE1, SED5) [52, 390, 105] which
suggests that some proteins are subject to one round of transport to the Golgi com-
plex followed by recycling to the ER [52, 406].
0.4.2 Ubiquitin ligases - Doa10 and Hrd1
All ERAD pathways converge on the ER cytosolic face, where they require other com-
ponents of the ubiquitination machinery and an ATPase complex consisting of the
AAA+ ATPase Cdc48 (called p97 or VCP in mammals) and a heterodimeric cofactor,
composed of Ufd1 and Npl4 [16, 40, 178, 305, 457, 458].
Central components of this process are the multimeric protein complexes contain-
ing membrane bound ubiquitin ligases. There are two main E3 ligase complexes in
the yeast ER: Doa10 and Hrd1, both multi-spanning membrane proteins [138]. They
also have in common the fact that they partner with substrate-recognition, targeting
34
and retrotranslocation components, and assemble in large protein complexes. Mainly,
they coordinate protein quality-control activities with cytoplasmic substrate ubiquityla-
tion, the Cdc48 action, and the proteasome action [101, 246].
Of both these complexes, Doa10 is the simpler (Figure 19 A). Besides Doa10 (green),
it contains Ubc7 (E2 ubiquitin conjugating enzyme; cyan), which is attached to Doa10
via Cue1 (grey) [29]. In addition, the Cdc48 subcomplex (Cdc48/Ufd1/Npl4; purple,
magenta and yellow, respectively), which provides the driving force for substrate ex-
traction [16, 457, 178, 305], is linked to it through Ubx2 (orange) [257, 345].
Figure 19: Ubiqutin ligases complexes. Schematic depiction of the twomain cellular ubiquitn ligase complexes. A) Doa10 complex.
B) Hrd1 complex. Figure from Thibault &Ng [391].
Hrd1 (Figure 19 B, light green), a ER-membrane protein with a cytosolic RING fin-
ger domain [159, 74], forms a complex with Hrd3 (dark green), which acts as a sub-
strate recruitment factor [113]. Despite little similarity between the two E3 enzymes,
the Hrd1 complex also includes Cue1, Ubc7, Ubx2, Cdc48, Ufd1, and Npl4 (grey,
cyan, orange, purple, magenta, and yellow respectively), which explains why mutat-
ing any of these component results in broad ERAD defects [389, 55]. Additionally,
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Usa1 bridges Der1 (lilac) to the complex. Lastly, Yos9 (red) is bound to the luminal
domain of Hrd3 [48, 26, 197, 385] (Figure19 B). Because Hrd3’s luminal domain can
bind proteins with or without glycans, these factors are believed to work together in
substrate recognition [111].
0.4.3 Ubiquitination
Most known ERAD substrates need to be ubiquitylated for proteasome-mediated
degradation. This process needs the action of a set of enzymes that include an E1
ubiquitin-activating enzyme, an E2 ubiquitin-conjugating enzymes and an E3 ubiquitin
ligases. In some cases, action of E4 ubiquitin-chain-extension enzymes was shown
to facilitate ERAD [255, 314, 204].
The ubiquitin conjugation process happens in a cascade of E1–E2–E3 enzymes
(Figure 20) [304]. It is initiated by E1 enzymes, like Uba1 (Figure 20, step 1). Acti-
vated ubiquitin can then be transferred to an E2 (or Ubc) enzyme by trans-esterification
(Figure 20, step 2). Finally, E3 enzymes (ubiquitin ligases) catalyze the protein-ubiquitylation,
by covalently binding ubiquitin to lysine residues (Figure 20, step 3 or 4) [78, 405]. Al-
though lysines are the most common acceptor for ubiquitylation, ubiquitylation of ser-
ine, threonine, or cysteine has been observed in both yeast and mammals [50, 358]
and of N-terminal amino groups in higher eukaryotes [32, 21]. The conjugation ma-
chinery shows hierarchical organization. In yeast, only one E1 exists, while it has 11
E2s and a large family of E3s (60–100). The admirable selectivity of E3s ubiquityla-
tion is mediated by their direct interaction with the substrate [101].
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Figure 20: Ubiquitylation cascade. Scheme illustrating the ubquitylation cascade necessary for ERAD. The sequential action of
E1-E2-E3 enzymes guarantee speciﬁcity and versatility of the ubiquitylation system. Based on ﬁgure fromVembar & Brodsky [409].
The E3 ubiquin ligases, like Hrd1 and Doa10, mediate only the initial oligo-ubiquitylation
of ERAD substrates; polyubiquitylation, which is required for degradation by protea-
somes, is catalyzed by so-called E4 enzymes such as Ufd2 [203, 314]. Ufd2, Cdc48,
the 19S proteasome regulatory particle (RP) subunits Rpn10 and Rpt5, Rad23 and
Dsk2, all bind ubiquitin conjugates and may transport substrates to the proteasome
proteolytic core, but their respective roles are unclear [203, 213, 242, 413].
It must be highlighted that since ubiquitylation takes place in the cytosol it cannot
be involved in initiating the export of soluble proteins from the ER [138].
0.4.4 Cdc48
After polyubiquitylation, and prior to or during targeting to the proteasome, proteins
must be extracted from the membrane. Although the proteasome being able, in a few
cases, to retrotranslocate substrates [237, 216], another cytoplasmic protein complex,
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the cell-division cycle-48 (Cdc48) complex, was shown to be involved in substrate
retrotranslocation [179]. In yeast, the complex consists of Cdc48, a hexameric AAA+
ATPase, and Ufd1 and Npl4. Recruitment of the complex to the ER membrane might
happen through its interaction with Ubx2 (vIMP in mammals) [257, 345, 459], by its
binding to Sec61 [41], or through its binding to Hrd1 [11].
The Cdc48/Ufd1/Npl4 complex has been described as being both a “dislocase”, ca-
pable of exerting force and extracting substrates from the retrotranslocon [457, 458],
and a “segregase,” recognizing and binding ubiquitinated proteins, thus selecting
them from non-ubiquitinated ones, facilitating their availability to the proteasome for
degradation [308, 40]. As Cdc48 associates with the proteasome cap [412], sub-
strates might be transferred directly from the Cdc48 complex to the proteasome for
degradation [413].
Increasing evidence suggests that other factors may have decisive roles in sub-
strate degradation [304], as is the case of Uba domain- and Ubl domain-containing
proteins, which interact with the proteasome and with ubiquitylated substrates [409],
and Rad23 and Dsk2, which increase ERAD efficiency [314, 242]. Curiously, one
Cdc48- and Rad23-associated protein is Png1, a deglycosylating enzyme [219, 196]
indicating that glycosilation may sterically hinder substrate access to the catalytic
chamber of the proteasome. Whether these factors are static or mobile members of
the Cdc48 complex, responsible for binding and escorting ERAD substrates to the
proteasome is unknown [409].
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0.4.5 Proteasome
Figure 21: 26S Proteasome schematic. The overall structure of the eukaryotic proteasome. A) Side-on cross-section of the eukary-
otic 26S proteasome. The 20S core particle is ﬂanked by 19S regulatory particles, and the proteolytic sites are located in the ￿-rings
of the 20S core particle. The scaffold proteins Rpn1 and Rpn2, the ubiquitin receptors Rpn10 and Rpn13 and the loops lining the
ATPase ring are depicted. B)More detailed subunit composition scheme showing a in-process substrate. Figures from Schrader et al.
[342] and Raasi &Wolf [304].
The proteasome, highly conserved in evolution and found in all eukaryotes, is the
most complex protease known, having 33 distinct subunits [100]. Its best investigated
function is that of degrading ubiquitin–conjugated proteins, being organized into two
sub assemblies: the 19S regulatory particle (RP) and the 20S core particle (CP) (Fig-
ure 21) [304]. The 19S RP participates in substrate recognition, while the 20S CP
contains the proteolytically active sites, which are protected within its cavity, ensuring
strict access control and minimal nonspecific proteolysis [342, 304]. Substrates are
driven from the 19S RP to the 20S CP through a narrow interconnecting tunnel. To al-
low the access of globular proteins to the channel, the six ATPases that form the hex-
americ ring complex of the 19S RP (Rpt1–Rpt6) are able to actively unfold them and
feed them into the 20S CP [342, 304]. This hexameric ring complex also contributes
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to substrate export from the ER [438, 126, 327, 216]. For the non-ubiquitinated ERAD
substrate pαF, the 19S RP is indeed the only cytosolic factor required for export from
the ER (in vitro) [216].
The 19S RP also contains ubiquitin receptors, like regulatory particle non-ATPase-
13 (Rpn13), Rpn10 and regulatory particle ATPase-5 (Rpt5). Data suggests that Rpn13
mediates the highest affinity binding, while is positioning supports a key role in sub-
strate selection [170], and that Rpn10 binds to and drives substrates into the 20S
CP for degradation [409]. Other components of the RP base, like the large subunits
Rpn1 and Rpn2, serve as scaffolds that allow recruitment of multiple factors, such as
ubiquitin–protein conjugates [101].
As it is, a significant fraction of cellular proteasome population was found to be as-
sociated with the ER [88, 318, 317], and a direct interaction of the AAA-ATPase con-
taining base of the 19S RP with Sec61 channels has been shown [187, 186].
0.4.6 Retrotranslocon
A central aspect of ERAD is the fact that luminal ER proteins have to be translocated
to the cytosol to be ubiquitinated and proteosome degraded. This process, mostly
referred to as retrotranslocation, would therefore be dependent, in most cases, on
a conducting channel for ER membrane crossing, although in some cases the pro-
teins may be pulled directly out of the bilayer during ERAD [297]. For the majority
of proteins that are subject to ERAD-L, the evidence suggests that retrotransloca-
tion occurs through one or more distinct retrotranslocation channels.The identity of
these channels is still under debate but the candidates are Sec61, Der1 and Hrd1
[439, 221, 56].
The first proposed retrotranslocation channel was the Sec61 translocon, when
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two transmembrane ERAD substrates (HC and US2) were found to associate with
the heterotrimeric Sec61 complex prior to degradation [439]. Following this discov-
ery, various mutations in the S. cerevisiae Sec61 protein were reported to cause de-
fects in retrotranslocation and degradation of ERAD-L substrates, while their antero-
grade transport into the ER was unaffected [293, 289, 28, 443]. Indeed, Sec61 mu-
tations have profound defects on ERAD of mutant pαF, causing its prolonged asso-
ciation with Sec61 and with PDI [289, 288, 120]. More recently, Sec61 was reported
to associate with the ERAD substrates CPY* and Deg1:Sec62ProtA just preceding
degradation [333] and to form disulphide bonds with an ERAD substrate that was
trapped in the channel during export [348]. Further supporting the idea of Sec61 as
the retrotranslocon is the fact that direct blockade of the Sec61 channels with ribo-
some nascent chain complexes in ER-derived vesicles abrogated the retrotransloca-
tion of cholera toxin and amyloid beta-peptide from the ER lumen [339, 340]. Also,
strains that are unable to induce the expression of SEC61 upon overexpression of
CPY* develop an ER protein import defect that is alleviated upon overexpression of
SEC61, suggesting that the protein translocation channel becomes limiting for im-
port into the ER if there is a high demand for export [261]. Direct interaction between
Sec61 and the proteasome [262, 187], and the fact that a mutation in SEC61 that re-
duces affinity for 19S RP also impairs ERAD of a 19S RP-dependent substrate [187]
provided yet other indications that Sec61 might be involved in ERAD.
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Figure 22: Sec61 retrotransloconmodel. Schematic representation of potential Sec61-containing retrotranslocon structures.
Based on ﬁgure fromRömisch [321].
Although the Sec63 complex is not required for ERAD, the role of Sec63 itself is
controversial [289, 293]. Recently Servas et al. demonstrated that mutations in the
DnaJ-domain of Sec63 causes a defect in ERAD, whereas mutations in the Brl, acidic,
and transmembrane domains only affect protein import into the ER [349].
An interesting piece of data shows that the Hrd1 ligase itself is unstable in cells
lacking Hrd3; however, a sec61 retrograde mutant can restore Hrd1 levels in this
background [294].
Taken together, the data provides compelling evidence that protein export from the
ER is mediated by a channel containing Sec61 (Figure 22).
However, experimental data exists supporting the idea that the other candidates
are also responsible for the formation of retrotranslocation channels that are respon-
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sible for the retrograde transport of either a subpopulation of substrates, or of some
substrates under some specific conditions.
The gene encoding the yeast homologue of Derlin-1, DER1, was identified in a
screen for mutants that stabilize CPY* [201]. Der1 has 4 TMs, which are not enough
to form a channel, but it has been found to oligomerize [243]. In contrast to SEC61,
DER1 is a non-essential gene, and its deletion completely blocks ERAD of two solu-
ble substrates (CPY* and PrA*) in yeast [201]. For other substrates, however, there is
either only a modest effect (a twofold increase in the half life of KHN, KWW, pαF) or
none at all (Pdr5*, Sec61-2) [201, 407, 295]. Moreover, some organisms (e.g Hansenula
polymorpha) have no DER1/DFM1 homologues making it unlikely that Der1 is a gen-
eral ERAD export channel [76]. Its transmembrane domains, however, have been
shown to associate with both Hrd1 and in transit ERAD substrates [463, 243].
The third candidate, and perhaps the most popular retrotranslocation channel can-
didate in the present days, is Hrd1. Initial evidence for Hrd1 forming a channel came
from the observation that its overexpression in yeast makes the other components
of the Hrd1 complex dispensable for the degradation of ERAD-L and -M substrates,
while all downstream components, such as the ubiquitination machinery and the Cdc48
ATPase complex were still required [56, 109, 294]. HRD1, as DER1, is also a non-
essential gene, and its deletion in yeast leads to ERAD defects for several substrates.
The fact that the 6 transmembrane domains in Hrd1 are sufficient to form a pore led
to the proposal that it is the ERAD channel [454]. Its role in retrotranslocation was
also supported by photocrosslinking of ERAD substrates to Hrd1 during retro-translocation
[56]. Like Sec61 and Der1, Hrd1 was found to associate with ERAD substrates via its
transmembrane domains and to polyubiquitinate soluble ERAD-L substrates [380]. In-
deed, in vitro retrotranslocation seems to have been reconstituted in proteoliposomes
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that contained both Hrd1 and a single-spanning substrate protein with a large mis-
folded domain [11]. These experiments, however, might have some conceptual and
experimental artifacts as discussed by a recent review [322].
Figure 23: Hrd1 retrotransloconmodel. Scheme representing amodel for the process of retrotranslocation through a Hrd1-based
retrotranslocon channel. Based on ﬁgure fromVembar & Brodsky [409].
According to Rapoport’s lab, auto-ubiquitination of Hrd1 was postulated to be the
trigger for retrotranslocation of the substrate. The crucial modification seems to oc-
cur in the RING finger of Hrd1, as mutation of lysines in this domain prevented retro-
translocation in vitro and the degradation of ERAD-L substrates in vivo [11]. These re-
sults led to a model in which auto-ubiquitination of Hrd1 opens the channel for ERAD-
L substrates [11]. Unidirectionality of the transport would be guaranteed by the attach-
ment of a polyubiquitin chain that could prevent its back-sliding into the ER lumen
(Figure 23). Interestingly, the lysine mutations in the RING finger domain do not have
a strong effect on ERAD-M substrates [451]. There is, however, another line of inves-
tigation that suggests that no auto-ubiquitination is needed [139].
44
Consequently, although much effort has been spent in the sense of identifying the
retrotranslocon, its identity remains unclear. Due to the amount of data supporting
each one of the alternatives, however, the most probable scenario is that depend-
ing on the substrate and cellular state, either one or a combination of these potential
retrotranslocating channels might serve the purpose of retrograde transport of mis-
folded proteins out of the ER.
0.5 Protein Interaction and Chemical Crosslinking
0.5.1 Protein interaction
Almost all cellular functions depend on and are executed by complex protein-protein
interactions (PPIs) [455]. Over 80% of the proteins were estimated to operate in com-
plexes, their interactions being regulated by multiple mechanisms (e.g metal-binding
or PTMs) that alter the affinity, co-operativity and kinetic parameters of the interaction
[23].
Generally, PPIs can be classified into either domain–domain or domain–motif inter-
actions. Domain–domain interactions involve the binding of two large contact inter-
faces (≈2000 Å), with relatively strong affinities, while domain–motif interaction form
much smaller contact interfaces (≈300–500 Å), being short linear motifs (up to 20–30
amino acid residues) that interact with its partner with low affinity [256, 466]
Due to their great biological impact, PPIs have been the object of intense study
across the years using a panoply of techniques [286].The advent of gene fusion and
protein labeling, together with the engineering of fluorescent probes, provided the ini-
tial spark for a technological revolution in the study of PPIs [39]. A variety of experi-
mental methods, based on either biophysical, genetic, or biochemical principles, have
also been developed to aid in their study. Each type of method has its own strengths
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and limitations in terms of sensitivity and specificity [466].
State of the art techniques to study PPIs include yeast two-hybrid systems [99],
affinity purification procedures based on immunoprecipitation (IP) or a single or dou-
ble affinity tag (e.g. FLAG tag and TAP tag, respectively [162, 315, 302]) associated
with protein identification by mass spectrometry, microarray technology [467, 306],
and computational prediction methods [332, 4].
One of the most widely used methods to analyze PPIs is the two-hybrid system but,
although its exact rate of false-positive results is unknown, it has been estimated as
high as 50% [75]. Another widely used technique is affinity chromatography, a bio-
chemical separation technique for purification of a specific molecule from complex
mixtures, based on highly specific interactions between two molecules, like receptor
and ligand or antibody and antigen. It greatly enhances the speed and efficiency of
protein purification and also provides the technology platform to perform PPI studies,
such as pull-down, tandem affinity purification (TAP), and antibody-based methods
including co-immunoprecipitation(Co-IP) and enzyme-linked immunosorbent assay
(ELISA) [466]. Since in affinity fusion-based protein purification a tag has been genet-
ically fused to the target protein, a selective binding is possible, making it an excellent
method to purify and identify multiprotein complexes [23].
Affinity-based techniques, however, are biased towards high abundance and/or
slow dissociation kinetics proteins. Therefore, when detecting transient PPIs, affinity
chromatography-based procedures may not be optimal, particularly if stringent wash-
ing steps are used [421, 23].
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0.5.2 Crosslinking
The main challenge that affinity-based methods face is the inherent difficulty in main-
taining protein and complex integrity during removal of non specific interactors by
washing steps. These washing steps must be often harsh, especially when dealing
with membrane proteins, as these commonly require high levels of detergent in or-
der to guarantee solubility [124, 312].To circumvent this issue, affinity-based methods
have been successfully combined with cross-linking strategies for protein-protein in-
teraction characterization, and became a standard method [466, 402].
Figure 24: Scheme of typical setup formass spectrometry analysis of afﬁnity puriﬁed chemical crosslinked samples. Scheme de-
picting a general setup for identiﬁcation of protein interactions. Cross-linking using a cross-linker composed of one or two reactive
groups separated by a spacer arm. Here bis(sulfosuccinimidyl)glutarate (BS2G) which reacts with primary amines (lysine side chain,
protein N-terminus). Part of the cross-linker, the leaving group, is replaced by the primary amine. R can stand for either the rest of
the cross-linker or another protein, if the cross-linker had already reacted on its other end. After complex stabilization by crosslink-
ing, it can be isolated by afﬁnity puriﬁcation, digested and identiﬁed bymass spectrometry. Figure from Turriziani et al. [402] and
Rappsilber [311].
Chemical crosslink is able to stabilize and lock PPIs by forming covalent bonds
between proteins in the native cellular environment [256, 435, 198]. This is achived
using chemicals that possess two terminal reactive elements (i.e bifunctional) that re-
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act with specific functional groups (such as primary amines and sulfhydryls) of amino
acids [83]. The crosslinked protein complexes remain intact during cell lysis and strin-
gent washes and can capture transient and/or low-affinity interactions (Figure 24)
[244, 132].
Overall, four protein functional groups account for most of the crosslinking tech-
niques:
• Primary amines (–NH): Present in the N- terminus of all polypeptides and in
lysine (Lys, K) side chains.
• Carboxyls (–COOH): Present in the C-terminus of all polypeptides, as well as in
aspartic acid (Asp, D) and glutamic acid (Glu, E) side chains.
• Sulfhydryls (–SH): Group present in cysteine (Cys, C) side chains.
• Carbonyls (–CHO): Aldehyde groups created by oxidation of carbohydrate groups
in glycoproteins.
(Source: www.piercenet.com)
Identifying the crosslinked residues/peptides can point towards the contact/binding
interfaces among protein complexes, potentially helping mapping the topology of pro-
teins and protein complexes [124, 10, 368, 394, 464].
Crosslinkers can be either homo- or hetero-bifunctional reagents. This means they
can possess identical or diferent reactive groups, respectively, allowing the establish-
ment of inter- and intra-molecular crosslinks [368]. The most widely used crosslink-
ers belong to the homobifunctional class of cross-linkers and contain two NHS esters.
NHS esters present a high reaction efficiency, yield a stable amide bond and react at
physiological conditions (pH 7-8) [38, 227, 369]. Moreover, NHS esters crosslink to
lysine residues, which is a frequent amino acid [470]. However, hetero bifunctional
crosslinkers present a more versatile character as they also allow sequential (two-
step) conjugations than can help minimize self-conjugation and unwanted polymerization[83].
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Crosslinker choice is not only based on chemical reactivities but also on other chem-
ical properties that allow their use in the desired conditions:
1. Spacer arm length - will it detect only close interaction or will it be more flexible?
2. Spacer arm cleavability - can the linkage be reversed or broken when desired?
3. Water-solubility and cell membrane permeability - can it cross lipid bi-layers
and/or crosslink hydrophobic within transmembrane domains?
4. Reaction induction - reagent acts upon addition or activation needed?
Chemical crosslinking is an ideal strategy to demonstrate protein-protein interac-
tions, since if two proteins are close enough to physically interact, then they can be
covalently linked by crosslinking. Thus crosslink of two distinct proteins is direct and
convincing evidence of their close proximity and can reveal the regions of contact be-
tween them [83]. Although the rate of false positive is low, the cross-linking has to be
well calibrated in order to decrease the amount of unspecific links [311, 402]
0.5.3 Mass Spectrometry
With the increased capacity of ”locking” both transient as well as low-abundance inter-
actors to their partners, the need for more sensitive methods of downstream detection
arose. Chemical cross-linking methods in combination with mass spectrometry have
become increasingly important tools for mapping of protein topology and for studying
protein–protein interactions [10, 394, 368, 408]. Mass spectrometric analysis of cross-
linked protein complexes allows identification of the protein interacting partners and in
principle, could lead to identification of interaction regions between proteins provided
that the crosslinked sites are identified. However, the identification of the sites of in-
teraction or crosslinker labeling sites are highly challenging due to the complexity of
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linked peptides inherent to cross-linking approaches [387, 311]. In crosslinking reac-
tions, excessive amounts of crosslinker are often used, as to increase reaction rate
and product yield, thus resulting in highly complex mixtures. Proteolysis results in a
population of peptides that might or might not be crosslinker-associated, or even as-
sociated to other peptide(s) through the crosslinker. All these factors result in a spec-
tral complexity that precludes peptide/protein identification (Figure 25, top) [464].
The abundance estimation of detected protein interactions also yields valuable in-
formation for structural biologists. Stoichiometry data can be obtained in experiments
with isotope-labeled reference peptides [436, 22, 338] or less labor-intensive label-
free quantification methods [436, 371]. However, due increased quipment sensitivity,
quantitative filters need to be introduced to distinguish contaminants from real interac-
tors. These filters typically rely on either isotope labels or normalization algorithms for
label-free quantitation [12, 372].
Prioritizing detected PPIs is not trivial, and this remains a major challenge in bio-
logical follow-up studies. Recently, a more direct measure of the importance of these
interactions was developed by determining the stoichiometry of all of the interactors in
single-step affinity purifications [436, 371]. Wepf et al. implemented isotope labeled-
reference peptides to quantify proteins, and used the resulting calibrated ion signal
intensities for label-free quantification in reciprocal pulldowns [436]. Smits et al. re-
ported a fully label-free stoichiometry quantitation method [371], which applies the
intensity-based absolute quantitation (iBAQ) algorithm [347] and does not require
isotope-labeled reference peptides. Importantly, this method can be directly applied
to afinity purification mass spectrometry (AP-MS) data of a single protein of interest
and a matched control. These measurements are performed on protein complex pop-
ulations that might be heterogeneous and stoichiometry values represent the average
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complex composition. Additional quantitative information can directly be used to dis-
tinguish core interactors from those that are substoichiometric [372].
Figure 25: Workﬂow of standard analysis procedure ofmass spectrometry data analysis.Outline of a typical cross-linking/mass
spectrometry setup. Target complex is cross-linked and digested with trypsin. The peptides are analysed by liquid chromatography
coupled high-resolutionmass spectrometry (LC–MS/MS). Peptide fragmentation spectra are subjected to database searching
to identify cross-linked peptides. Peptides types that can be observed after cross-linking and trypsin digestion. Proteomics data
can then be analyzed and visualized, as well as interpreted through different approaches (bottom panels). Based on ﬁgure from
Rappsilber [311] andOveland et al. [276].
This information is especially valuable in combination with the recently developed
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crosslinking mass spectrometry (XL-MS) workflows [462, 163], which allow identifying
neighboring protein complex subunits (Figure 25, middle). Developments in crosslink-
ing reagents, instrumentation, and analysis software have resulted in a broader use
of XL-MS [218, 311, 155]. This methodology was recently optimized to be compat-
ible with single-step affinity purification and can be performed parallel to label-free
PPI identification and quantitation [357, 233]. Recently, the XL-MS approach was ex-
tended to crude lysates for global topology analysis using an MS-cleavable crosslinker
[222]. Combination of high-confidence PPI data and the stoichiometry and topological
information derived from XL-MS data facilitates modeling the architecture of protein
complexes. A modeling approach based on interactor identification and interaction
weights based on reported contacts has even recently been reported (Figure 25, bot-
tom) [1, 299].
0.6 Aim of this Study
The main objectives of this study are:
• Establish a chemical crosslinking setup for Sec61 crosslinking to known and
new interactors
• Establish a setup for crosslinked-complex enrichment and analysis
• Functional characterization of Sec61 interactions
Throughout the project, the primary goal was the identification of Sec61 lumenal
interactors that might be involved in ERAD, as these could validate the hypothesis
that Sec61 is part of the retrotranslocon.
As most Sec61 interaction studies in the past focused on nascent chain-Sec61 in-
teractions, my crosslinking studies also provided a more comprehensive picture of
Sec61 interactors with new proteins in both ER membrane and ER lumen.
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Material and Methods
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1.1 Materials
1.1.1 Laboratory equipment and their Suppliers
The laboratory equipment used in this study is listed in Table 1.1.
Table 1.1: Laboratory Equipment
Company Product
AGFA Healthcare GmbH CP1000 X-ray film processor
Beckman Coulter Inc.
Optima L-90K ultracentrifuge
Optima MAX-XP benchtop ultracentrifuge
Avanti® J-E high-speed centrifuge
Bio-Rad Laboratories Inc.
583 gel dryer
PowerPac HC power supply
Trans-Blot electrophoretic transfer cell
BioLegend LP Purification system
BioSpec Products Inc. Mini-BeadBeater -24
Eppendorf AG
Microcentrifuge 5415R
Thermomixer Comfort
GE Healthcare
Amersham autoradiography Hypercassettes
Amersham Ultrospec 2100 pro UV/VIS Spec-
trophotometer
ImageQuant TL software
Storage Phosphor Screens and cassettes
Typhoon TRIO phosphorimager
Amersham Imager 600
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Company Product
Gilson Inc. Pipette set
Hellma Analytics Quartz cuvettes
Hirschmann Gmbh & Co.
KG
Pipet-Aid pipette controller
IKA-Werke GmbH
EUROSTAR power-b overhead stirrer
RCT basic magnetic stirrer
Infors AG Multitron Standard incubation shaker
Merck KGaA Millipore MilliQ water purification system
neoLab Migge gmbH
Overhead rotator
Rocking shaker
Roth GmbH & Co. KG Neubauer Hemocytometer
Sartorius AG Analytical balance
Scientific Industries Inc. Vortex-Genie 2
Singer Instruments MSM 300 tetrad dissection microscope
Sigma Laborzentrifugen
GmbH
4K15 refrigerated centrifuge
Systec DX-150 autoclave
Thermo Fisher Scientific Inc.
XCell SureLock Mini-Cell electrophoresis system
Sorvall Evolution RC centrifuge
3UV-Lamp
VWR/PEQLAB
E-BOX VX2 gel documentation system
peqSTAR 2X gradient thermocycler
PerfectBlue Gelsystem Mini S
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Company Product
Zeiss Microscopy &
GmbH
Axioskop microscope
Wheaton 55 ml tissue grinder, Potter-ELV
1.1.2 Reagents, Chemicals and their Suppliers
All reagents, consumables and chemicals are listed in Table 1.2.
Table 1.2: Reagents, chemicals and consumables
Company Product
AGFA HealthCare GmbH
Agfa Developer G153
Agfa Fixer G354
Applichem GmbH
Ampicillin Sodium Salt (BioChemica)
DEPC (BioChemica)
Kanamycin Sulfate (BioChemica)
Tunicamycin
HEPES-Sodium Salt
Sodium Chloride
Magnesium Chloride
Sodium Acetate
Magnesium Acetate
Ammonium Acetate
BD
Bacto™ Casamino Acids
Bacto™ Peptone
Bacto™ Yeast Extract
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Company Product
BD
Difco™ Yeast Nitrogen Base without Amino Acids &
Ammonium Sulfate
Difco™ Yeast Nitrogen Base without Amino Acids
Beckman Coulter GmbH
Polycarbonate Bottles, thick-walled, 70 ml (rotor type
45 Ti)
Polyallomer Tubes, thin-walled, 4.4 ml (rotor type
SW 60 Ti)
Polycarbonate Tubes, thick-walled, 1.0/1.4 ml (TLS-
55)
Polycarbonate Tubes, thick-walled, 3.0/3.5 ml (TLA-
100.3)
Microfuge® Tubes, Polyallomer, 1.5 ml
Bio-Rad Laboratories Inc.
Nitrocellulose Membrane (0.2 µM, 0.45 µM pore
size)
Precision Plus Protein™All Blue Standards
Carl Roth GmbH
PMSF (!99%)
Roti®-Aqua-Phenol (RNA extraction)
Rotiphorese® Gel 30 (37,5:1)
ȿ-Mercaptoethanol (99 %, p.a.)
TEMED (99 %, p.a.)
Roti®-Phenol/Chloroform/Isoamyl-Alcohol (Nucleic
acid extraction)
Peptone (from Casein)
Yeast Extract
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Company Product
Carl Roth GmbH
Glycine (PUFFERAN®, !99 %, p.a.)
Agar-Agar, Kobe I
Ammonium Peroxydisulfate (!98 %, p.a.)
SDS Pellets (!99 %)
RNase AWAY®
Glycerol (!98 %
Triton X 100, pure
Sodium Carbonate
Urea
Potassium Acetate
2-Nitrophenyl-ȿ-D-Galactopyranoside
Fermentas
Conventional and FastDigest® Restriction Enzymes
T4 DNA Ligase
FastAP™ Thermosensitive Alkaline Phosphatase
GeneRuler™ 1 kb DNA Ladder
GeneRuler™ 1 kb Plus DNA Ladder
PageRuler™ Prestained Protein Ladder
PageRuler™ Plus Prestained Protein Ladder
RNase A, DNase and Protease-free (10 mg/ml)
5-Fluoroorotic Acid
Formedium™
Synthetic Complete Drop-Out Mixture, (SC) (-Ade,
-His, Leu, -Lys, -Trp, -Ura), (Kaiser Mixture)
FujiFilm Medical X-ray Film (Super HR-E30)
GE Healthcare Protein A Sepharose™ CL-4B
58
Company Product
GE Healthcare
Con-A Sepharose® 4B
HisTrap FF crude 1mL
Invitrogen™
NuPAGE® Novex 4-12 % Bis-Tris Gel 1.5 mm, 10
Well (Novex®)
NuPAGE® MOPS SDS Running Buffer (20X)
(Novex®)
Calbiochem® Cycloheximide
New England Bio-
Labs® (NEB)
Conventional Restriction Enzymes
PEQLAB Biotechnolo-
gie GmbH
KAPA HiFi™ PCR Kit
PerkinElmer Inc.
EXPRESS Protein Labeling Mix, [S]-, 50mM
Tricine (pH 7.4), 10mM 2-mercaptoethanol
COUNT-OFF Liquid Concentrate
Promega GmbH Recombinant RNasin® Ribonuclease Inhibitorm
Rockland™ HRP-conjugated anti-rabbit
Sartorius AG
Minisart® Plus Syringe Filters (0.2, 0.45 µm pore
size)
Sigma-Aldrich®
Adenine (!99 %)
L-Cysteine (!98 %)
L-Histidine (Sigma)
Uracil (!99 %)
L-Leucine (!98.5 %)
Sigma-Aldrich®
L-Tryptophan (!98 %)
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Company Product
L-Methionine (!99 %)
L-Cysteine (!99 %)
DL-Dithiothreitol, BioUltra, !99.0 %
Sucrose BioXtra, !99.5 %
Tryptone, enzymatic digest from casein
D-(+)-Glucose (!99.5 % )
Deoxyribonucleic Acid Sodium Salt
Absolute Ethanol
Bromophenol Blue Sodium Salt
Trizma® Base, for molecular biology, !99.8 %
Urea
Sodium Azide, BioUltra, !99.5 %
Tween® 20
DMSO
Glass Beads, acid-washed 425-600 μm
EDTA, anhydrous, !99 %
Lithium Acetate Dihydrate, BioXtra
Polyethylene Glycol, BioXtra, average mol wt 3,350
D-(+)-Galactose (!99 %)
Sodium Chloride, for molecular biology (!98 %)
GenElute™ PCR Clean-Up Kit
GenElute™ Gel Extraction Kit
Corning® Cryogenic Vials, internal thread (2.0 mL)
Tunicamycin
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Company Product
Sucofin Skimmed Milk Powder
Thermo Fisher Scientific
Pierce 660 nm Protein Assay Reagent
SuperSignal West Dura Extended Duration
Chemiluminescent Substrate (ECL)
Filter Units – 115/250/500 ml capacity, MF75™
Series, 0.45 µm pore size
DMSO
DSS (disuccinimidyl suberate)
SDAD (succinimidyl 2-[(4,4´-azipentanamido)ethyl]-
1,3´-dithioproprionate)
SMPH (Succinimidyl-6-[(ȿ-
maleimidopropionamido)hexanoate])
LC-SPDP (succinimidyl 6-[3´-(2-pyridyldithio)-
propionamido] hexanoate)
VWR® International
Cloridric acid 99 % GPR RECTAPUR®
Ethanol Absolut AnalaR NORMAPUR®
ZChL
All other chemicals not mentioned above but men-
tioned in the respective sections of this chapter
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1.1.3 Software
In Table 1.3 is listed all the software used throughout this work.
Table 1.3: Software used in this study
Name Use
BibDesk Bibliography Software
ChemSketch Draw chemical structures
GraphPad Prism Data plotting
Illustrator Image editing
ImageQuant Band intensity quantitation
Lightroom Image managing
MaxQuant Mass spectrometry data analysis (Mandy
Rettel)
MsConvert Convert mass spectrometry spectrums to the
.mzXML format for xQuest analysis
Photoshop Image editing
PyMOL 3D structure analysis
R Mass spectrometry statistical analysis (Frank
Stein)
SnapGene DNA sequence editing
TexMaker Text Editor (LATEX)
xQuest/xProphet Crosslinked peptide analysis
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1.1.4 E. coli Strains
All E. coli strains used and generated throughout this study are listed in Table 1.4 or-
ganized by their Strain Collection code.
Table 1.4: E. coli strains
Strain Genotype Source
DH5α F- endA1 glnV44 thi-1 recA1 relA1
gyrA96 deoR nupG Φ80dlacZΔM15
Δ(lacZYA-argF)U169,hsdR17(rK-
mK+), λ–
Hanahan [140]
KRB3 Lyticase expressing E. coli (in DH5α) Shen et al. [355]
KRB351 p416 pΔgpαf (in DH5α) Mumberg et al. [253]
KRB356 pBW11 (SEC61 WT in pRS315)(in
DH5α)
Stirling et al. [382]
KRB842 pRS315 in DH5α M. Schmitt, Sikorski &
Hieter [365]
KRB856 pRS313-PHO8-URA3 (in DH5α) Ng et al. [258]
KRB863 pRS315-sec61-S353C (in DH5α) Kaiser & Römisch [186]
KRB866 pRS306-truncsec61-S353C (in DH5α)
(in DH5α)
Kaiser & Römisch [186]
KRB882 pSM70 KHN-HA (URA3)(in DH5α) D. Ng, Vashist et al.
[406], Vashist & Ng [407]
KRB883 pSM101 KWW-HA (URA3) (in DH5α) D. Ng, Vashist & Ng [407]
KRB951 pRS315-sec61∆L7 (in DH5α) Tretter et al. [397]
KRB966 pRS305-truncsec61∆L7 (in DH5α) This work
63
Strain Genotype Source
KRB1060 pRS426 Stein et al. [380]
KRB1055 pRS426-14His-SEC61 This work
KRB1056 pRS426-14His-sec61S353C This work
KRB1057 pRS426-14His-SBH1 This work
KRB1058 pRS426-14His-SSS1 This work
KRB1090 pRS315-14His-SEC61 This work
KRB1091 pRS315-14His-sec61S353C This work
KRB1093 pRS316-NSG1-HA Carvalho lab, Foresti et al.
[102]
KRB1094 pRS316-ERG11-HA Carvalho lab,Foresti et al.
[102]
KRB1113 pRS315-sec61∆201-216 This work
KRB1114 pRS315-sec61∆230-236 This work
KRB1115 pRS315-sec61∆201-216/∆230-236 This work
1.1.5 S. cerevisiae Strains
Listed in Table 1.5 are all S. cerevisiae strains used and generated throughout this
study organized by their Strain Collection code.
Table 1.5: S. cerevisiae strains
Name Genotype Source/Reference
KRY37 MATa his4 trp1-1 leu2-3,112 ura3-52 hoc1-1
sec61-3
Schekman lab Stirling
et al. [382]
KRY47 MATα leu2-3,112 ura3-52 Pilon et al. [289]
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Name Genotype Source/Reference
KRY153 MATα can1-100 leu2-3,112 his3-11,15 trp1-1
ura3-1 ade2-1 sec61::HIS3 [pDQ SEC61]
R. Schekman, Pilon
et al. [288]
KRY157 MATα can1-100 leu2-3,112 his311,15 trp1-1
ura3-1 ade2-1 sec61::HIS3 [pDQ sec61-32]
R. Schekman, Pilon
et al. [288]
KRY160 MATa eu2-3,112 his3-11,15 trp1-1 ura3-1
ade2-1 can1-100 leu23,112::LEU+ UPRE-
lacZ MET+ ire1::TRP1 pRS304
Sidrauski/Peter Wal-
ter, Shamu & Walter
[351]
KRY161 MATα ade2-1 ura3-1 his3-11,15 leu23,112
trp1-1 can1-100 prc1
D. Wolf, [201]
KRY461 MATα sec61::HIS3 leu2 trp1 prc1-1 his3 ura3
[pGAL-SEC61-URA3]
Römisch Lab
KRY486 MATa/α can1-100 ura3-1 trp1-Δ1 ade2-1
leu2-3,112 his3-11,15 can1-100 ura3-1 trp1-
Δ1 ade2-1 leu2-3,112 his3-11,15
Schekman lab, [35]
KRY850 BMA38a, kanr-pGAL-Sec61, his3Δ200 leu2-
3.112 trp1-Δ1 ura3-1 ade2-1 can1-100
Kaiser & Römisch
[186]
KRY853 MATα leu2-3,112 ura3-52 [pRS306-
truncsec61-S353C]
Kaiser & Römisch
[186]
KRY896 MATα sec61::HIS3 leu2 trp1 prc1-1 his3 ura3
pRS315-sec61∆L7
Tretter et al. [397]
KRY897 MATα sec61::HIS3 leu2 trp1 prc1-1 his3 ura3
pRS315-SEC61
Tretter et al. [397]
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Name Genotype Source/Reference
KRY956 can1-100 ura3-1 trp1-∆1 ade2-1 his3-11,15
SEC61::trunc.sec61∆L7(LEU2)
This work
KRY962 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 Euroscarf
KRY963 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0
hrd1::kan
Euroscarf
KRY964 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0
hrd3::kan
Euroscarf
KRY1005 MATα ura3-52 leu2-3,112 sec61::truncsec61-
S353C(URA3) hrd3::KanMX
This work
KRY1061 MATα sec61::HIS3 leu2 trp1 prc1-1 his3 ura3
ade2 [pGal-14His-sec61S353-LEU2]
This work
KRY1081 MATα sec61::HIS3 leu2 trp1 prc1-1 his3 ura3
ade2 [pGal-14His-SEC61-LEU2]
This work
KRY1097 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0
ASI3::Kan
Euroscarf
KRY1098 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0
YNR021w::Kan
Euroscarf
KRY1099 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0
PSG1::Kan
Euroscarf
KRY1100 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0
SHE2::Kan
Euroscarf
KRY1116 MATα sec61::HIS3 leu2 trp1 prc1-1 his3 ura3
ade2 [pRS315-sec61∆201-216]
This work
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Name Genotype Source/Reference
KRY1117 MATα sec61::HIS3 leu2 trp1 prc1-1 his3 ura3
ade2 [pRS315-sec61∆230-236]
This work
KRY1118 MATα sec61::HIS3 leu2 trp1 prc1-1 his3 ura3
ade2 [pRS315-sec61∆201-216/∆230-236]
This work
KRY1119 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0
[pRS426-MID2-HA]
This work
KRY1120 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0
SHE2::kanM [pRS426-MID2-HA]
This work
KRY1121 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0
pmt2::LEU2 [pRS426-MID2-HA]
This work
KRY1122 MATα can1-100 leu2-3,112 his3-11,15 trp1-1
ura3-1 ade2-1 sec61::HIS3 [pDQ sec61-32]
[pRS426-MID2-HA]
This work
KRY1124 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0
SHE2:Kan SEC61::trunc.sec61S353C-URA
This work
KRY1130 MATα can1-100 leu2-3,112 his3-11,15 trp1-1
ura3-1 ade2-1 sec61::HIS3 [pDQ SEC61]
[Nsg1-HA-Trp]
This work
KRY1131 MATα can1-100 leu2-3,112 his3-11,15 trp1-1
ura3-1 ade2-1 sec61::HIS3 [pDQ SEC61]
[Erg11-HA-Trp]
This work
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Name Genotype Source/Reference
KRY1132 MATα can1-100 leu2-3,112 his3-11,15 trp1-1
ura3-1 ade2-1 [pDQ sec61-32] [Nsg1-HA-
Trp]
This work
KRY1133 MATα can1-100 leu2-3,112 his3-11,15 trp1-1
ura3-1 ade2-1 [pDQ sec61-32][Erg11-HA-
Trp]
This work
1.1.6 Plasmids
Listed in Table 1.6 are all plasmids used in this study.
Table 1.6: Plasmids
Plasmid Strain
cat. #
Use/Description Source/ Refer-
ence
pBW11 KRB356 SEC61 expression Stirling et al.
[382]
p416pΔgpαf KRB351 Overexpression of pΔgpαf
(URA3)
Mumberg et al.
[253]
pRS315 KRB842 Cloning vector M. Schmitt,
Sikorski &
Hieter [365]
pRS313-PHO8-URA3 KRB856 Expression of the chimeric
Pho8-Ura substrate
Ng et al. [258]
pRS315-sec61S353C KRB863 Expression of Sec61S353C Kaiser &
Römisch [186]
68
Plasmid Strain
cat. #
Use/Description Source/ Refer-
ence
pRS306-truncsec61-
S353C
KRB866 Genomic integration of
sec61S353C
Kaiser &
Römisch [186]
pSM70 KHN-HA
(URA3)
KRB882 KHN-HA D. Ng, Vashist
& Ng [407]
pSM101 KWW-HA
(URA3)
KRB883 Expression of KWW-HA D. Ng, Vashist
& Ng [407]
pRS315-sec61∆L7 KRB951 Expression of Sec61∆L7 Tretter et al.
[397]
pRS305-
truncsec61∆L7
KRY966 Genomic integration of
sec61∆L7
This work
pRS426 KRB1060 14His gene tagging Stein et al.
[380]
pRS426-14His-SEC61 KRB1055 Sec61 tagging with a 14His-
tag
This work
pRS426-14His-
sec61S353C
KRB1056 Sec61S3534C tagging with
a 14His-tag
This work
pRS426-14His-SBH1 KRB1057 Sec61 tagging with a 14His-
tag
This work
pRS426-14His-SSS1 KRB1058 Sec61 tagging with a 14His-
tag
This work
pRS315-14His-SEC61 KRB1090 Expression of His-Sec61 This work
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Plasmid Strain
cat. #
Use/Description Source/ Refer-
ence
pRS315-14His-
sec61S353C
KRB1091 Expression of His-
Sec61S3534C
This work
pRS315-sec61∆201-
216
KRB1113 Expression of sec61del1 This work
pRS315-sec61∆230-
236
KRB1114 Expression of sec61del2 This work
pRS315-sec61∆201-
216/∆230-236
KRB1115 Expression of
sec61del1/del2
This work
pRS316-NSG1-HA KRB1093 Expression of HA tagged
Nsg1
Foresti et al.
[102]
pRS316-ERG11-HA KRB1094 Expression of HA tagged
Nsg1
Foresti et al.
[102]
1.1.7 Primers
Listed in Table 1.7 are all plasmids used in this study.
Table 1.7: Primers
Name Sequence (5’ −→ 3’) Tm [ºC]* Application
16 GGATCCGCGCATTTGCTTAAGCAA-
GGATAC C
60 SEC61 downstream.
Hinge mutants con-
struction
70
Name Sequence (5’ −→ 3’) Tm [ºC]* Application
24 GTAAAACGACGGCCAGT 53 M13 primer (Frw).
Used in sequencing or
Colony PCR
25 CAGGAAACAGCTATGAC 47 M13 primer (Rev).
Used in sequencing or
Colony PCR
51 CTAGGGGGTCCGTCTTCTC 56 HRD3 upstream. Hrd3
deletion
52 CCAATTGTATCACCTTCGCC 55 HRD3downstream.
Hrd3 deletion
61 ATGTCAAGCCCAACTCC 52 SBH1 ATG. Cloning
into pRS426-14His
62 CTTCTATAGAAgCTTGAATC 40 SBH1 downstream.
Cloning into pRS426-
14His
63 ATGTCCTCCAACCGTGT 54 SEC61 ATG. Cloning
into pRS426-14His
64 CAACTTCCTaaGCTTCACGCC 51 SEC61 downstream.
Cloning into pRS426-
14His. Hinge mutants
construction
66 ATGGCTAGAGCTAGTGAAAAAGGTG-
AAGAG
61 SSS1 ATG. Cloning
into pRS426-14His
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Name Sequence (5’ −→ 3’) Tm [ºC]* Application
73 GTTGGAAAGCTTTCCATG 43 SSS1 downstream.
Cloning into pRS426-
14His
85 GCAAATTAAAGCCTTCGA 49 CYC. Subcloning of
14His-construct into
pRS315
93 GCTGGAGCTCTAGTACG 52 pGAL. Subcloning of
14His-construct into
pRS315
95 GTATATTCATGTTAAACGCCTTT 60 PSG1 upstream. Dele-
tion confirmation
100 AAATTCGGTACTATCAGCTTTCC 64 YNR021W upstream.
Deletion confirmation
101 TTTGTTGTAGTTATGCTCCACGA 64 SHE2 upstream. Dele-
tion confirmation
102 ATATCACTAAACGACGCTCAAAA 62 ASI3 upstream. Dele-
tion confirmation
103 ATACTCTCACACAATATTCCCAA 51 HRD1 upstream. Dele-
tion confirmation
104 TTTAAACTTAATACTAGGGGGTC 50 HRD3 upstream. Dele-
tion confirmation
105 CTGCAGCGAGGAGCCGTAAT 62 KanB. Deletion confir-
mation
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Name Sequence (5’ −→ 3’) Tm [ºC]* Application
106 GGAAAAAGGCAGGAGCAAACGCTC-
TCCAG
90 deletion1. SOE PCR of
sec61del1
107 CGTTTGCTCCTGCCTTTTTCCATCTT-
TTGGCTG
98 deletion1. SOE PCR of
sec61del1
108 GGACAAGAAATACCGTACCAATCTA-
CCTAATATGTTCC
106 deletion2. SOE PCR
of sec61del2 (and
sec61del1/2)
109 TGGTACGGTATTTCTTGTCCTTTCTG-
ACAGCC
94 deletion2. SOE PCR
of sec61del2 (and
sec61del1/2)
110 GCCAATTAAAAAGAACCATTCCTCC
TCAGGAAACAAGCACGAC-
GAATTGCGTACGCTGCA GGTC-
GAC
S3-MPD1. MPD1 HA
genomic tagging
111 CATATGTTGTGTTTAATTAGATAATC-
ATTGAATGAGGAAACGTACCA
CTAATCGATGAATTCGAGC TCG
S2-MPD1. MPD1 HA
genomic tagging
114 GGATACAAGTCGACGCAAATTTCTC 72 MPD1 upstream. Sub-
cloning of genomic
MPD1-HA into pRS426
73
Name Sequence (5’ −→ 3’) Tm [ºC]* Application
115 CAATTTTTGGATGGGAATTCAATTAT-
AC
72 MPD1 downstream.
Subcloning of ge-
nomic MPD1-HA into
pRS426.
118 GTGGTGAACGATAGATGGAC 60 ACT1. HAC1 mRNA
splicing assay
119 ATTCTGAGGTTGCTGCTTTG 58 ACT1. HAC1 mRNA
splicing assay
120 CTGGCTGACCACGAAGACGC 66 HAC1. HAC1 mRNA
splicing assay
121 TTGTCTTCATGAAGTGATGA 54 HAC1. HAC1 mRNA
splicing assay
124 TTTTTTTTTTTTTTTTTT 36 Oligo-dT. cDNA synthe-
sis
*TM as given by SnapGene Software.
1.1.8 Antibodies
Listed in Table 1.8 are all antibodies used in this study.
Table 1.8: Antibodies
Antibody Use & Dilution Source
Anti-Sec61(N-terminus) Western Blot 1: 2.500; IP 1:100 KB Römisch
Anti-Sec61(C-terminus) Western Blot 1: 2.500; IP 1:100 KB Römisch
Anti-Sec63 Western Blot 1: 2.500; IP 1:100 Schekman lab
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Antibody Use & Dilution Source
Anti-Sss1 Western Blot 1: 2.500; IP 1:100 Schekman lab
Anti-Sec62 Western Blot 1: 2.500; IP 1:100 Schekman lab
Anti-Sec71 Western Blot 1: 2.500; IP 1:100 Schekman lab
Anti-Rpn12 Western Blot 1:2.500 Römisch lab
Anti-Rpl24 Western Blot 1:2.500 Ng lab
Anti-Hrd1 Western Blot 1:10.000 T. Sommer lab
Anti-Hrd3 Western Blot 1:10.000 T. Sommer lab
Anti-HA Western Blot 1:5.000 ; IP 1:200 BioLegend
Anti-CPY Western Blot 1:2.000; IP 1:100 KB Römisch lab
Anti-ppȾF Western Blot 1:2.000; IP 1:100 KB Römisch lab
Anti-DPAPB IP 1:100 Stevens lab
Anti- rabbit (HRP) Western Blot 1:10.000 Rockland™
Anti- rat (HRP) Western Blot 1:10.000 SIGMA
Anti-She2 Western Blot 1: 200; IP 1:100 Jansen lab
Anti-Asi3 Western Blot 1: 5000; IP 1:100 Carvalho lab
Anti-Pdi1 Western Blot 1: 5000; IP 1:100 Römisch lab
Anti-Kar2 Western Blot 1: 5000; IP 1:100 Römisch lab
1.1.9 Enzymes
Listed in Table 1.9 are all enzymes used in this study.
Table 1.9: Enzymes used in this study and their sources
Class Enzyme Company
Restriction Enzymes BamHI New England Biolabs (NEB)
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Class Enzyme Company
Restriction Enzymes
BgII
New England Biolabs (NEB)
EcoRI
HindIII
MscI
NheI
SalI
SmaI
SfoI
Polymerases
OneTaq
NEB
Crimson Taq
KAPA HiFi™ Peqlab
Reverse Transcriptase Maxima® RT Fermentas
Ligase T4 DNA Ligase Fermentas
Other enzymes
FastAP™ Thermo Fisher Scientific
Lyticase Römisch Lab
1.1.10 Media and Buffers
Routinely used media in the course of this study for both S.cerevisiae and E.coli growth
are listed in Table 1.10 and Table 1.12, respectively.
Table 1.10: S.cerevisiae growthmedia routinely used in this study
Medium Composition
YP (Yeast Ex-
tract, Peptone)
1 (w/v) % Yeast Extract, 2 (w/v) % Peptone (For solid
media: 2 (w/v) % Agar-Agar)
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Medium Composition
YPD* (Yeast
Extract, Peptone,
Dextrose)
1 (w/v) % Yeast Extract, 2 (w/v) % Peptone, 2 (w/v) %
Glucose (For solid media: 2 (w/v) % Agar-Agar)
Minimal
Medium**
0.67 (w/v) % Yeast Nitrogen Base without Amino Acids,
0.13 (w/v) % Synthetic Complete Drop-Out Mixture***
(-Ade, -His, -Leu, -Lys, -Trp, -Ura), 2 (w/v) % Glucose,
Amino Acids according auxotrophies (Table 1.11) (For
solid media: 2 (w/v) % Agar-Agar)
Sporulation
Medium
1% Potassium Acetate, 0.1% Yeast Extract, 0.05% Glu-
cose (For solid media: 2 (w/v) % Agar-Agar)
*Glucose (50 %) filtrated and added to the YP solution prior to use.
**Sterilized by filtration. Auxotrophic amino acids added as listed in Table 1.5. For solid media, MQ water with agar-agar was autoclaved and other
components filtered in before plate-pouring.
***composition of the complete synthetic “drop-out” mixture used is listed in Table 1.11.
Table 1.11: Composition of Synthetic Complete amino acid drop-out mixture for S.cerevisiae
Compound mg/l Compound mg/l
Adenine 18 L-Leucine 380
L-Alanine
76
L-Lysine
76
L-Arginine HCl L-Methionine
L-Asparagine para-Aminobenzoic
acid
8
L-Aspartic Acid L-Phenylalanine
76L-Cysteine L-Proline
L-Glutamine L-Serine
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Compound mg/l Compound mg/l
L-Glutamic acid
76
L-Threonine
76
Glycine L-Tryptophan
L-Histidine L-Tyrosine
myo-inositol Uracil
L-isoleucine L-Valine
Table 1.12: E.coli growthmedia routinely used in this study
Medium Composition
LB (Lysogeny Broth) 0.5 % (w/v) Yeast Extract, 1 % (w/v) Tryptone,
0.05 % (w/v) NaCl, 1.0 mM NaOH (For solid
media: 2 % Agar-Agar)
LB-Amp LB with 100 µg/ml Ampicillin* (For solid media: 2
% Agar-Agar)
LB-Kan LB with 50 µg/ml Kanamycin*
*Antibiotics stock solutions were sterile filtered, and added to the media prior to use at the designated concentration.
All buffers composition is described at the appropriate section of use.
1.2 Methods
1.2.1 Sterilization
All glassware and media were sterilized by autoclaving at 100 kPa and 121 °C for 20
min if not stated otherwise.
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1.2.2 Growth of S.cerevisiae
S. cerevisiae cells were grown at 30°C in YPD or in SC medium with continuous shak-
ing at 220 rpm. Cells on solid medium were also grown at 30°C if not stated other-
wise. To test temperature sensitivity, cells were counted and serial dilutions were pre-
pared. A volume of 5 µl of each dilution (containing 10 – 10 cells) was pipetted onto
YPD plates. To test tunicamycin (Tm) (SIGMA) sensitivity, cells were grown on YPD
plates supplemented with 0, 0.25, 0.5, or 0.75 µg/ml Tm. Plates were incubated at
indicated temperatures for 3 days (Table 1.10 and 1.11).
1.2.3 Growth of E.coli
E.coli cells were grown at 37 °C in LB medium with continuous shaking at 160 rpm
or on LB medium plates. When necessary, both liquid and solid media were supple-
mented with adequate concentration of appropriate antibiotic (Table 1.12).
1.2.4 Polymerase Chain Reaction
Polymerase Chain Reaction (PCR) is a technique that allows the amplification (i.e
exponential increase of the copy number) of a targeted DNA sequence. For this pur-
pose, three key elements are necessary: template DNA (containing region to be am-
plified); flanking primers (short single-stranded oligonucleotides, which are designed
to specifically bind to the template DNA at the 5’ and 3’ end of the target sequence);
and a DNA polymerase, which will be the responsible for the actual polymerization of
the new DNA copies.
A standard PCR reaction consist of a 20-35 cycle (depending on the polymerase
used) of three steps: denaturing, primer annealing, and primer extension. During
the first step, the PCR mix (Table 1.13 ) is heated at a high temperature (also poly-
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merase dependent) so as to denature the double-stranded DNA and allow access of
primers to their area of homology. Primer annealing (step 2) is performed at a lower,
sequence-specific temperature to ensure specific binding of the primer pair to the
template DNA. During the extension, or elongation step, the DNA polymerase ex-
tends the primers and adds nucleotides complementary to the template DNA. Since
these three step are repeated in cycle, when in non-limiting concentration of dNTPs
and primers, will result in an exponential increase of the copy number of the target
sequence.
During this study PCR was performed in order to amplify multiple DNA targets. Un-
less stated otherwise, Kapa HiFi (Peqlab) was used for all cloning-purpose amplifica-
tions (Section 1.1.9, Table 1.9). The standard reaction composition and program used
is described in Tables 1.13 and 1.14, respectively. Temperature and duration of each
step (Table 1.14) were optimized for each reaction/sequence. Gene-specific primers
(Table 1.7) were designed using the sequences acquired on www.yeastgenome.org.
The peqSTAR 2X Gradient Thermocycler (Peqlab) was used routinely for PCRs.
The correct size of each PCR product was verified by agarose gel electrophoresis
(Section 1.2.6). Resulting PCR products were either cloned into a vector or used to
directly transform S.cerevisiae.
Table 1.13: Standard reactionmixture for PCRs
Component Volume (µl) Final concentration/
5X KAPAHiFi™ Reaction Buffer 10 1X
KAPA dNTP Mix (10 mM each)
1.5 0.3 mMForward primer (10 μM)
Reverse primer (10 μM)
Template DNA
1
10ng plasmid DNA
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Component Volume (µl) Final concentration/
Quantity
KAPAHiFi™ Polymerase 0.02 U/µl
dHO to 50 –
Table 1.14: Standard thermal cycler program for PCRs
Nº of Cycles Operation Temperature (ºC) Duration
1 Initial
denaturation
95ºC 5sec
35
Denaturation 98 20sec
Primer annealing 58* 15sec
Primer extension 72 30 sec/kb
1 Final extension 72 5 min
1 Store 4 ∞
*Primer annealing for the great majority of the PCR reactions was 58°C. For all other PCRs (eg. HAC1 mRNA splice assay) primer annealing tempera-
ture is mentioned in the Methods section when specific protocol is described.
1.2.4.1 Splice Overlap Extension (SOE) PCR
PCR-driven overlap extension was used for site-directed mutagenesis during this
study. During SOE-PCR, overlapping gene fragments are generated (Figure 1.1, 1TU
round). These overlaping fragments will, upon annealing of the homologous regions,
generate a continuous unit, that is used as template in a new PCR reaction, gener-
ating the fused (full-length) product (Figure 1.1, 2OE round). By choosing appropri-
ate internal primers that overlap each other and flank the mutagenesis-targeted se-
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quence, one can either delete, add or exchange a given sequence. The intermediate
fragments can then be fused together in a final PCR using flanking primers [161, 164]
Figure 1.1: General SOE-PCR schematic .
For generation of the sec61 hinge mutants, SOE PCR setup was as described in
Table 1.15
In between reactions, samples were resolved in agarose gel 1% for size confirma-
tion and cleaned out of the gel using the GeneElute Gel extraction Kit as described
in Section 1.2.7. The amplification reactions were done as described in Section 1.2.4
using the KAPA HiFi (Peqlab), an annealing temperature of 58ºC, and an adequate
extension period. During the second round of PCR, as template, equal amounts of
each complementary fragments (i.e both halfs of the gene) were used (100ng).
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Table 1.15: Genral setup of SOE-PCR for the generation of the sec61mutants.
1TU round 2OE round
sec61
deletion
Template Reaction
(#)
Primer
(Frw)
Primer
(Rev)
Template Reaction
(#)
Primer
(Frw)
Primer
(Rev)
1 SEC61
1 64 106 1TU round
products
1 64 16
2 107 16
2 SEC61
1 64 108 1TU round
products
1 64 16
2 109 16
1/2 sec61del1
1 64 108 1TU round
products
1 64 16
2 109 16
1.2.4.2 Colony PCR
Colony PCR is a variation of the traditional PCR reaction, in which cell crude extract
is used as source of template DNA. To obtain this crude extract, a sample of each
transformant colony to be screen was resuspended in 50 µl of MQ water, and dena-
tured at 95ºC for 5min. After debris sedimentation (16.000 x g, 1 min), 10 µl of the su-
pernatant was used as ”template DNA” in a PCR reaction. In this study, colony PCRs
were done in a total volume of 25 µl and using the OneTaq® DNA polymerase (Table
1.9). Reaction composition and programs used with this setup are described in Table
1.16 and 1.17, respectively. Whenever possible, the M13 primers were used for these
reaction (Table 1.7) .
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Table 1.16: Standard colony PCR reactionmixture
Component Volume (µl) Final concentration/
Quantity
2X OneTaq Master Mix 12.5 1X
Forward primer (10 μM) 0.5 0.2 µM
Reverse primer (10 μM) 0.5 0.2 µM
Template DNA 10 (of crude extract) x
dHO 1.5 –
Table 1.17: Standard thermal cycler program for colony PCRs
Nº of Cycles Operation Temperature (ºC) Duration
1 Initial
denaturation
94 5min
30
Denaturation 94 30sec
Primer annealing 45-68* 30sec
Primer extension 68 1 min/kb
1 Final extension 68 5 min
1 Store 4 ∞
* Primer annealing temperature was optimized according to the primer pair used.
Full volume of the reaction was then resolved in an agarose gel of appropriate con-
centration as described in Section 1.2.6, and positive clones selected by band-size
confirmation. Positive clones were then further confirmed by sequencing.
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1.2.5 Small Scale DNA Extraction
1.2.5.1 Isolation of Plasmidic DNA from E.coli
To isolate plasmidic DNA from E.coli, the Plasmid Isolation Kit (Sigma) was used. Cel-
lular mass of 2 ml of an over-night culture of E.coli grown as described in Section
1.2.3, and collected. Pellet was then resuspended in 250 µl Solution A, 250 µl of So-
lution B was added, and sample incubated at room temperature for 5 min. This step
is responsible for the cell lysis. After incubation, 250 µl of Solution C was added, as
to stop the lysis process. Sample was then centrifuged at 14.000 x g for 5 min, super-
natant applied to a minispin column and respective collector tube, and submited to
new centrifugation step. Flow-through was discarded, as DNA stays trapped in the
cellulose-based membrane. DNA is then washed with Washing solution, flowthrough
discarded, and membrane properly dry. After fitting column into clean collector tube,
DNA was eluted by applying 50 μl of warm MQ-water onto the membrane and spin-
ing it for 1 min at 14.000 x g. Plasmid DNA was quantified using the NanoDrop spec-
tophotometer (Thermo Scientific) and stored at – 20 °C.
1.2.5.2 Isolation of Plasmidic DNA from S.cerevisiae
For isolation of plasmidic DNA from S.cerevisiae strains, no kits were used, and in-
stead a manual phenol/chloroform extraction protocol was applied. To this end, cells
were grown overnight on YPD as described in Section 1.2.2, in 10 ml cultures. En-
tire cell mass was collected by low speed centrifugation (5 min at 3000rpm), super-
natant discarded, and pellet disrupted by vortexing. Cells were re-suspend in 200 μL
of Breaking Buffer (10 mM Tris Hcl, pH 8.0 / 2 % Tx-100 / 1 % SDS / 100 mM NaCl / 1
mM EDTA, pH 8.0) and ≈200 μl volume of glass beads and 200 μl phenol/chloroform/isoamyl
alcohol was added. Sample was then submitted to 3 min of bead-beating (4ºC) and
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centrifuged for 5 min at 13.000rpm (RT). Supernatant was transferred to new tube,
and 1/10 of the total volume of cold sodium acetate (3 M, pH 5.2) and 3 volumes of
cold 100 % ethanol were added. Sample was incubated for 1 h at -80ºC, centrifuged
at 16.000 x g for 30 min (4ºC), supernatant discarded and tube rinsed with 70 % ethanol.
After another step of centrifugation (15min, 16.000 x g), supernatant was discarded
and pellet air dryed. Finnaly, pellet was resuspended in 100 µl of TE Buffer (10 mM
Tris-HCl, pH 7.5 / 1 mM EDTA) and quantified using a NanoDrop spectophotometer
(Thermo Scientific) and stored at 4 ºC.
1.2.5.3 Isolation of S.cerevisiae total DNA
For isolation of total DNA from S.cerevisiae, cells were grown overnight on YPD as
described in Section 1.2.2, in 10 ml cultures. Cells were collected at 3000rpm for 5
min (RT) and washed with 0.5 ml of distilled water. After a quick sedimentation step
(5 sec at 16.000 x g, RT), supernatant was discarded, pellet disrupted by vortexing,
and resuspended in 200 µl of Breaking Buffer (10 mM Tris Hcl, pH 8.0 / 2 % Tx-100
/ 1 % SDS / 100 mM NaCl / 1 mM EDTA, pH 8.0). After adding ≈200 µl and 200 µl
phenol/chloroform/isoamyl alcohol, sample was vortexed at highest speed for 3 min.
At this point, 200 µl of TE Buffer (10 mM Tris-HCl, pH 7.5 / 1 mM EDTA) were added
and sample was vortexed briefly, followed by a centrifugation at 16.000 x g for 5 min
(RT). Aqueous layer was transferred to new tube, 1 ml of 100 % ethanol was added,
and sample mixed by inversion. After new sedimentation step (16.000 x g for 3min,
RT), pellet was resuspend in 400 µl TE Buffer and 15 µl of DNase-free RNase A (10
mg/ml, Sigma) was added, sample mixed and incubated for 15min at 37ºC. After in-
cubation, 10 µl of 4 M ammonium acetate and 1 ml of 100 % ethanol were added,
sample mixed by inversion and centrifuged at 16.000 x g for 3 min (RT). Pellet was
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washed with 15 % ethanol, air dryed, resuspended in 100 µl of TE Buffer and quanti-
fied using a NanoDrop spectophotometer.
1.2.6 Agarose Gel Electrophoresis
Agarose gel electrophoresis was performed to separate, identify and purify DNA frag-
ments. In general, DNA samples were mixed with DNA Loading Dye (6X: 50 % (w/v)
Sucrose / 0.15 % (w/v) Bromophenol Blue / 0.02 M EDTA) and loaded onto a 1 %
Agarose Gel (1 % (w/v) Agarose / 2 % (v/v) 50X TAE / 90 % (v/v) dH2O) containing
0.5 µg ml-1 Ethidium Bromide (EtBr). The gel was placed in a Peqlab gel tank con-
taining 1X TAE buffer (Tris Acetate EDTA / 50X: pH 8.4 / 20 M Tris- HCl / 10 M Acetic
Acid / 0.05 M EDTA). Electrophoresis was then carried out at 100 - 120 V for 1-2
hr. GeneRuler™ 1 kb DNA ladder (Fermentas) was used as the size standard (0.5
µg loaded). The gel was placed over a transilluminator for visualization of the DNA,
which was photographed using the E-Box VX2 Gel Documentation System (Peqlab).
1.2.7 Recovery of DNA Fragments
In order to recover DNA from agarose gels, the GenElute™ Gel Extraction Kit (Sigma-
Aldrich) was used. The appropriate DNA band was excised from the agarose gel us-
ing a sterile scalpel, and then transferred into a 2 ml microcentrifuge tube. The gel
slice was resuspended in 3 gel volumes of Gel Solubilization Solution. The mixture
was incubated at 60 °C until the gel was dissolved followed by the addition of 1 gel
volume of 100 % isopropanol. The gel solution was loaded onto an equilibrated bind-
ing column and spun for 1 min at full speed in a benchtop centrifuge (MiniSpin®, Ep-
pendorf). The flow-through liquid was discarded each time. Next, 700 µl of Wash So-
lution were added to the binding column and the column centrifuged for 1 min at RT,
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full speed. Once all of the solution had been passed through the binding column, the
column was centrifuged as before in order to remove residual Wash Solution. The
DNA was eluted by addition of 50 µl warm MQ water to the membrane of the bind-
ing column and incubated for 1 min at RT followed by centrifugation for 1 min at full
speed. DNA was stored at – 20 °C until needed.
1.2.8 Restriction Digestion of PCR Products and Plasmid DNA
All endonuclease restriction digestions were carried out in a 50 µl reaction mixture
containing the appropriate buffer, as recommended by the supplier (NEB, if not stated
otherwise), and 10 units of enzyme per µg of DNA. Reaction mixtures were incubated
for 1-2 hr at 37 °C (SmaI: 25 °C) and afterwards either heat-inactivated as recom-
mended or cleaned with the PCR cleaning Kit (Sigma). DNA was then analyzed by
gel electrophoresis (Section 1.2.6). In the case of two enzymes being used, the buffer
in which both enzymes exhibit the highest efficiency was used at the appropriate con-
centration. The standard reaction mixture is outlined in Table 1.18. For digestions of
larger amounts of DNA, the amounts of enzymes and buffer were increased and the
amount of water adjusted accordingly.
Table 1.18: Standard reactionmixture for the restriction of DNA.
Component DNA Buffer* Restriction Enzyme dHO
Volume (µl) x (1 µg) 5 1 (10U) to 50
* The buffers were those recommended by the suppliers.
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1.2.8.1 DNA cleaning
For liniarized DNA cleaning after processing (either by PCR or by enzymatic treat-
ment) the GenElute™ PCR Clean-Up Kit was used. Briefly, mini-spin columns sup-
plied in the kit were prepared by adding 500 µl of Column Preparation Solution and
centrifuging at 14.000xg for 1 min. Flowthrough was discarded. DNA sample was
then diluted by adding 5 volumes of Binding Solution to 1 volume of the DNA sample,
mixed, applied to the column, centrifuged at 14.000xg for 1 min and flowthrough dis-
carded. Column was washed with 750 µl of Washing Solution, centrifuged twice at
14.000xg (once for 1 min and once for 2 min, exchanging collector tube in between),
and left to dry for some minutes. DNA elution was done by adding 50 µl of warm MQ
water to the center of the column, leting it sit for a couple of minutes, and then cen-
trifuge the column at 14.000xg for 1 min in a clean eppendorf. Sample was then quan-
tified using a NanoDrop spectophotometer (Thermo Scientific).
1.2.9 Dephosphorylation of Vector DNA
FastAP™ Thermosensitive Alkaline Phosphatase (Thermo Fisher Scientific) was
used to hydrolyze 5’ phosphate group prior to ligation in case of double blunt end
cloning, in order to avoid re-ligation of the digested vector. The reaction mix (Table
1.19) consisted of 1 unit of FastAP™ Thermosensitive Alkaline Phosphatase, 1/10
volume of 10X FastAP™ buffer and 1 µg of vector DNA. The sample was incubated
at 37 °C for 10 min and heat-inactivated at 65 °C for 15 min.
Table 1.19: Reactionmixture for the dephosphorylation of digested vector DNA.
Component DNA Buffer FastAP dHO
Volume (µl) x (1 µg) 2 1 to 20
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1.2.10 Phosphorylation of insert DNA
T4 Polynucleotide Kinase (PKN) (NEB) was used to add a 3’ phosphate group to the
insert prior to ligation, in case of double blunt end cloning, in order to allow ligation
with the dephosphorilated digested vector. The reaction mix (Table 1.20) consisted
of 1 unit of FastAP™ Thermosensitive Alkaline Phosphatase, 1/10 volume of 10X
FastAP™ buffer and 1 µg of vector DNA. The sample was incubated at 37 °C for 10
min and heat-inactivated at 65 °C for 15 min.
Table 1.20: Reactionmixture for the dephosphorylation of digested vector DNA.
Component DNA Buffer T4 PKN dHO
Volume (µl) x (1 µg) 2 1 to 20
1.2.11 Ligation of Vector DNA and Insert DNA
In general, following digestion of vector and insert DNA with the appropriate enzyme(s)
to create matching sticky ends, the ligation was carried out for 10 min at 22 °C in a
water bath using the T4 DNA ligase (Fermentas). The reaction mixture contained
10X T4 DNA ligase buffer, 2 units of T4 DNA ligase (2 U/µl) and a 3:1 ratio of insert
to vector. Ligations were prepared according to the reaction mixture presented in Ta-
ble 2.17. Generally, 10 µl of the ligation were used to transform E. coli cells.
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Table 1.21: Standard reactionmixture for the ligation of vector and insert DNNA.
Component Buffer Vector DNA Insert DNA dHO T4 DNA Ligase
Volume (µl) 2 x (50 ng) y (3:1*) to 20 1
* Molecular ratio insert : vector
1.2.12 Transformation of E.coli Cells with Plasmidic DNA
1.2.12.1 Preparation of Chemically Competent E.coli Cells
E.coli DH5α cells were grown to an OD of approximately 0.5-0.7 and subsequently
centrifuged at 4000 rpm at 4°C for 6 min (Sorvall Evolution RC centrifuge, SLA3000
rotor). The pellet was resuspended in 8.5 ml of cold and sterile TFPI buffer at pH 5.8
(30 mM KOAc / 100 mM KCl / 10 mM CaCl / 50 mM MnCl / 10 % glycerol) and incu-
bated on ice for 10 min. After centrifugation at 4000 rpm at 4°C for 6 min, the pellet
was resuspended in 1 ml of cold and sterile TFPII buffer at pH 6.5 (10 mM KCl / 75
mM CaCl / 10 % glycerol / 10 mM MOPS) and incubated on ice for 30 min. The sam-
ple was then divided into 50 or 100 µl aliquots that were flash frozen in liquid nitrogen
and stored at -80°C until use.
1.2.12.2 Transformation of chemically competent E. coli cells
To generate recombinant bacteria, 10-100 ng of plasmid DNA were added to 100
μl of chemically competent E.coli DH5α cells. Cells were incubated for 20 min on
ice and subsequently heat-shocked at 42°C for 2 min. Next, 700 μl of pre-warmed
LB medium were added and cells were incubated for 1 h at 37°C under shaking. Af-
ter centrifugation (1 min, 10000 rpm; Eppendorf 5415 R microcentrifuge), the super-
natant was discarded by decanting and cells were resuspended in the residual LB
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medium. Cells were finally plated onto LB agar plates containing the appropriate se-
lection marker (ampicillin, kanamycin, etc.).
1.2.13 DNA Sequencing
In order to analyze DNA sequences all plasmids were sequenced. Miniprep DNA
samples of all transformants of interest were sent for sequencing. Sequencing (single
read sequencing) was performed by GATC Biotech AG (Konstanz) according to the
sequencing method by Sanger et al. [330]. For the great majority of sequencings the
M13 primers were routinely used if not stated otherwise. The results were analyzed
with the Snapgene® software.
1.2.14 Preparation of Lyticase
Lyticase preparation was done according to a protocol from R. Schekman’s labora-
tory. Briefly, from a 200 ml overnight culture of the strain RSB805, 10 L (8 x 1.25 L)
of LB-Amp medium were inoculated with 15 ml of the culture. Cells were grown at 37
°C, 200 rpm to an OD of 0.5. The cultures were then induced with 0.5 mM IPTG
for 5 hr at 37 °C, 200 rpm. Cells were then harvested (4200 rpm for 10 min, 4 °C)
(Sorvall Evolution® RC Centrifuge, SLA3000 rotor). Pellets were resuspended with
400 ml 25 mM Tris, pH 7.4 and pooled. The resulting pellet was centrifuged for 5 min,
4 °C at 8000 rpm. The supernatant was discarded and the pellet resuspended with
200 ml 25 mM Tris, pH 7.4 / 2 mM EDTA. An equal volume of 25 mM Tris pH 7.4 / 40
% sucrose was slowly added to the suspension which was stirred very slowly for 20
min at RT on a magnetic stirrer (RH basic 2 IKAMAG®, IKA®). The suspension was
then centrifuged as before and the supernatant discarded carefully (in the cold room)
as the resulting pellet was very soft. The pellet was resuspended with 150 ml of ice-
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cold 0.5 mM MgSO4, slowly stirred in the cold room for 20 min and centrifuged as
before. The supernatant containing the lyticase was aliquoted in 15 ml falcon tubes,
snap-frozen in liquid nitrogen and stored at – 80 °C. Lyticase activity was determined
using the yeast strain KRY49 (Table 1.5). Cultures (50 ml) were grown in YPD to an
OD of 2, harvested for 5 min at 4200 rpm (Sorvall Evolution® RC Centrifuge, SS34
rotor), RT and resuspended in 50 mM Tris-HCL pH 7.4/ 10 mM DTT to an ODof
2 (ODSTART). Aliquots (1 ml) of the yeast culture (duplicates or triplicates) were
incubated with various concentrations of lyticase (0.01, 0.02, 0.5, 1, 2 µl). Samples
were incubated at 30 °C for 30 min and the OD was immediately measured. The
lyticase activity was determined based on the principle that a 10 % decrease of OD
corresponds to 1U of lyticase activity. The higher the lyticase activity, more shifted to
the low lyticase-amount range will the activity linearity zone be.
1.2.15 Transformation of S.cerevisiae
S. cerevisiae transformations were done using the Lithium Acetate method (LiAc/SS-
DNA/PEG) [117, 118]. Briefly, a 25 ml culture of S.cerevisiae was grown overnight at
30 °C as described in Section 1.2.2. For each transformation reaction, 2 ml of cells
were harvested (3000 rpm for 2 min at RT) (Minispinner Table top) and washed with 1
ml of sterile LiAc/TE Solution (10 mM Tris -HCl, pH 7.5 / 100 mM LiAc / 1 mM EDTA).
The pellet was resuspended in 100 µl of LiAc/TE Solution, and 20 µl of carrier DNA
(DNA from salmon testes, 10 mg/ml (Sigma), boiled for 5 min prior to use), 1 µg of
DNA (previously linearized if it is an integrative vector), 600 µl of PEG solution (10
mM Tris -HCl, pH 7.5 / 100 mM LiAc / 1 mM EDTA / 40 % PEG), and 50 µl of 1
M LiAc were added (all solution were filter-sterilized). Sample was mixed gently and
incubated for 1 hr at 30 °C, followed by 15 min at 42 °C after adding 20 µl of DMSO.
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Cellular fraction was collected (3000 rpm for 2 min) and pellet washed in 1 ml of TE
(10 mM Tris-HCl pH 8.0 / 1 mM EDTA pH 8.0). After one last resuspension in 100 µl
of TE Solution, cells were plated onto the appropriate minimal medium plates or an-
tibiotic supplemented plates and incubated at 30 °C for 2-4 days. The LiAc method
was applied to transform all S. cerevisiae strains in this work with the appropriate
plasmid DNA or linear DNA (Table 1.6) to create the desired strains.
1.2.16 Verification of S.cerevisiae Transformants
Positive transformants were picked and plated onto minimal medium plates lacking
the auxotrophic aminoacid followed by isolation of their genomic DNA (Section 1.2.5.3)
which was used as template in a PCR reaction (Section 1.2.4) with target-gene spe-
cific primers to confirm proper integration of the desired sequence into the yeast genome.
The PCR product was further sequenced to guarantee gene identity and quality. Trans-
formants in the KRY461 (pGAL-SEC61) background were verified by plating onto
minimal medium without LEU (2 % (w/v) Galactose/ 0.2 % (w/v) Glucose) after the
transformation. Plates were incubated at 30 °C for 2-4 days. Transformants were
plated onto 5-FOA plates (0.002 % (w/v) Uracil, supplements according to auxotro-
phies (lacking Uracil) / 0.67 % (w/v) YNB w/o Amino Acids / 2 % (w/v) Glucose / 2 %
(w/v) Agar / 0.1 % (w/v) 5-Fluoroorotic acid (Fermentas)). Real positive transformants
were able to grow.
1.2.17 S.cerevisiae Growth on Plates (Drop Test)
YPD Cultures (5 ml) were inoculated with a single colony and grown overnight at 30
°C and 220 rpm. In the next day the cells were counted in a hemocytometer (Neubauer
chamber) and the cell number per ml was determined. For each strain serial dilutions
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in sterile MQ water were prepared and 5 μl of each dilution were dropped onto YPD
or minimal medium (concentrations on plate: 10 – 10). For temperature sensitivity
assays, the plates were incubated at various temperatures (20, 30 or 37 °C) for at
least 3 days. For tunicamycin sensitivity, the plates were supplemented with 0.25, 0.5
or 0.75 µg/ml of tunicamycin and incubated at 30 ºC for at least 3 days.
1.2.18 Isolation of S.cerevisiae RNA
The preparation of yeast total RNA was done according to Current Protocols in Molec-
ular Biology. Briefly, 10 ml of a yeast culture were grown to an OD of 1 at 30 °C,
220 rpm. Cells were harvested for 5 min at 4 °C, 7000 rpm (Sigma 4K15 Refrigerated
Centrifuge, 11140 rotor). The supernatant was discarded and the pellet was resus-
pended in 1 ml of ice-cold RNase-free water (DEPC-treated) and transferred to clean
RNase-free microcentrifuge tube. The cells were centrifuged at full speed, 4 °C for
10 sec. The supernatant was discarded and the pellet resuspended with 400 μl TES
Solution (10 mM Tris-HCl, pH 7.7 / 10 mM EDTA / 0.5 % (w/v) SDS). Next, 400 μl of
Acid Phenol (Roti®-Aqua-Phenol, Carl Roth) were added and the sample vortexed
for 10 sec and incubated at 65 °C for 1 hour with occasional vortexing. After the in-
cubation step, the sample was placed on ice for 5 min, followed by a centrifugation
at full speed, 4 °C for 5 min. The aqueous (top) phase was transferred to a clean mi-
crocentrifuge tube. 400 μl Roti®-Aqua-Phenol were added and the sample was vor-
texed for 20 sec, incubated on ice for 5 min and centrifuged as before. The resulting
aqueous phase was transferred to a clean microcentrifuge tube and mixed with 400 μl
chloroform, vortexed for 20 sec and centrifuged as before. The aqueous phase was
transferred to a clean microcentrifuge tube and 40 μl of 3 M NaAc (pH 5.3) and 1 ml
of ice-cold 100 % ethanol were added. The sample was vortexed and centrifuged as
95
before. The resulting pellet was washed with 1.5 ml 70 % (v/v) ethanol, centrifuged as
before and resuspended in 50 μl RNase-free dH2O (DEPC-treated). RNA concentra-
tion was determined using a NanoDrop spectrophotometer (Thermo Scientific), and
RNA was stored at – 20 °C.
1.2.19 Protein Gel Electrophoersis and Western Blot Analysis
1.2.19.1 Preparation of Cell Extracts
For the preparation of yeast cell extracts fresh overnight cultures were used to inocu-
late 25 ml YPD. Cells were grown to an OD of 1 at 30 °C, 220 rpm. Next, 2 OD
of cells were harvested at 8000 rpm for 1 min (MiniSpin® Centrifuge, Eppendorf) and
the supernatant was discarded. The pellet was washed with 1 ml of sterile MQ wa-
ter, resuspended in 200 µl 2X SDS Sample Buffer (100 mM Tris-HCl, pH 6.8 / 4 %
SDS / 0.2 % bromophenol blue / 20 % glycerol / 200 mM DTT). About 100 μl of glass
beads (acid washed, 1 mm, Sigma) were added and the cells disrupted in the cold
room using a bead beater (Mini-Beadbeater-16; Bio Spec Products Inc.). Disruption
was conducted over 3 cycles of 2 min (with 1 min of disruption followed by 1 min of
rest). The samples were heated for 10 min at 65 °C and centrifuged at 14.000 x g for
1 min. Samples were then ready to be resolved by SDS-PAGE (Section 1.2.19.2).
1.2.19.2 Protein Gel Electrophoresis
Protein gel electrophoresis (SDS-PAGE) was routinely conducted using NuPAGE®
Novex® Pre-Cast Bis-Tris gels (generally 4-12 % gels, 1.5 mm, 10 wells) and the
XCell SureLock™ Mini-Cell (both Invitrogen) if not stated otherwise. Prior to loading
an appropriate volume of the protein sample onto the gel, samples were prepared by
adding the appropriate volume of 2X SDS-Sample Buffer and heating samples at 95
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°C (65 °C for membrane proteins) for 5 min (10 for membrane proteins). The sam-
ples were run in 1X NuPAGE® MOPS SDS Running Buffer (Invitrogen) at 80-160 V,
RT using a Bio-Rad PowerPac™ HC power supply, until the gel front ran off the bot-
tom of the gel. The PageRuler™ Prestained Protein Ladder or the PageRuler™ Plus
Prestained Protein (both Fermentas) were used as the size standard according to the
supplier’s instructions.
1.2.19.3 Coomassie Staining (Normal)
For Coomassie gel staining, after SDS-PAGE, the gels were incubated with 50-100 ml
of staining solution (0,025 % CBB G-250 ) in a lid containing box, the box was closed,
and the gel was incubated for 20 min at 65 ºC. After incubation, gel was rinsed multi-
ple times with destaining solution (30 % methanol / 10 % acetic acid), and incubated
in it (under shacking) until adequate background was reached. After destaining, gel
was rinsed with MQ Water two times.
1.2.19.4 Coomassie G-250 Staining (Normal)
For Coomassie G-250 gel staining, after SDS-PAGE, the gels were incubated under
shaking with 50-100 ml MQ Water (3X10min). After disposing of all the water, 50-100
ml of staining solution (0,02 % CBB G-250 / 5 % Aluminum Sulfate Hydrate / 10 %
Ethanol / 2 % Orthophosphoric acid) were added to the gel in a lid containing box, the
box was closed, and the gel was incubated overnight under shaking. After incuba-
tion, gel was rinsed twice with MQ Water and incubated with destaining solution (10
% Ethanol / 2 % Orthophosphoric acid) for 60min. After destaining, gel was rinsed
with MQ Water two more times.
97
1.2.19.5 Coomassie Staining for Mass Spectrometry
After SDS-PAGE the gel was placed into staining solution (0.08 % Coomassie Bril-
liant Blue G250 / 10 % citric acid / 8 % ammonium sulfate /20 % methanol) for 6h to
overnight. Gel was de-stained with distilled water (several changes) until the back-
ground was clear. Protocol suggested by the EMBL Proteomics Core Facility.
1.2.19.6 Western Blot Analysis
Western Blotting was employed to identify target proteins using appropriate antibod-
ies. The first part of the Western Blot protocol consists on the transfer of proteins
from the protein gel (Section 1.2.19.2) onto nitrocellulose (NC) membranes (0.45 μm
pore size, Bio-Rad). To this end, a ”sandwich” containing the acrylamide gel and the
NC membrane, as well as 3 MM Chromatography Paper (Whatman®) and sponges
soaked in Transfer Buffer (25 mM Tris / 200 mM Glycine / 20 % (v/v) Methanol / 0.2
% (w/v) SDS) were assembled . The protein transfer was then conducted in Transfer
Buffer for 2 hr at 100 V in the cold room using a Trans-Blot® Electrophoretic Transfer
Cell (with plate electrodes and super cooling coil, Bio-Rad).
For the the second part of the Western Blot protocol, the immunoblot and detec-
tion phase, the membrane was blocked in Blotto (50 mM Tris-HCl, pH 7.4 / 150 mM
NaCl / 2 % (w/v) Milk Powder / 0.1 % (v/v) Tween-20 / 5 mM Sodium Azide) for 1 hr
under shaking (RT). The membrane was then incubated under shaking with the pri-
mary antibody (Section 1.8) diluted in Blotto for 2h at RT or overnight in the cold room.
The membrane was then washed twice (10 min) in Blotto followed by 2 washes (also
of 10 min) in 1X TBS-T (50 mM Tris-HCl, pH 7.4 / 150 mM NaCl / 0.1 % (v/v) Tween-
20 / 5 mM Sodium Azide). For the last step, the membrane was incubated with the
secondary antibody (Table 1.8) diluted in 1X TBS-T shaking for 1 hr at RT. The mem-
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brane was washed 4 times for 10 min with TBS-T. The blot was prepared for detec-
tion using the SuperSignal™ West Dura Extended Duration Chemiluminescent Sub-
strate (Pierce) according to the supplier’s instructions. Signals were detected using
the Amersham Imager 600 (GE Healthcare).
1.2.20 Preparation of Rough Microsomal Membranes
The isolation of rough microsomal membranes from S. cerevisiae was performed
according to Lyman & Schekman [230] and Pilon et al. [289]. Briefly, 2.5-10 L of a
yeast culture were grown overnight in YPD at 30 °C and 200 rpm to an OD of ≈2.
The cells were harvested at 5.000 rpm and RT for 3 min (Sorvall Evolution® RC cen-
trifuge, SLA3000 rotor), the pellet was resuspended in 100 mM Tris-HCl pH 9.4 / 10
mM DTT to 100 OD/ml and then incubated for 10 min at RT in order to weaken
the cell walls. Cells were pelleted for 5 min at 5.000 rpm, RT and then resuspended
in Lyticase Buffer (50 mM Tris-HCl, pH 7.5 / 0.75 X YP / 700 mM Sorbitol / 0.5 %
Glucose / 10 mM DTT) to 100 OD/ml. Lyticase was added to a final concentra-
tion of 40 U per OD of cells, and sample incubated for 20 min at 30 °C, 80 rpm
(Multitron Standard Incubation Shaker, Infors HT). Following the incubation, the cells
were chilled on ice for 2 min and then pelleted for 5 min at 5000 rpm, 4 °C. The su-
pernatant was carefully discarded and the pellet washed with 2X JR Buffer (40 mM
Hepes-KOH, pH 7.4 / 400 mM Sorbitol / 100 mM KOAc / 4 mM EDTA) to 250 OD/ml
and centrifuged at 10.000 rpm and 4 °C for 10 min (Sorvall Evolution® RC centrifuge,
SS34 rotor). The resulting pellet was resuspended in 2X JR buffer to 500 OD/ml
and frozen at – 80 °C for at least 1 hr. The spheroplasts were thawed in an ice-cold
water bath and mixed with an equal volume of cold MQ water. PMSF and DTT were
added to a final concentration of 1 mM and the spheroplasts were disrupted with ten
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strokes of a motor-driven Potter Elvehjem homogenizer (EUROSTAR power basic,
IKA®) in the cold room. The lysate was centrifuged for 5 min at 3.000 rpm, 4 °C (Sor-
vall Evolution® RC Centrifuge, SS34 rotor) and the supernatant transferred to a clean
polycarbonate SS34 tube and centrifuged at 17.500 rpm, 4°C for 15 min to pellet the
membranes. The sample was placed on ice and the pellet was resuspended in a min-
imum volume (≈0.5 ml) of B88 (20 mM Hepes-KOH, pH 6.8 / 250 mM Sorbitol / 150
mM KOAc / 5 mM Mg(OAc)) and gently homogenized on ice using a small teflon pes-
tle and carefully resuspended using a Gilson® pipette. The sample was loaded onto
a 1.2 M/1.5 M Sucrose Gradient (20 mM Hepes-KOH, pH 7.5 / 50 mM KOAc / 2 mM
EDTA / 1 mM DTT / 1.2 M or 1.5 M Sucrose) and centrifuged at 44.000 rpm, 4 °C for
1 hr (Optima™ L-90 K Ultracentrifuge, SW 60 Ti rotor). For the sucrose gradient, 1.5
ml of each sucrose solution (1st: 1.5 M, 2nd: 1.2 M) was layered into an SW60Ti tube
(Beckman Coulter). ER-derived microsomes were collected at the interphase of the
1.2 M/1.5 M sucrose gradient and washed with 25 ml of cold B88. The sample was
centrifuged at 17.500 rpm, 4 °C for 15 min (Sorvall Evolution® RC Centrifuge, SS34
rotor). The microsome pellet was carefully resuspended in the appropriate volume of
B88. Membrane concentration was measured at OD in 2 % (w/v) SDS at a 1:200
dilution. The concentration was adjusted to an OD of ≈30 with B88 and the sam-
ples aliquoted (50 μl), snap-frozen in liquid nitrogen and stored at – 80 °C.
1.2.21 Small Scale Preparation of Hot Rough Microsomal Membranes
To prepare radiolabeled ER vesicles, 7 OD of early log-phase cells were incubated
in synthetic minimal media supplemented appropriately and lacking methionine, cys-
teine, and ammonium sulfate for 30 min at 30ºC, 220 rpm. Cells were labelled with
6,5 MBq []S methionine/cysteine (Express Labeling, PerkinElmer) mix for 30 min. Af-
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ter labelling, cells were immediately washed twice with Tris-Azide Buffer (20 mM Tris-
HCl, pH 7.5 / 20 mM sodium azide). Cells were then incubated in 100 mM Tris-HCl,
pH 9 / 10 mM DTT for 10 min at room temperature, sedimented, and resuspended
in 300 µl of 2 x JR Lysis Buffer (40 mM Hepes-KOH, pH 7.4 / 400 mM sorbitol / 100
mM KOAc / 4 mM EDTA / 1 mM DTT / 1 mM PMSF) [289]. Acid-washed glass beads
(1/2 volume) were added and the sample submitted to 2 cycles of 1 min bead-beating
(Mini-beadbeater-16, BioSpec) with 2 min of incubation on ice after each cycle. From
this point on, all samples were kept at 4ºC. Beads were washed 3 times with 300 µl
of B88, pH 7.2 (20 mM Hepes-KOH, pH 6.8 / 250 mM sorbitol / 150 mM KOAc / 5
mM Mg(OAc)). Washes were pooled and sedimented for 2 min at 1.500 x g and the
microsome-containing supernatant was transferred to a clean tube. Microsomes were
then sedimented at 16.000 x g for 10 min, washed and resuspended in 200 µl B88,
pH 7.2. Crude radiolabelled ER vesicles were then aliquoted (50 µl), flash frozen in
liquid nitrogen, and stored at -80ºC.
1.2.22 HAC1 mRNA Splice Assay
Upon induction of the UPR the HAC1 mRNA is spliced. Thus, the comparison of the
two species, HAC1V and HAC1J (u = uninduced; i = induced), allows for the evaluation
of the UPR status of various yeast strains. Cultures of the appropriate strains were
prepared in minimal medium and grown at 30 °C, 220 rpm to an OD of 1. For posi-
tive controls each strain was grown in the presence of tunicamycin (Tm). In this case,
when an OD of 1 was reached, 2 μg/ml Tm were added to the cultures. The cul-
tures were then incubated for another 3 hr at 30 °C, 220 rpm. A volume of 10 ml of
each culture was pelleted, and used to isolate yeast RNA according to Section 1.2.18.
RNAs were then diluted to a final concentration of 0.1 μg/μl, and used in reverse tran-
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scription reactions to generate cDNA using the Maxima® Reverse Transcriptase (Fer-
mentas). The reaction setup was as shown in Table 1.22. The samples were incu-
bated for 30 minutes at 50 °C, followed by an inactivation at 85 °C for 5 minutes.
Table 1.22: Reverse transcription reactionmixture.
Component Volume (µl) Final concentration
RNA 1 0.1 µg
Oligo(dT-primer (100 mM) 1 100 pmol
dNTP mix (10 mM) 1 0.5 mM
RNase-free dHO to 14.5 to 14.5 µl
5X RT Buffer 4 1X
RNasin (40 U/µl) 0.5 20U
Maxima® RT 1 200U
* Molecular ratio insert: vector
Each cDNA (0.1 μg) was used in a PCR using the HAC1 as well as the ACT1 spe-
cific primers (Table 1.7). The PCR setup was as described in Table 1.13. The thermal
cycler program was as described in Table 1.14 with the following exceptions: primer
annealing (step 3) was at 50 °C, primer extension (step 4) was for 45 sec, final primer
extension was for 3 min and steps 2 to 4 were cycled 24 times. The PCR products
(10 μl) were resolved on a 1 % Agarose Gel in 1X TAE Buffer (50X TAE pH 8.4 / 20 M
Tris-HCl / 10 M Acetic Acid / 0.05 M EDTA) at 100 V and RT for 1 hr (Section 1.2.6).
Bands were visualized and photographed using the E-BOX VX2 gel documentation
system (Peqlab).
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1.2.23 Cyclohexemide chase
For cycloheximide chases, cultures were grown to a maximum OD of 1 and were
treated with 200 μg/ml cyclohexemide (Merck), time at which the 0 time points were
taken, cells sedimented and flash-frozen. After all time points had been taken in simi-
lar fashion, samples were thawed on ice, washed with Tris-Azide Buffer (20 mM Tris-
HCl, pH 7.5 / 20 mM Sodium Azide), resuspended in 50 μl of 2x SDS-buffer (100 mM
Tris-HCl, pH 6.8 / 4 % SDS / 0.2 % bromophenol blue / 20 % glycerol / 200 mM DTT)
and lysed with glass beads (Sigma) in a Mini-Beadbeater-16 (BioSpec; three 1 min
disruption cycles at 4ºC with 1 min of incubation at 4ºC between cycles). Lysates
were heated for 10 min at 65ºC before Western Blot analysis as described in Section
1.2.19.6.
1.2.24 Pulse-Chase Experiments
1.2.24.1 Pulse Labeling
Pulse experiments were performed as described by Gillece et al. [120] and Verma
et al. [412]. Briefly, cells were grown overnight at 30 °C, 220 rpm in Growth Medium
(0.67 % (w/v) Yeast Nitrogen Base (YNB) w/o Amino Acids (AA) / 0.13 % (w/v) SC
drop-out mix / 0.2 % (w/v) Casamino Acids (CAA) / 5 % (w/v) Glucose, Supplements
as required by the strain’s auxotrophies) to an OD of 0.5–1. Cells were harvested
at 3000 rpm, RT for 5 min, washed twice with Labeling Medium (0.67 % (w/v) YNB
w/o AA and Ammonium Sulfate / 5 % (w/v) Glucose, Supplements as required by
the strain’s auxotrophies), and resuspended in Labeling Medium to an OD of 6.
Aliquots of 1.5 OD were transferred to clean 2 ml microcentrifuge tubes. The sam-
ples were pre-incubated at 30 °C, 800 rpm for 15 or 30 min (Thermomixer® comfort,
Eppendorf). Cells were then pulsed with 0.35 mCi/ml Express Protein Labeling Mix
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(Perkin Elmer) and incubated for 5, 10 or 30 min (depending on the substrate) at 800
rpm, 30 °C or 20 ºC (if at the restrictive temperature). Following the pulse, cells were
immediately transferred to ice killed by adding 750 μl of cold Tris-Azide Buffer (20 mM
Tris-HCl, pH 7.5 / 20 mM Sodium Azide). The cells were then sedimented for 1 min at
full speed, the pellets resuspended in 1 ml of Resuspension Buffer (100 mM Tris-HCl,
pH 9.4 / 10 mM DTT / 20 mM Ammonium Sulfate) and incubated for 10 min at RT.
The samples were centrifuged as before and resuspended in 150 μl of Lysis Buffer
(20 mM Tris-HCl, pH 7.5 / 2 % (w/v) SDS / 1 mM PMSF / 1 mM DTT). Acid washed
glass beads (≈150 μl, 1 mm, Sigma) were added and the cells disrupted in a Mini-
Beadbeater-24 (Bio Spec Products Inc.) for 2 x 1 min with 1 min pause in between cy-
cles. Samples were then denatured at 90 °C for 5 min (10 min at 65 °C for membrane
proteins). Beads were washed 3 times with 250 μl of IP Buffer w/o SDS (15 mM Tris-
HCl, pH 7.5 / 150 mM NaCl / 1 % (v/v) Triton X-100 / 2 mM Sodium Azide), the sam-
ples vortexed and centrifuged as before, each time and the supernatants pooled in a
clean 2 ml microcentrifuge tube. The sample was then submitted to immunoprecipita-
tion as described in Section 1.2.24.3 and resolved by SDS-PAGE (Section 1.2.19.2).
1.2.24.2 Chasing
For pulse-chase experiments, after labeling, two aliquots per sample were immedi-
ately killed and set aside, while to the other time points 250 µl of 2x Chase Mix (0.008
% Met / 0.006 % Cys / 20 mM ammonium sulphate) was added and incubation con-
tinued until they reached desired incubation time. Samples were then treated as for
normal pulses (Section 1.2.24.1)
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1.2.24.3 Immunoprecipitation
The samples were precleared by adding 60 μl of 20 % (w/v) Protein A Sepharose™
CL-4B (GE Healthcare) in IP Buffer(15 mM Tris-HCl, pH 7.5 / 150 mM NaCl / 1 %
(v/v) Triton X-100 / 2 mM Sodium Azide / 0.1 % (w/v) SDS) incubating for 30 min
under rotation at RT. After pre-clear, sample was centrifuged for 2 min at full speed,
RT and each supernatant was transferred to a clean microcentrifuge tube contain-
ing 60 μl of 20 % (w/v) Protein A Sepharose™ CL-4B as well as the appropriate an-
tibody/antiserum (Table 1.8). The samples were then incubated either overnight at 4
°C (cold room) or at RT for 2 hours on a rotating wheel. Samples were centrifuged
for 2 min at full speed, RT, washed with 1 ml of IP Buffer with SDS and 1 ml of Urea
Wash (2 M Urea / 200 mM NaCl / 1 % (v/v) Triton X-100 / 100 mM Tris-HCl, pH 7.5
/ 2 mM Sodium Azide) three tines each, and washed once with 1 ml of ConA Wash
(500 mM NaCl / 1 % (v/v) Triton X-100 / 20 mM Tris-HCl, pH 7.5 / 2 mM NaN3) and 1
ml of Tris-NaCl Wash (50 mM NaCl / 10 mM Tris-HCl, pH 7.5 / 2 mM NaN3). Sam-
ples were centrifuged for 1 min at full speed, RT, and the supernatants discarded.
After the washes, 20 μl of 2X SDS-PAGE Protein Sample Buffer (125 mM Tris-HCl,
pH 6.8 / 4 % (w/v) SDS / 10 % (v/v) β-Mercaptoethanol / 0.002 % (w/v) Bromophenol
Blue / 20 % (v/v) Glycerol) were added and the samples incubated at 95 °C for 5 min
(10 min at 65 °C for membrane proteins). Samples were centrifuged for 10 sec at full
speed, RT and the supernatant carefully loaded onto a protein gel using a gel-loading
tip to avoid transfer of sepharose. Generally, proteins were resolved using a 4-12 %
Bis-Tris gel (NuPAGE® Novex® Pre-Cast gels) as described in Section 1.2.19.2. Fol-
lowing the electrophoresis protein gels were incubated in Fixator 1 (10 % (v/v) Acetic
Acid / 40 % (v/v) Methanol / 2 % (v/v) Glycerol) for 15 min and in Fixator 2 (50 % (v/v)
Methanol / 1 % (v/v) Glycerol) for 30 min, under shaking. Gels were then dried at 80
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°C for 1 hour in a gel dryer (Model 583, Bio-Rad), exposed to phosphorimager plates
and signal acquired in Typhoon Trio™ Variable Mode Imager, GE Healthcare. Signal
were analyzed and quantified using the ImageQuant™ TL software (GE Healthcare).
1.2.25 Chemical Crosslinking
Microsomes (17 eq) were washed and resuspended in B88 (20 mM Hepes-KOH /
250 mM sorbitol / 150 mM KOAc / 5 mM Mg(OAc)). For SMPH and LC-SPDP crosslink-
ing B88 was used at pH 7.2, for DSS and SDAD crosslinking pH was 7.9. The total
reaction volume for subsequent detection by immunoblotting was 100 µl with appro-
priate amount of crosslinker (SMPH or LC-SPDP: 1 mM; SDAD: 1.5 mM; DSS: 0.8
mM). Control reactions were prepared with 5 µl of DMSO, but otherwise treated iden-
tically. For up-scaling, proportion of microsomes/total volume was maintained. After
crosslinker addition, samples were incubated on ice for 30 min. For DSS crosslink-
ing, incubation was at 20ºC for 20 min. Then, Quenching Buffer (1M Tris-HCl, pH 8
/ 100 mg/ml L-cys) was added (1/10 of total volume), and the sample incubated on
ice for 15 min. For DSS, quenching was done by adding 7.5 µl of 8.4 M ammonium
acetate for 20 min on ice. Samples were then washed twice (always in the presence
of quenching buffer) with appropriate pH B88 , membranes sedimented at 16.000 x g
for 10 min, and resuspended in appropriate form for subsequent use. For LC-SPDP
cleavage, membranes were incubated for 15 min at room temperature in the pres-
ence of 100 mM of DTT. For SDAD crosslinking, after the washes the sample was
exposed, on ice, to a 15 min UV (365 nm) irradiation with a 3UV Lamp (115V, 60Hz)
(ThermoFisher) at a distance of 3,6 cm.
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1.2.26 Extraction of Luminal and Cytosolic Microsome-Associated Proteins
For extraction of cytosolic membrane-associated proteins, microsomes were resus-
pended in B88/Urea (20 mM Hepes-KOH, pH 6.8 / 250 mM sorbitol, 150 mM KOAc
/ 5 mM Mg(OAc) / 2,5 M urea), incubated for 20 min on ice, followed by sedimenta-
tion and washing of the membranes with B88, pH 6.8. For extraction of ER-luminal
proteins, microsomes were resuspended in 100 mM sodium carbonate, pH 11.5, incu-
bated on ice for 20 min, followed by sedimentation (20 min at 346.000xg, 4ºC) of the
membranes through a sucrose cushion (200 mM sucrose / 100 mM sodium carbon-
ate, pH 11.5), and resuspension in B88, pH 6.8. For mock extractions, samples were
treated in same way, but in absence of either urea or sodium carbonate.
1.2.27 Purification of Sec61
ER membranes (500 eq) were treated as described in ”Chemical Crosslinking”, ei-
ther with DMSO (control), SMPH, or LC-SPDP in a total volume of 1.5 ml. After wash-
ing, membranes were resuspended in 150 µl of Quenching Buffer (1 M Tris-HCl, pH
8 /100 mg/ml L-cys) and diluted with 1 ml of IP Buffer (15 mM Tris-HCl, pH 7.5 / 150
mM NaCl / 1 % Triton X-100 / 0,1 % SDS) for solubilization (30 min at 4ºC) followed
by 10 min denaturation at 65ºC. From this point on, all steps were done at 4ºC. Sam-
ple was diluted with cold Binding Buffer (50 mM Tris-HCl, pH 7.4 / 300 mM KCl / 0,5
% Triton X- 100 / 40 mM imidazole) to a final volume of 5 ml and applied to an His-
Trap FF crude (1 ml) column integrated into a BioLegend LP automated purification
system (Biorad). After sample loading (0.5 ml/min for 10 ml), the column was washed
with Binding Buffer (10 ml; 1 ml/min) and sample eluted along a step gradient of imi-
dazole (100-500 mM, 15 ml per step, 1ml/min. Steps: 100; 200; 400; 500). Fractions
(7,5 ml) were collected along the gradient with an automatic fraction collector. DTT
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(100 mM) was added to each fraction. Each differently treated sample was applied
to an independent column. Between purifications, the system was washed with 10
ml HO, 10 ml ethanol 20 %, 10 ml HO, and 20 ml Binding Buffer. Fractions where
Sec61 was eluted (fraction 3-10 - 50 ml total) were pooled, proteins precipitated with
10 % TCA on ice for 2h and washed with ice-cold acetone. Each pellet was resus-
pended in 2 x Laemmli Buffer, and resolved for 5 cm on 4-12,5% NuPAGE gel. The
gel was then stained by Coomassie Colloidal Staining (0.08% Coomassie Brilliant
Blue G250 (CBB G250) / 10 % citric acid / 8% ammonium sulfate / 20 % methanol)
overnight and destained with water as described in the EMBL online Proteomics Core
Facility Protocols. The gels where then sealed in individual plastic bags with a few
milliliters of water and shipped to the Mass Spectrometry Facility.
1.2.28 Mass Spectrometry
1.2.28.1 Sample preparation
The whole lane of each samples was cut out into small cubes and subjected to in-
gel digestion with trypsin [331]. After overnight digestion, peptides were extracted
from the gel pieces by sonication for 15 minutes, tubes were centrifuged, the super-
natant removed and placed in a clean tube. Followed by a second extraction round
with a solution of 50:50 water: acetonitrile / 1% formic acid (2 x the volume of the
gel pieces), the samples were sonicated for 15 min, centrifuged and the supernatant
pooled with the first extract. The pooled supernatants were then subjected to speed
vacuum centrifugation. Samples were reconstituted in 96:4 water: acetonitrile / 0.1%
formic acid and further processed using an OASIS® HLB µElution Plate (Waters) ac-
cording the manufacturer’s instructions.
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1.2.28.2 LC-MS/MS
Peptides were separated using the nanoAcquity Ultra Performance Liquid Chromatog-
raphy (UPLC) system (Waters) using a trapping (nanoAcquity Symmetry C18, 5 µm,
180 µm x 20 mm) as well as an analytical column (nanoAcquity BEH C18, 1.7 µm,
75 µm x 200 mm). The outlet of the analytical column was coupled to a Linear Trap
Quadrupole (LTQ) Orbitrap Velos Pro (Thermo Fisher Scientific) using the Proxeon
nanospray source. Solvent A consisted of water / 0.1% formic acid and solvent B con-
sisted of acetonitrile / 0.1% formic acid. Sample was loaded with a constant flow of
solvent A at 5 µl/min onto the trapping column. Peptides were eluted over the an-
alytical column with a constant flow of 0.3 µl/min. During elution the percentage of
solvent B increased linearly from 3% to 7% in 10 min, then increased to 25% in 110
min and to 40% for the final 10 min. A cleaning step was applied for 5 min with 85%
B followed by 3% B 20 min. The peptides were introduced into the mass spectrom-
eter via a Pico-Tip Emitter 360 µm OD x 20 µm ID; 10 µm tip (New Objective), and
a spray voltage of 2.2 kV was applied. Capillary temperature was 300 °C. Full scan
MS spectra were acquired with a resolution of 30000. The filling time was set at a
maximum of 500 ms with a maximum ion target of 1.0 x 10. The fifteen most intense
ions from the full scan MS (MS1) were sequentially selected for sequencing in the
LTQ. Normalized collision energy of 40% was used, and the fragmentation was per-
formed after accumulation of 3.0 x10 ions or after a maximum filling time of 100 ms
for each precursor ion (whichever occurred first). Only multiply charged (2+, 3+, 4+)
precursor ions were selected for MS/MS. The dynamic exclusion list was restricted
to 500 entries with maximum retention period of 30 s and a relative mass window of
10 ppm. In order to improve the mass accuracy, a lock mass correction using the ion
(m/z 445.12003) was applied.
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1.2.28.3 Data analysis
The raw mass spectrometry data was processed with MaxQuant (v1.5.2.8) [65] and
searched against an Uniprot Saccharomyces cerevisiae proteome database. The
search parameters were as follows: Carbamidomethyl (C) (fixed), Acetyl (N-term)
and Oxidation (M) (variable) were used as modifications. For the full scan MS spec-
tra (MS1) the mass error tolerance was set to 20 ppm, and for the MS/MS spectra
(MS2) to 0.5 Da. Trypsin was selected as protease with a maximum of two missed
cleavages. For protein identification a minimum of one unique peptide with a peptide
length of at least seven amino acids and a false discovery rate below 0.01 were re-
quired on the peptide and protein level. The match between runs function was en-
abled, a time window of one minute was set. Label free quantification was selected
using iBAQ (calculated as the sum of the intensities of the identified peptides and di-
vided by the number of observable peptides of a protein) [347] with the log fit function
enabled.
The xQuest/xProphet pipeline [217] was also used to identify crosslinked peptides
in our samples. For this, we used the basic protocol and conditions used in Leitner
et al. [217], correcting the meaningful parameters to fit our crosslinker (e.g monoiso-
topic shift, only light chain, reactive groups, etc.). Databases of no more than 30 pro-
teins were fed into the pipeline.
1.2.28.4 Statistical Analysis
The raw output data of MaxQuant (proteinGroups.txt file) was processed using the
R programming language (ISBN 3-900051-07-0). As a quality filte, only proteins that
were quantified with at least 2 unique peptides were allowed. Potential batch-effects
were removed from the log2 of the iBAQ values using the limma package [316]. Fur-
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thermore, batchcleaned data was normalized with the vsn package (variance stabi-
lization) [166]. Missing values were imput using the MSNbase package [110]. For
conditions with at least 2 out of 3 identifications, the “knn” method was used. For less
identifications, the “MinDet” method was applied. Finally, limma was used again to
identify differentially expressed proteins. A protein was called a ”hit” with a false dis-
covery rate (fdr) smaller 5 % and a fold change of at least 3 and a ”candidate” with a
fdr smaller 20 % and a fold change of at least 3.
1.2.29 Mutant Construction
1.2.29.1 sec61∆L7 integration in the genomic DNA
In order to integrate the sec61∆L7 we subcloned the gene from pRS315-sec61∆L7
into pRS305. Plasmid pRS315-sec61∆L7 (1 µg) was digested with BglI in a standard
restriction digestion as described in Section 1.2.8 using NEBuffer™ 3.1 and perform-
ing the reaction at 37 ºC for 2h. This resulted in a truncation of the sec61∆L7 gene,
which is necessary to assure the presence of a single copy of the gene after integra-
tion of the mutation into the genome. After enzyme inactivation (65ºC for 20min) and
cleaning as described in Section 1.2.8.1, sample was incubated with T4 DNA ligase
in the absence of ATP, which resulted in a blunting of the overhang end generated by
the BglI digestion. After new cleaning step by the same process used before, sample
was digested again in a standard restriction digestion as described in Section 1.2.8,
this time with SalI-HF in Cutsmart™ Buffer at 37 ºC for 2h. This resulted in a 1705
bp fragment that was resolved in agarose gel, confirming its size, and recovered as
described in Section 1.2.7. This fragment was then ligated as described in Section
1.2.11 into a SmaI/SalI digested pRS305. Half the ligation reaction was used to trans-
form E.coli DH5α as described in Section 1.2.12.2. After overnight growth at 37ºC,
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positive clones were screened by colony PCR as described in Section 1.2.4.2 using
the M13 primers for the reactions. Positive clones were further confirmed by sequenc-
ing. With this process, a truncated version of sec61∆L7 was subcloned into pRS305,
originating pRS305-trunc.sec61∆L7
For integration, pRS305-trunc.sec61∆L7 was linearized by MscI digestion as de-
scribed in Ssection 1.2.8, and the full reaction volume was used to transform S.cerevisiae
cells as described in Section 1.2.15. Screen of positive clones was done by isolating
genomic DNA from the transformants as described in Section 1.2.5.3, and using it
as template for a PCR using Sec61 flanking primers. Positive clones were detected
by increased mobility of the sec61∆L7 in agarose gel when compared with that of
SEC61. I started by transforming an haploid yeast strain. Although having sporadic
postive clones, expression of Sec61∆L7 was never achieved. I then tried integrating
this construct in a diploid strain. After genomic integration of the mutation, I sporu-
lated this diplod strains by growing them in Sporulation Medium (1% Potassium Ac-
etate / 0.1% Yeast Extract / 0.05% Glucose) for 5 to 10 days at 25ºC with slow shack-
ing. As soon as spores were detected, samples (1 ml) of culture were collected, cells
sedimented and washed with sterile MQ water. Cells were then resuspended in Tris-
HCl, pH 5 , 10 µl of β-Glucuronidase (SIGMA) were added, and sample was incu-
bated at 37 ºC. Different incubation times were tried until proper ascus digestion was
obtained. Tetrads were then dissected using an MSM Tetrad Dissector, and spores
were isolated. Positive clones were selected in the same way as previously. In this
way, the integrant sec61∆L7 strain (KRY956) was generated.
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1.2.29.2 14His-Tagged constructs
For His-tagging of SEC61 and sec61S353C, both genes were amplified from pBW11
and pRS315-sec61S353C, respectively, using Primer 63 and Primer 64. The result-
ing PCR products were cloned into pRS426pGAL1 [380] using the SfoI and HindIII re-
striction sites. Correct cloning was confirmed by sequencing. The pGal-His-SEC61-
CYC and pGal-His-Sec61S353C-CYC cassettes were then amplified using Primer
85 and Primer 93. The resulting PCR products were cloned into pRS315 (CEN, LEU2).
Transformants in the JDY638 (pGAL-SEC61-URA3) S. cerevisiae background were
first selected on SC -URA medium containing 2% (w/v) galactose and 0.2% (w/v) glu-
cose lacking leucine. The pGAL-SEC61 plasmid was selected against on SC 5-FOA
plates containing 2% (w/v) galactose and 0.2% (w/v) glucose without leucine. Con-
structs were confirmed by sequencing.
1.2.29.3 SEC61 Loop 5 deletion mutants
Mutations sec61del1, sec61del2, and sec61del1/2 were generated by PCR-driven
overlap extension (SOE PCR) [3, 164] as described in Section 1.2.4.1. SOE-PCR re-
sulting fragments were then digested HindIII/BamHI as described in Section 1.2.8, as
was the pRS315(CEN, LEU2) vector. After cleaning the digested DNA with a PCR
celaning Kit (Sigma), each mutant gene (sec61del1, sec61del2, and sec61del1/2)
was ligated into the digested pRS315 as described in Section 1.2.11 and transformed
into E.coli DH5α as described in Section 1.2.12.2. After overnight growth at 37ºC,
positive clones were screened by colony PCR as described in Section 1.2.4.2 using
the M13 primers for the reactions. Positive clones were further confirmed by sequenc-
ing. Correct pRS315-sec61del1, pRS315-sec61del2, and prRS315-sec61del1/2 were
then transformed into KRY461 as described in Section 1.2.15. Transformants into
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JDY638 (pGAL-SEC61-URA3) were first selected on SC -URA medium containing
2% (w/v) galactose and 0.2% (w/v) glucose without leucine. The pGal-SEC61 plas-
mid shuffle was done on SC 5’-FOA plates lacking leucine. All constructs were con-
firmed by sequencing.
1.2.29.4 MPD1 HA-Tagging
In order to generate a detectable form of Mpd1, the MPD1 gene was genomically
tagged with a C-terminal HA-tag. For this purpose the protocol described in Janke
et al. [177] was used. Briefly, the HA cassette was amplified from pYM24 (supplied
by Michael Knop) using Primer 111 and Primer 112. The plasmid contains the HA-
cassette as well as the hphNT1 marker for selection. The primers designed have the
plasmid homology as described in the mentioned paper, so as to amplify the correct
cassete/marker and also an homology with the appropriate regions of the gene of in-
terest. The forward primer has to have homology with the last stretch of the coding
region (in this case, MPD1) not including the STOP codon. The reverse primer has to
have homology with the Stop codon and the region immediately downstream of the
interest gene. Once adequate primers were designed, a PCR reaction as decribed in
Table 1.23 was made. The resulting PCR product was cleaned, its size confirmed by
gel electrophoresis (Section 1.2.6 and its sequence confirmed by sequencing (Sec-
tion 1.2.13). Once the correct tagging was confirmed, the PCR product was used to
transform KRY897, KRY1116, KRY1117, and KRY1117 as described in Section 1.2.15.
Transformants were selected on YPD plates containing hygromycin (300µg/ml). Ex-
pression of Mpd1-HA was confirmed by making extract from mentioned strains as de-
scribed in Section 1.2.19.1 and analyzing them by Western Blot as described in Sec-
tion 1.2.19.6, where anti-HA antibodies were used for protein detection. Unfortunately
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the expression level of the genomic MDP1-HA was very low. To circumvent this is-
sue, the tagged MPD1 form was cloned into a 2µ plasmid, and therefore, of high copy
number, in order to obtain higher tagged protein levels. MPD1-HA was amplified from
the genomic DNA of one of the positive clones using Primer 114 and Primer 115, and
cloned into pRS426 (2µ, URA3) after SalI/EcoRI digestion (of both insert and vector).
This plasmid was then used to transform the wildtype (KRY897) and hinge mutant
strains (KRY1116, KRY1117, and KRY1118), originating strains KRY1162, KRY1163,
KRY1164, and KRY1165, respectively.
Table 1.23: Standard reactionmixture for PCRs
Component Volume (µl) Final concentration/
Quantity
5X KAPAHiFi™ Reaction Buffer 10 1X
KAPA dNTP Mix (10 mM each)
1.5 0.3 mMForward primer (10 μM)
Reverse primer (10 μM)
Template DNA
1
10ng plasmid DNA
KAPAHiFi™ Polymerase 0.02 U/µl
dHO to 50 –
1.2.30 Detection of Sec61 Interactors in Radiolabeled Membranes
Crude radiolabeled ER vesicles (10 µl) (Section 1.2.21) were crosslinked as described
in Section 1.2.25 and submitted to two consecutive immunoprecipitations (Section
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1.2.24.3. For the first precipitation, the membranes were solubilized in Lysis Buffer
(20 mM Tris, pH 7.5 / 2% SDS / 1 mM PMSF) and denatured at 65ºC for 10 min. Pro-
teins were then diluted in Washing Buffer (15 mM Tris-HCl, pH 7.5 / 150 mM NaCl /
1% Triton X-100 / 2 mM NaN3 / 1 mM PMSF). After pre-clearing, 60 µl of 20% Protein
A-Sepharose beads (GE Healthcare) and saturating amount of Sec61 antibody were
added. Samples were then incubated with rotation overnight at 4ºC. After sedimen-
tation, Protein A Sepharose pellets were washed as in standard immunoprecipitation
sample (Section 1.2.24.3). For elution 20 µl of 20 mM Tris-HCl, pH 7.5 / 5% SDS /
50 mM DTT were added, sample was incubated for 15 min at room temperature and
denaturated for 10 min at 65ºC. Eluted proteins were then diluted in Washing Buffer
and the Mpd1-HA precipitated using anti-HA polyclonal antibody (BioLegend). Pre-
cipitation was done for 2h at room temperature followed by elution with 2 x Laemmli
Buffer / 200 mM DTT. Proteins were denatured again as before, resolved on 4-12,5%
NuPAGE gels exposed to Phosphorimager plates, and the signal acquired with a Ty-
phoon PhosphoImager (GE Healthcare).
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“‘Tis a lesson you should heed:
Try, try again.
If at first you don’t succeed,
Try, try again.”
William Edward Hickson
2
Results
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The core objective of this project was to identify Sec61 lumenal interactors by chem-
ical crosslink. To achieve that, a setup that allowed efficient chemical crosslink of
Sec61 to its interactors, as well as detection of these crosslinked forms and identifi-
cation of their components had to be generated.
I devised and optimized a crosslink setup for different crosslinkers, to allow both
immunoblotting and mass spectrometric analysis of Sec61 interactors.
2.1 Determination of Sec61 and Sec61∆L7 DSS crosslink pattern
The very first step in the establishment of a crosslink setup was the choice of crosslinker.
Many crosslinkers with different reactivities, lengths, solubilities, etc., are commer-
cially available, so a selection had to be made. Since my target (Sec61) is an ER-
membrane protein, and my main interest was to identify lumenal interactors, the use
of a membrane permeable crosslinker was paramount. Another important consider-
ation was the length of the crosslinker. Since I was interested in direct Sec61 inter-
actions, the spacer-arm of the crosslinker would have to be short, to decrease the
chance of crosslink to indirect interactors. It could not be too small, however, or else
I risked missing direct interactions just due to the lack of crosslinkable amino acids
in the interaction position or even by blockage of such crosslinkable amino acid by
the actual interaction. Also, since this was still the initial setup phase, the better es-
tablished and more efficient the reactivity of its reactive groups, better the chances of
successfully finding conditions where Sec61 was efficiently crosslinked.
After careful crosslinker analysis, disuccinimidyl suberate (DSS) seemed to be a
good first candidate. DSS is a water-insoluble, membrane permeable, homobifunc-
tional N-hydroxysuccinimide ester (NHS ester), which is characterized by the pres-
ence of two reactive (i.e crosslinkable) groups (NHS esters) that, at pH 7 to 9, react
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with primary amine groups (e.g NH - Lysines, N-terminus) (Figure 2.1). DSS was
chosen due to its standardized character. It is one of the most widely used and well
established chemical crosslinkers. Also, its short spacer arm (11.4 Å), one of the
shortest available, as well as the high crosslink efficiency associated to its reactive
groups, seemed to make it the perfect candidate for this initial study. Since a DSS
crosslink setup using microsomes had been tested previously in our lab (data not
shown), there was no need for DSS titration and a working concentration of 0.8 mM
was used for all crosslink reactions. Also, the conditions for the crosslink (e.g pH, in-
cubation periods, incubation temperatures) were the same as previously used and
stated in Section 1.2.25.
Figure 2.1: DSS structure. Scheme representing DSS structure. Molecular weight and spacer arm length also shown in ﬁgure.
Here I tested whether DSS treatment resulted in a crosslink-specific pattern for
Sec61, but also whether such pattern, when present, was affected by the lack of the
Sec61 lumenal loop 7. In previous work, sec61∆L7 (the sec61 mutant in which the
Sec61 protein is lacking the full lumenal loop 7), was shown to have an ERAD impair-
ment, but it also displayed some import defects [397]. Since the lack of such promi-
nent lumenal loop might affect Sec61 lumenal interactions, potentially with ERAD
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factors, as well as cytosolic ones, I deemed that comparing the crosslink pattern of
Sec61 versus Sec61∆L7 might yield some interesting results.
For this purpose, microsomes from two different backgrounds (SEC61 and sec61∆L7)
were crosslinked with 0.8 mM of DSS for 20 min at 20ºC, quenched with ammonium
acetate, resolved by SDS-PAGE, and immunoblotted against Sec61 (Figure 2.2 A).
Comparing DSS untreated and treated samples (lane 1 versus lanes 2/3; lane 4 ver-
sus lanes 5/6), it could be observed that in the SEC61 background a very distinct
Sec61-containing band was present at around 50 kD, representing a shift or approx-
imately 10 kD (Figure 2.2 A; lane 1 versus 2/3). In the sec61∆L7 background a new
crosslink-dependent Sec61∆L7-containing band can also be detected but at around
45 kD (Figure 2.2 A; lane 4 versus 5/6). This also represents a shift of around 10 kD,
since the free Sec61∆L7, being smaller than Sec61, has an increased acrylamide gel
mobility, running at around 35 kD (Figure 2.2 A; lanes 4-6). However, the 45 kD band
detected in the sec61∆L7 background showed a significantly lower intensity than the
50 kD band detected in the SEC61 background (Figure 2.2 A; lanes 2/3 versus 5/6).
Since the size of the shift in both backgrounds was the same, the probability of the
non-Sec61-component of each band being the same seemed high. Its identity, how-
ever, had to be determined. Since the ER protein content is well known and I had ac-
cess to several specific antibodies against ER proteins, I postulated that by identify-
ing potential candidates based on the size of the shift, an immunoblotting approach
could be used to identify the crosslinked-bands components. The reasoning was that
if two different proteins could be detected (using their specific antibodies) showing the
same uncharacteristic mobility (i.e co-localization of bands in a location different than
their characteristic molecular size) only in crosslinked samples, a crosslink between
both of them could be assumed.
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Figure 2.2: Sec61DSS crosslink pattern determination. Immunoblot analysis of the DSS crosslink pattern. ER vesicles (17eq) were
crosslinkedwith 0.8mMof DSS and analyzed by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen).
Sec61was detected by Immunoblotting and signal acquired on ECL ﬁlm. A) Comparison of the crosslink pattern obtained on SEC61
and sec61∆L7 backgrounds when Sec61 is detected. B) Immunoblot analysis of DSS crosslink pattern on a SEC61 backgroundwhen
both Sec61 and Sss1 are detected.
Since Sss1, one of the components of the Sec61 trimeric complex has a molec-
ular weight compatible with the shift observed, I started by applying this approach
to verify if the interaction detected was with Sss1. For that purpose, wild-type mem-
branes were crosslinked with DSS and immunoblotted for both Sec61 and Sss1. By
immunoblot analysis of the same reaction (resolved side-by-side) with both a Sec61-
and a target protein-specific antibody, a potential co-migration of Sec61 and the target-
protein could be evaluated. As can be seen in Figure 2.2 B, the 50 kD band was de-
tected with both Sec61 and Sss1 antibodies in a crosslink-dependent manner (Figure
2.2 B; lanes 2/3 and 5/6). This confirmed the hypothesis that the band at 50 kD rep-
resents a crosslink between Sec61 and Sss1 (Figure 2.2 B; lanes 5 and 6). It should
also be noticed that several other crosslinker-dependent bands are detectable when
immunoblotting against Sss1, showing that this setup might also be good to identify
Sss1 interactors. Such study was beyond the scope of this work, however, and as
was not pursued further.
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Sbh1 was also present in the 50 kD band, although crosslink specific bands al-
ways presented weak intensities (data not shown) indicating a low accessibility of the
crosslinked amino acids of either Sec61 or Sbh1 or of the antibody to Sbh1, due to
epitope inaccessibility when in complexed form.
With these results, I could assess that a microsome-based chemical crosslink setup
to identify Sec61-interactors was possible. Also, in doing so I was able to show that
the Sec61 interaction with Sss1 was impaired when loop 7 was missing (data pub-
lished in Tretter et al. [397]).
2.2 Immunoblotting analysis of Sec61 SDAD crosslink pattern
Figure 2.3: SDAD structure. Scheme representing SDAD structure. Molecular formula, molecular weight, and spacer arm length
also shown in ﬁgure
Having been able to establish an efficient crosslink setup, a more broad approach
was deemed necessary. My initial aim was to identify loop 7 interactions. DSS is
only lysine-reactive and there are no lysines in loop 7. Therefore, the next step was
to apply a crosslinker with an ampler reactivity. With this in mind, I chose succin-
imidyl 2-[(4,4’-azipentanamido)ethyl]-1,3’-dithioproprionate (SDAD). SDAD is a water-
insoluble, membrane-permeable heterobifunctional crosslinker that contains an N-
122
hydroxysuccinimide (NHS) ester and a diazirine ring (Figure 2.3). NHS esters effi-
ciently react with primary amino groups (−NH) to form stable amide bonds. Diazirine
rings are photoactivatable with long-wave UV light, creating reactive carbene interme-
diates that form covalent bonds through addition reactions with any amino acid side
chain or peptide backbone. SDAD has yet another characteristic: it is cleavable. As
it possesses a disulfide bond in its spacer arm, crosslinked peptides can be cleaved
upon sample reduction. Taking advantage of the more promiscuous reactivity of the
diazirine ring when compared to the NHS-ester reactive group, as well as the slightly
longer spacer arm, a more broad-spectrum crosslink setup was implemented.
The first step was to establish a crosslink protocol. Due to the intrinsically dynamic
Sec61 environment, setting the reactions on ice was thought to slow down possible
dissociation reactions, increasing the chance of effectively locking them by crosslink.
Therefore, all reactions were done on ice, instead of the 20ºC used for DSS crosslink.
As stated before, SDAD as two reactive groups, an NHS-ester and a diazirine ring.
Since the NHS-ester reactive group is the same as in DSS, the same reaction-pH
(7.9) was used. The diazirine group, however, needed an extra UV-activation step.
The optimal duration and distance of UV-irradiation had also to be tested along with
an appropriate working concentration (Figure 2.4 A and B).
In this first assay, SDAD concentration was titrated from 0 to 2 mM (Figure 2.4 A).
Microsomes of two wild-type strains were tested: one where SEC61 is under the con-
trol of a galactose-inducible promoter (GAL-SEC61, left panel), and one were the
SEC61 is under the control of its endogenous promoter (right panel). To limit the
number of variables to be assessed, maximum UV-exposure time suggested by the
supplier (15 min) and a convenient UV-irradiation distance (3.6 cm - height of 1.5 ml
Eppendorf tube) were used. An SDAD specific pattern was immediately observable
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in all treated samples (Figure 2.4 A; lanes 2, 4, 6, 8, 10 and 12). Besides the Sec61
specific band at around 40 kD, at least two new Sec61-containing bands could be
detected: one at around 50kD and another at around 80 kD, representing a shift of
around 10 and 40 kD, respectively (Figure 2.4 A; lanes 2, 4, 6, 8, 10 and 12; Figure
2.4 B, ”+” lanes).
Figure 2.4: Sec61 SDAD crosslink pattern determination. Immunoblot analysis of the SDAD crosslink pattern. ER vesicles (17eq)
were crosslinkedwith SDAD for 30min on ice, quenched for 15min, UV-irradiated and analyzed by SDS-PAGE on 4-12%Bis-Tris
gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen). Protein detection was done byWestern Blotting using Sec61N-terminal anti-
body and signal acquired on ECL ﬁlm. A) SDAD concentration titration in wild-typemicrosomes. Microsomes fromGAL1-SEC61 (left
panel) and SEC61 (right panel) were used. UV irradiation distance wasmaintained constant (3.6 cm) as well as the duration of the
irradiation (15min). B)Duration of UV irradiation test. Microsomes fromGAL1-SEC61 (left panel) and SEC61 (right panel) were used.
Concentration of SDAD usedwas 1.5mMand the UV irradiation distance was alsomaintained constant (3.6 cm). Two different
periods of irradiation were tested: 8 and 16min.
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As I have determined in Section 2.1, the 10 kD-shifted band corresponds to a crosslink
between Sec61 and Sss1 (Figure 2.2 B; lanes 2/3 and 5/6). This crosslink pattern
was visible independently of SDAD concentration used, although its intensity seemed
to be higher at higher concentrations (lane 4, 6, 10 and 12). A third band at around
65 kD (25 kD shift) was also detected. Its intensities increased with SDAD treatment,
but it was also present even in the absence of SDAD (Figure 2.4 A; lanes 1, 3, 5, 7, 9
and 11; Figure 2.4 B, ”-” lanes). This might be the result of a co-migration of a Sec61-
containing complex with this unspecific band, or just a stabilization of a complex that
is unspecifically detected in the wild-type caused by the crosslink process. It became
also obvious that the intensity of the 80 kD band was much higher and the intensity of
the Sec61xSss1 band (50 kD) slightly lower in the samples where microsomes from
the GAL-SEC61 strain had been used (left versus right panels). Since the main ob-
jective of this project was to identify new Sec61 interactors, I chose to prioritize the
quality of the 80 kD band instead of the Sec61xSss1 band. Hence, microsomes from
a GAL1-SEC61 strain were used for the remainder of this SDAD crosslink.
I also tested the effect of ATP during crosslink in both wild-type and sec61∆L7
backgrounds, but observed no effect (Supplemental Figure A.3 B).
In addition, I tested the reactivity of N- versus C-terminal Sec61 antibodies after
SDAD crosslink (Supplemental Figure A.1 A). The N-terminal antibody was better for
Sec61-crosslinked-complexes detection. Interestingly, the 50 kD band had a lower
intensity when detected with the C-terminal antibody (lane 2 to 5 versus lane 6 to 9).
This might indicate that the interaction with Sss1 happens trough Sec61’s C-terminus,
making access of the C-termius antibody harder, resulting in a lower detectability.
Based on these results, 1.5 mM was deemed the best working SDAD concentra-
tion (Figure 2.4 A; lane 4).
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After establishing a working concentration, titration of the duration of the UV irra-
diation was needed. I repeated the crosslink assays, varying the duration of the UV-
irradiation period (8 and 16 min) (Figure 2.4 B). No drastic difference in band inten-
sity can be seen between both conditions, although a slightly higher intensity was ob-
tained with higher irradiation periods (Figure 2.4; left panel, lanes 1-4 versus 5-4; right
panel, lanes 9-12 versus lanes 13-16. The longer irradiation period (15min) was used
for the remainder of the study.
Since the supplier suggested that shorter irradiation distances might yield better
crosslink efficiencies, I also tested if reducing the distance of the irradiation to 1.6
cm (height of PCR tube) yielded better results (Supplemental Figure A.1 B). This as-
say was done with both SEC61 and sec61∆L7 microsomes, as a way of determining
whether, as with DSS, the lack of loop 7 influences the crosslink pattern. The intensity
of the crosslinked bands was lower when a shorter distance was used (Supplemental
Figure A.1 B; left panel, lane 2 and 3). In the sec61∆L7 background, independently
of the distance of irradiation, the Sec61∆L7 specific band was detected at around 35
kD and only one other SDAD-dependent band at around 45 kD (Supplemental Fig-
ure A.1 B; right panel, lane 5-8). The latter represents the same 10 kD shifted band
present in the SEC61 background, although it seems to have a lower intensity than
the Sec61-containing counterpart (Supplemental Figure A.1 B; lane 2 versus lane 7 or
lane 3 versus lane 9).
Having identified at least two Sec61-containing complexes, the next step was trying
to determine their components. To this end, different populations of proteins were ex-
tracted from the microsomes prior to crosslink. The reasoning behind this approach
was that if extraction of a specific protein pool affected the crosslink pattern, then
the Sec61-crosslinked partner would be either a protein from that pool or needed a
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protein/cofactor from that fraction to interact with Sec61. Microsomes were either ex-
tracted with 2.5 M urea, with 100 mM sodium carbonate, pH 11.5, or high salt-treated.
Carbonate treatment induces denaturation of soluble domains of transmembrane
proteins, and sheeting of vesicles, resulting in a loss of lumenal proteins [106]. Urea
treatment removes the cytosolic proteins that are peripherally associated with the ER-
membrane [122], as does the high-concentration salt treatment (Strip).
Figure 2.5: Effect of the absence of different protein populations on SDAD crosslink pattern. ER vesicles (17eq) were extracted
with 2.5MUrea (Urea), 100mMof sodium carbonate (NaCO), or 500mMpotassium acetate (Strip) before SDAD crosslink, and
analyzed by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen). Protein detection was done byWest-
ern Blotting using Sec61N-terminal antibody and signal acquired on ECL ﬁlm.
As can be seen in Figure 2.5, all shifted bands are present independently of microsome-
extraction protocol used, except for the Sec61xSss1 band, which was almost com-
pletely abolished by carbonate extraction (lanes 14/15 versus lane 13). Extraction of
Sss1 by carbonate as been shown previously [90]. This strengthens the conclusion
that this band represents in fact an Sec61xSss1 interaction. The fact that none of the
other bands are affected by the treatment suggests that the detected potential interac-
tions could only be with membrane proteins.
Sec61 forms both a trimeric complex with Sbh1 and Sss1, and an heptameric com-
plex, where this trimeric complex joins the Sec63 complex [248, 277]. The Sec63
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complex is composed by Sec62, Sec63, Sec71 and Sec72 [79, 44]. Since antibod-
ies against Sec62, Sec63 and Sec71 were available from Rand Schekman’s lab, I
tried applying the same approach used to identify the Sss1 interaction in Section 2.1,
and used these specific antibodies to detect a co-localization of Sec61 crosslinked
bands and any of these targets. Wild-type membranes were crosslinked with 1 mM
SDAD in three independent reactions (one untreated sample and two SDAD-treated
samples). Each set was resolved by SDS-PAGE side-by-side, revealed with the spe-
cific antibody against one of the proteins mentioned above, and signal acquired on
ECL film. In addition, one set was also developed using the Pdi1 antibody. Pdi1 is a
protein dissulfideisomerase which role in ERAD is well established [120].
Figure 2.6: Multi-antibody analysis of SDAD crosslink pattern. ER vesicles (17 eq) were crosslinkedwith 1mMSDAD crosslink for
30min on ice, quenched for 15min, UV-irradiated for 15min (3.6 cm) and analyzed by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®
Novex® Pre-Cast gels, Invitrogen). Protein detection was done byWestern Blotting using either Sec61, Sec62, Sec63, Sec71 or Pdi1
antibody and signal acquired on ECL ﬁlm. For each set of reactions (one untreated sample and two treated with SDAD), a different
antibodywas used for detection. 5 aligned panels are shown, each comprising a set. From left to right: anti-Sec61-N (40 kD), anti-
Sec62 (32 kD), anti-Sec63 (73 kD), anti-Sec71 (35 kD) and anti-Pdi1 (65 kD).
As can be seen in Figure 2.6, no SDAD-specific bands with a migration pattern sim-
ilar to the shifted bands observed in the anti-Sec61 revealed set (Figure 2.6; lanes
2 and 3) can be detected in the Sec62, Sec63 or Pdi1 immunobloted samples (Fig-
ure 2.6; lanes 4-6, 7-9 and 13-15, respectively). In the anti-Sec71 revealed set, how-
ever, several shifted band are detected upon SDAD treatment. Indeed, a shifted band
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at round 80 kD can be detected (Figure 2.6; lanes 10-12), showing thus a band co-
localization between anti-Sec61 and anti-Sec71 revealed, and SDAD treated samples
(compare Figure 2.6; lanes 1-3 to lanes 10-12). This data suggests that an interac-
tion between Sec61 and Sec71 could be identified by SDAD crosslink. It should also
be noted that a series of other shifted bands can be detected in the anti-Sec71 re-
vealed, SDAD treated samples (Figure 2.6; lanes 11 and 12). Namely, bands contain-
ing Sec71 (32 kD) can be detected at around 45, 65, 80 and 120 kD, representing a
shift of 10, 30, 50 and 90 kD. Since Sec71 interactor determination was beyond the
scope of this work, the identity of the interactors was not further investigated. Nev-
ertheless, some Concavalin A precipitations of SDAD treated samples were done
(Supplemental Figure A.3 A), and the 80kD, Sec61-containing band was marginally
precipitated, supporting the idea that Sec71 is one of its components, since Sec71 is
glycosilated [95].
Interaction with another ERAD-relevant protein involved in targeting of ERAD-substrates
for export to the cytosol, Yos9, was investigated. I used the same immunoblotting ap-
proach, in both wild-type and ∆yos9 backgrounds, detecting with both Yos9 (35 kD)
and Sec61 specific antibodies (Supplemental Figure A.2 A and B, respectively). Un-
fortunately the Yos9 antibodies were rather weak, so no obvious difference in crosslink
pattern could be observed between wild-type and ∆yos9 backgrounds (Supplemental
Figure A.2 A). Also, upon Sec61 detection, no difference in crosslink patterns could
be detected between wildetype and ∆yos9 microsomes (Supplemental Figure A.2 B,
respectively).
To further confirm whether the other subunits of the Sec complex were crosslinked
to Sec61, immunoprecipitation of several of these proteins from SDAD crosslinked
samples using specific antibodies was attempted. Unfortunately, the high levels of
129
background associated with the unfortunate co-migration of both linked and cleaved
heavy and light antibody chains with several of the SDAD-specific bands (and also
the free Sec61) made it impossible to obtain any useful data from these assays (data
not shown; Supplemental Figure A.4).
Although multiple crosslinked bands had been detected with this SDAD crosslink/immunoblotting
approach, I was able to identify only a single interactor, Sec71, which represents a
known Sec61 interaction, since Sec71 is a comoponent of the heptameric Sec com-
plex. So, although SDAD crosslink showed itself as being a suitable setup to study
Sec61-interactors, no novel information stemmed from this analysis.
2.3 Immunoblotting analyis of Sec61 SMPH crosslink pattern
Until this point I had only characterized potential interactions with known Sec61 in-
teractors (Sss1 and Sec71). Trying to increase the chances of detecting lumenal in-
teractions, I idealized a new crosslink setup. In this setup, microsomes from a point
mutant generated previously in our lab (sec61S353C) [186], where a serine in Sec61
loop 7 had been mutated to a unique cysteine, could be used in conjugation with a
sulfhydryl-reactive crosslinker, in the hope of detecting primarily lumenal crosslinks.
This mutant has no ER import defects, with a decreased affinity to the 19S RP of the
26S proteasome, resulting in a ∆gpαF-specific ERAD defect, whose export from the
ER is dependent on the 19S RP-Sec61 interaction [186].
For this purpose, a new crosslinker had to be chosen, tested and optimized. After
careful consideration, Succinimidyl-6-[(β-maleimidopropionamido)hexanoate] (SMPH)
was chosen. SMPH is an heterobifunctional crosslinker with N-hydroxysuccinimide
(NHS) ester and maleimide groups that allow covalent conjugation of amine- and
sulfhydryl-containing molecules. NHS esters react with primary amines at pH 7-9 to
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form amide bonds, while the maleimides react with sulfhydryl groups at pH 6.5-7.5 to
form stable thioether bonds. Unlike SDAD, SMPH is uncleavable. The main reason
for choosing this crosslinker, besides its reactivity, was its spacer arm length (14.2 Å),
which is in the range of the previously used crosslinkers.
Figure 2.7: SMPH structure. Scheme representing SMPH structure. Molecular formula, molecular weight, and spacer arm length
also shown in ﬁgure
Since the pH interval at which each one of the reactive groups reacts overlaps at
pH 7-7.5, a working pH in that range seemed to be the optimal option. The possibility
of allowing the reaction of each group in turns existed, by pH shift in between phases.
I tested this approach, but it showed itself to be more technically demanding and with-
out any gain in result quality (data not shown).
As before, the first step was to establish the best working SMPH concentration and
pH. For this purpose, a series of SMPH concentrations were tested, always using
pH 7.2 as the reaction pH. This screen was done with microsomes from a wild-type
(SEC61) strain, a sec61S353C strain, and a sec61∆L7 strain (Supplemental Figure
A.5 A and B). For simplicity sake, an image illustrating the best conditions found and
henceforth used for standard SMPH crosslink reactions is supplied in Figure 2.8.
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Figure 2.8: Sec61 SMPH crosslink pattern determination.Microsomes (17 eq) from SEC61, sec61∆L7, and sec61S353C back-
grounds were crosslinkedwith 1mMSMPH for 30min on ice, quenched for 15min and analyzed by SDS-PAGE on 4-12%Bis-
Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen). Protein detection was done byWestern Blotting using a speciﬁc Sec61N-
terminus antibody, and signal acquired on ECL ﬁlm. Here the SMPH-speciﬁc Sec61-crosslink pattern obtained in either a sec61∆L7
background (left panels; lanes 1-3), a SEC61 background (right panel; lanes 4-6) or a sec61S353C background (right panel; lanes 7-9)
were compared.
In Figure 2.8 lanes 2/3, 5/6 and 8/9, it can be seen that besides the already char-
acterized Sec61xSss1 interaction that can be detected in all three strains (band at
50 kD in SEC61 and sec61S353C backgorund; band at 45 kD in the sec61∆L7 back-
ground), in the sec61S353C background, three other shifted bands could be identi-
fied. This shifted bands migrated at 60, 80 and 120 kD representing, respectively, a
shift of 20, 40 and 80 kD (Figure 2.8; lanes 8 and 9). In the sec61∆L7 background,
however, besides the Sec61∆L7xSss1 only two other bands could be detected: one
around 55 kD and a faint one at around 110 kD (Figure 2.8; lanes 2 and 3), potentially
the 120 kD Sec61S353C counterpart.
I also attempted SMPH crosslink in permeabilized cells, but it proved unsuccessful
in shifted bands identification (Supplemental Figure A.7 A and B).
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Figure 2.9: Effect of the absence of different protein populations on SMPH crosslink pattern.Microsomes of sec61S353C (17eq)
were extractedwith 2.5MUrea (Urea) or 100mMof sodium carbonate (NaCO) before crosslink with 1mMof SMPH for 30min
on ice, quenched for 15min, and analyzed by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen).
Protein detection was done byWestern Blotting using Sec61N-terminal antibody and signal acquired on ECL ﬁlm.
In order to narrow down the location of the detected crosslinked-partners, as in
Section 2.2, cytosolic associated and lumenal proteins were extracted prior to crosslink,
by treating the microsomes with 2.5 M of urea or 100 mM sodium carbonate, pH 11.5.
As can be seen in Figure 2.9, the only treatment that resulted in band loss was the
extraction of lumenal proteins, as is evident by comparing lanes 8 to 6 and 11. In lane
6, all bands detected in the control lane 8 are present, suggesting that no cytosolically
membrane-associated protein is involved in the detected crosslinks. But, in lane 11,
none of the shifted bands seen in lane 8 are detected, not even the 50 kD, that as
determined before, represents an interaction with Sss1 and is carbonate sensitive.
The lack of all these crosslinks indicates that they represent interactions either with a
lumenal protein or with a transmembrane protein through its soluble domains, which
was denatured upon carbonate treatment.
In an effort to identify the interactor partners that were SMPH-crosslinked to Sec61,
immunoblot analyis using specific antibodies was applied. As it had already been de-
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termined that the SMPH crosslinks were carbonate-sensitive, I focused on lumenal
proteins.
Figure 2.10: Multi-anitbody analysis of SMPH crosslink pattern.Microsomes from sec61S353C (17eq) were crosslinkedwith 1mM
SMPH for 30min on ice, quenched for 15min, and analyzed by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels,
Invitrogen). Protein detection was done byWestern Blotting using speciﬁc antibodies and signal acquired on ECL ﬁlm. For each set
of reactions (one untreated sample and two treated with SMPH), a different antibodywas used for detection. A) Protein detection
done using either either Sec61, Bip, Pdi or Hrd3 antibody and. Figure shows 4 aligned panels, each comprising a set. From left to
right: anti-Sec61-N (40 kD), anti-Bip (75 kD), anti-Pdi (65 kD), and anti-Hrd3 (95 kD). B) Protein detection done using either Sec61
N-terminal or Sec63 antibody.
In Figure 2.10 A, I analyzed the SMPH crosslink pattern in a sec61S353C back-
ground, blotting against Kar2 (75 kD), Pdi1 (60 kD) and Hrd3 (95 kD), all lumenal pro-
teins whose molecular weight would roughly fit with the size shifts observed in the
SMPH crosslinked samples when Sec61 was detected. None of the immunoblots
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with the tested antibodies resulted in the detection of a SMPH-dependent shifted
band that showed the same migration as any of the shifted bands observed when
Sec61S353C was detected.
Since a crosslink to Sec71 had already been established (Section 2.2), the prob-
ability of a crosslink to another element of the Sec63 complex also being detected
seemed high. With this in mind, and encouraged by the fact that the observed shift
(around 65 kD) would fit with a crosslink to Sec63, I used a Sec63 specific antibody
for protein detection. A direct interaction with Sec63 seemed potentially interesting
since this protein possesses a lumenal domain that is involved in ERAD [349]. In Fig-
ure 2.10 B, two sets of crosslinked sec61S353C microsomes can be seen: one was
immunobloted against Sec61 and the other against Sec63. Comparing lanes 2 and
3 to lane 5, one can see that in both panels, a SMPH specific shifted band can be
detected at around 120 kD. This suggested that a crosslink to Sec63 was identified,
clarifying, at least partially, the composition of the corresponding shifted band. As this
interaction was only present in the sec61S353C mutant and was carbonate-sensitive
(Figure 2.9) it might represent a direct contact of Sec61 loop 7 with the lumenal J-
domain of Sec63.
An immunoprecipitation approach (as in Section 2.2) was also attempted, but as
before, the quality of the Western Blots obtained from the immunoprecipitated sam-
ples did not allow proper data analysis due to the overlap of the IgG bands with the
relevant bands (Supplemental Figure A.6).
To further probe whether there was any interaction with Hrd3, SMPH crosslink
was attempted in microsomes from a sec61S353C/∆hrd3 strain (Figure 2.11 A). The
reasoning was that if any of the detected shifted bands had Hrd3 in their composi-
tion they would either disappear or shift size again if Hrd3 was absent. To this end,
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the sec61S353C/∆hrd3 strain was generated by deletion of the HRD3 gene in the
sec61S353C background by transformation of this strain with the HRD3 deletion cas-
sette amplified from a ∆hrd3 strain obtained from the Euroscarf strain collection. Primers
51 and 52 were used for the amplification and the resulting DNA fragment was di-
rectly transformed into yeast. This fragment was characterized by the HRD3 flanking
areas fused to the Kan (KanMX4) resistance cassette. Transformants were selected
in YPD+G418 plates, potential positive clones screened by PCR using the above
mentioned primers, followed by PCR-product sequencing. As can be seen in Figure
2.11 A, the bands detected when Hrd3 is present (lanes 3 and 4) are also detected
when Hrd3 is absent (lanes 7 and 8).
Since the most popular hypothesis at the time of these experiments was that Hrd1/Hrd3
E3 ubiquitin ligase forms the ERAD channel for transport to the cytosol, I chose to in-
vestigate the effect of deletion of HRD1 and HRD3 on degradation of the non-ubiquitinated
ERAD substrate pro-Ⱦ-factor (∆gpȾF) [142, 326, 240]. The ΔgpȾF is a mutant form
of the pȾF peptide, that in turn is the precursor for of the Ⱦ mating pheromone (ȾF)
[367, 54]. In wild-type cells, the ȾF is translated as a precursor form called pre-pro-Ⱦ-
factor (ppȾF; ∼ 18 kDa) and is rapidly post-translationally imported into the ER [326].
Upon import into the ER this peptide has its signal sequence cleaved, resulting in a
∼ 16 kDa peptide denominated pro-Ⱦ-factor (pȾF) [434]. This form is promptly glyco-
sylated resulting in 3gpȾF (∼ 26 kDa), which is transported to the Golgi where it is
further processed [210, 182]. Like ppȾF, p∆gpȾF (∼ 18 kDa), which has 3 point mu-
tations that prevent N-glycosylation, is post-translationally imported into the ER and
has its signal sequence equally cleaved, maturing to ∆gpȾF (∼ 16 kDa) [54]. Since
this form lacks the glycosylation sites, it is not glycosylated, which results in retention
in the ER and it becomes an ERAD substrate [54, 240]. Although ΔgpȾF retrotranslo-
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cation onto the cytosol has been shown to be via the Sec61 channel [289], I though it
might be interesting to verify whether Hrd1 and/or Hrd3 had any role in this process.
Wild-type (HRD1/HRD3) cells, as well as ∆hrd1 and ∆hrd3 cells were labeled with
[S]-met/cys and the ERAD dynamics of ΔgpȾF were evaluated by taking samples at
different time points an immunoprecipitating ΔgpȾF (Figure 2.11 B)
Figure 2.11: Analysis of ∆hrd3 SMPH crosslink and∆hrd1 and∆hrd3∆gpαF ERAD. A)Microsomes from sec61S353C and
sec61S353C/∆hrd3 (17 eq) were crosslinkedwith 1mMSMPH for 30min on ice, quenched for 15min, and analyzed by SDS-PAGE
on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen). Protein detection was done byWestern Blotting using Sec61
N-terminal antibody and signal acquired on ECL ﬁlm. B)Analysis of ∆gpαF ERAD in ∆hrd1 and ∆hrd3 backgrounds. Early log-phase
cells were pulse labeled (1.5 OD per sample) with [S]-met/cys, lysed, andmutant α-factor precursor (∆gpαF - post-translational
imported, unglycosilated, ERAD substrate) immunoprecipitated. Starving and labeling were done at 30ºC. Labeling was done for 5
min. Proteins were detected by phosphorimaging.
As can be seen in Figure 2.11 B, no significant ΔgpȾF ERAD defect could be ob-
served in either the ∆hrd1 nor the ∆hrd3 mutants, but both mutants displayed a slight
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delay in degradation of ∆gpȾF. This delay may or may not be indirect due to the ac-
cumulation of ubiquitin-dependent ERAD substrates in the mutants, but it definitely
excludes the Hrd1/Hrd3 complex as ERAD channel for ∆gpȾF.
With this SMPH analysis, I could determine that SMPH was the better candidate for
Sec61 lumenal interactors crosslink, as I was able to detect a SMPH specific Sec61S353C-
crosslink pattern that was mostly disturbed when lumenal proteins were extracted
prior to crosslink. I was able to identify an extremely consistent Sec61xSec63 crosslink,
which is also carbonate sensitive. This, although not surprising, gives us not only a
strong control for efficient S353C-dependent, lumenal crosslink, but also tells us that
the caught interaction between Sec61 and Sec63 might be through Sec63 J-domain,
whose role in ERAD was previously described [349].
2.4 Sec61-crosslinked-complex Purification and Analysis
Since my immunoblotting analysis had limited success in identifying Sec61 partners,
alternative approaches had to be considered. Until this point, only crosslinks to other
elements of the Sec complex had been identified. Although these vouched for the effi-
ciency of my crosslink setup, it did not result in any information about new lumenal in-
teractors of Sec61. Except for an interaction with the Sec63 J-domain, that might rep-
resent a link with ERAD, the most probable explanation for the detected interactions
within the Sec complex is the fact that they are pretty stable, of very close proximity
and of ubiquitous frequency, unlike lumenal interactions, which by character, should
be more transient and less stable. With this in mind, a viable approach seemed to
be the enrichment of Sec61 and its crosslinked forms, to boost the amount of low
frequency crosslinked forms representing more transient interactions. If in addition
to this, a more sensitive form of protein detection (in alternative to immunoblotting)
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was implemented, the detection of these less frequent, and consequently, less repre-
sented crosslinked forms might be possible.
To this end, and as a means of enriching the Sec61-crosslinked forms in my sam-
ple, I first tagged Sec61 with an 14-His N-terminal tag that could be used to enrich
both the free and the crosslinked forms of Sec61 in my sample by affinity chromatog-
raphy.
2.4.1 Sec61 N-Terminal 14His-tagging
Figure 2.12: His-tagging Vector.Map of the pRS426-GAL-His-TEV vector used for N-terminal His-tagging of Sec61 and
sec61S353C. The lower panel represent a zoom of the vector’s area of interest (GAL1, TEV restriction site, 14His tag andMCS
available). Also to be noted that priming locations for Primer 85 and 95 are labeled in the ﬁgure.
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The first step in this endeavor was to N-terminally tag Sec61 and Sec61S353C with a
14His-tag. A 6His-tag would be inadequate, since yeast proteome is rich in histidines
[89, 446], and a short 6His-tag might have resulted in too much of a background in
the purification setup, as the binding and elution conditions could not not be so strin-
gent. An N-terminal tagging instead of a C-terminal one was chosen because previ-
ous data showed that N-terminal tagging did not impair Sec61 function at the optimal
growth temperature [288].
For the 14His N-terminal tagging of Sec61, I used the pRS426-GAL1-14His (URA)
generously supplied by Alexander Stein [380] (Figure 2.12). As can be seen in the
schemes presented in Figure 2.12, this vector has an ORF that includes a 14His
tag, followed by a TEV restriction site, with a convenient SfoI restriction site after
it, to allow easy in frame cloning of any target gene. Since SfoI is a restriction en-
zyme that generates blunt ends, and its restriction site is already in frame with the
14His-tag and the GAL1 promoter encoded in the vector, by cloning into this posi-
tion I was able to generate an ORF that was under the control of the GAL1 promoter
and that included all the mentioned features. Using a primer complementary to the
START codon region of SEC61 (Primer 63) and another that primed downstream of
the STOP codon (and also included a HindIII restriction site - Primer 64) I was able to
generate a fragment that had a SfoI compatible end (blunt) and a overhang that per-
mitted a directed cloning. This fragment was then cloned into the SfoI/HindIII digested
pRS426-GAL1-14His. Correct cloning was confirmed by sequencing. A scheme of
the final construct can be seen in Figure 2.13.
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Figure 2.13: Constructs obtained by cloning into pRS426-GAL-His .. Maps of the construct generated by cloning SEC61 and
sec61S353C into pRS426-GAL-14His-TEV. pRS426-His-SEC61 on the left and pRS426-His-sec61S353C on the right.
Since SEC61 is an essential gene, no null mutant strains are available. In order to
study the effect of SEC61 mutations one has to either directly integrate the mutant
gene in place of the wild-type gene into the genome, or have a strain in which the ge-
nomic copy of the gene is deleted and where a vector containing a functional copy
of SEC61 is present to compensate for the genomic deletion. In the first instance the
gene of interest (in a truncated form) has to be cloned into an integrative plasmid. In
the second case, the plasmid can be centromeric or 2µ, only constraint being that
it possesses a different auxotrophic marker from the plasmids already in the strain.
Unfortunately, pRS426-GAL-14His is neither a integrative plasmid nor has a marker
compatible with transformation into the needed strain background. I therefore had
to subclone the His-tagged SEC61 into pRS315. For this purpose, two new primers
were designed. One that primed at the beginning of the GAL1 coding region (Primer
93), and a second one priming at the CYC1 coding region end (Primer 85) as can be
seen in Figure 2.12. Primer 93 contained also a SacI restriction site.This primer pair
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was used to amplify the GAL1-14His-Sec61-CYC fragment which could then be sub-
cloned into a CEN vector. For the purpose of this work, the cassette was subcloned
into pRS315 (LEU2, CEN) (Figure 2.14).
It should be said that throughout this process, not only the SEC61 and sec61S353C,
but also the SBH1 and SSS1 genes were cloned into pRS426-GAL-14His vector and
subcloned into pRS315 (Supplemental Figure A.8 and A.9). This was done so pull-
downs of Sec61-containing crosslinked complexes could potentially be made through
the tagged trimeric Sec complex subunits.
Figure 2.14: Constructs obtained by subcloning 14His-tagged constructs into pRS315.. Maps of the construct generated by sub-
cloningGAL1-14His-SEC61-CYC1 andGAL1-14His-sec61S353C-CYC1 into pRS315. A)Map of the subcloned region. Here the SEC61
fragment is shown. The sec61S353C fragment was equal in every way, except for the point mutation in position 353. B)Maps of the
generated constructs. pRS315-His-SEC61 on top and pRS315-His-sec61S353C at the bottom.
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After successful subcloning of both GAL1-14His-SEC61-CYC and GAL1-14His-
sec61S353C-CYC into pRS315, this constructs were transformed into KRY461. This
strain has the genomic SEC61 deleted and a functional copy being expressed from
pGAL-SEC61 (URA3, CEN). Selection of transformants with the 14His plasmids was
done on minimal solid medium (-LEU / -URA / 2 % Gal / 0,2 % Glu). The transfor-
mants were then replated in -LEU / 5’-FOA / 2 % Gal / 0,2 % Glu. Yeast with an ac-
tive URA3 gene (Ura+) convert 5-Fluoroorotic Acid (5-fluorouracil-6-carboxylic acid
monohydrate; 5-FOA) to fluorodeoxyuridine, which is toxic to cells [33]. So, if the cell
is actively producing Ura3 (like the KRY461), it dies, unless it loses the plasmid with
the URA3 gene allowing a chase out of the pGAL-SEC61. Since the SEC61 gene
is essential, and its only functional copy is also in the inserted plasmid, the cell will
only survive if, in addition to losing the pGAL-SEC61, it keeps the second plasmid
(pRS315-GAL1-14His-SEC61 or pRS315-GAL1-14His-sec61S353C), resulting in an
effective plasmid-shuffle [33].
Figure 2.15: His-tagged constructs expression conﬁrmation. Different volumes of microsomes (at Abs=30) from 3 different
strains (SEC61 , 14His-SEC61 , and 14His-sec61S353C) were resolved, side by side, by SDS-PAGE and blotted against Sec61. From
left to right, 2.5, 5 and 10 µl of microsomes from: SEC61 , 14His-sec61S353C and 14His-SEC61.
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After strain construction, expression of the 14His-tagged forms of Sec61 were con-
firmed by immunoblotting. Different amounts of microsomes prepared from each one
of the strains were resolved side by side and compared (Figure 2.15). It is clear that
steady state levels of each one of the Sec61 forms is roughly equal. It could be said
that they seem even somewhat higher than the one observed in the wild-type strain.
By adding a 14His-tag to Sec61 and Sec61S353C N-termini, I had now the raw
material necessary to establish an enrichment of Sec61-crosslinked proteins. Before
efforts were channeled to establish such enrichment system, I needed to make sure
the 14His-tagging of Sec61 (and Sec61S353C) had no deleterious effects on protein
transport across the ER membrane.
2.4.2 Characterization of the 14His-tagged Sec61 forms
Once the strains expressing the 14His-SEC61 (KRY1081) and 14His-sec61S353C
(KRY1061) forms were obtained I had to characterize them, and make sure they did
not display any phenotype that would make them inadequate for use in further stud-
ies.
To this end I did a standard strain characterization, screening for general growth
defects, temperature and tunicamycin sensitivity, as well as any UPR induction.
To screen for generalized growth defects I determined the specific doubling time
of each strain. To this end, strains GAL-SEC61, GAL-14His-SEC61, and GAL-14His-
sec61S353C61 were grown overnight in YPGal (2% Gal / 0.2% Glu), diluted to an
OD of 0.02 in the same medium, applied onto a Biolector Flower plate (1 ml per
well, 5 wells per strain), and grown for 24h in the microbioreactor BioLector, monotor-
ing the biomass (measured at 620 nm) every 15 min (growth at 30ºC, with shaking at
1200 rpm, 85% humidity, and 20.95% O2). The specific growth curves of each strain
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can be seen in Figure 2.16. None of the mutants grew slower than the wild-type, indi-
cating that the 14His-tagging did not have an impact on general cell growth. By rough
estimation through graph analysis I could determine that in the conditions used the
tested strains have, respectively, a doubling time of 9h for SEC61 and 14His-SEC61,
and 7.5h for 14His-sec61S353C. These values, however, are quite different from the
usual yeast doubling times of approximately 2h in YPGal. This might indicate that this
setup might be suboptimal for yeast. It should be said that the 14His-sec61S353C
mutant, although showing normal growth in YPGal, shows a slower, bi-phasic growth
curve when grown in minimal medium (Supplemental Figure A.10)
Figure 2.16: Growth rate of 14His-taggedmutants. Cells were grown overnight in liquid YPGal (Gal 2%, 0.2%Glu), diluted in the
same type of medium to anOD of 0.02 and 1ml of culture applied per well (5 x 1ml per strain) in a FlowerPlate. The plate was
then incubated in themicroreactor Biolector at 30ºC, with 1200 rpm, 85% humidity and 20.95%O , for 24h. Calibration was done
at 320 nm, and biomass determination at 620 nm using Filter 15. Readings were done every 15min. In the ﬁgure the plotted re-
sults (after averaging) are shown. SEC61 in blue, sec61S353C in red, 14His-SEC61 in green, and 14His-sec61S353C in purple. Shown
biomass values are in the log scale. Horizontal doted line serving as guiding for doubling time determination. Vertical dotted lines
represent the time points were an biomass of 2.4 units was reached. The coloring of the doted line corresponds the data set being in-
tersected by it at 2.4 units of biomass. The black vertical dotted line represents the time point when the least lagged strain reaches
the biomass of 1.2 units.
The next step was to determine whether this mutants showed any temperature or
tunicamycin sensitivity. Sensitivity to either higher (37ºC) or lower (20ºC) temperature
when compared to the standard growth temperature (30ºC) is a common indicator
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used to characterize yeast strains with ER translocation defects as transport into the
ER is essential [325]. Tunicamycin (Tm) sensitivity is also a useful indicator, inform-
ing about the capacity of the mutants to clear misfolded proteins.Tunicamycin inter-
feres with N-linked glycosylation in the ER which often is a prerequisite for protein
folding. Hence tunicamycin-sensitivity is often indicative of perturbations in ER home-
ostasis [395, 349]. For this purpose, sequential dilutions of each strain were prepared
(including isogenic controls) and grown on solid media (YPGal 2% Gal, 0.2% Glu).
For temperature sensitivity determination, each set was plated in triplicate, in which
each replica was grown either at 20, 30 or 37ºC for at least 3 days. For tunicamycin
sensitivity determination, each set was also plated in triplicate either in the absence or
presence of tunicamycin (0.25 or 0.5 µg/ml). All three replicas were then incubated at
30ºC for at least 3 days (Figure 2.17).
In Figure 2.17 A the results of the temperature sensitivity are shown. The sec61-3
mutant shows a growth defect at 20ºC and 37ºC, and sec61-32 sensitivity at 20ºC, as
expected [289, 382]. The sec61S353C mutant was also included to screen for any
sensitivity characteristic of the point mutation, opposed to any sensitivity caused by
the tagging. This untagged mutant, in the conditions used, shows a sensitivity at 37ºC
but a normal growth at 20ºC, as reported [186]. None of our 14His-tagged mutants,
however, showed a significant temperature sensitivity, either at 20 or 37ºC.
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Figure 2.17: Temperature and tunicamycin sensitivity of 14His-tagged strains.. Cell were grown overnight in YPD, counted using a
Neubeur chamber and sequentially diluted ( 10−). Samples of each dilution (5 µl) were then plated side by side, in solid YPD (2%
Gal / 0.2%Glu) and grown for at least 3 days. Each set was replicated 3 times in different plates. A)Plates for temperature sensitivity
were incubated at 20, 30 or 37 ºC (one replica per temperature). B) For tunicamycin sensitivity, all plates were grown at 30 ºC, but
two of the plates where supplementedwith 0.25 and 0.5 µg/ml of Tunicamycin, respectively.
As for the tunicamycin sensitivity (Figure 2.17 B), one can see that for the posi-
tive control I used a ∆ire1 mutant, for which strong tunicamycin sensitivity has been
widely reported [265, 58, 397]. IRE1, encoding Ire1, is the signal transducer for the
UPR [409]. Upon accumulation of misfolded proteins in the ER, it is vital as a central
component of the UPR [66]. As expected, the growth of this mutant in the presence of
0.25 µg/ml of tunicamycin was almost null, and completely abolished in the presence
of 0.5 µg/ml of tunicamycin (Figure 2.17 B; top). The sec61S353C mutant was also
included in the assay for the same reason as described above. In its case, a signifi-
cant growth compromise is seen only in the presence of 0.5 µg/ml of tunicamycin, as
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is the case of the wild-type strain, that seems to have its viability at least as affected
as the sec61S353C mutant (Figure 2.17 B; bottom). Our 14His-tagged Sec61 and
Sec61S353C, however, show a very slight growth impairment in the presence of 0.25
µg/ml of tunicamycin, but a serious growth impairment in the presence of 0.5 µg/ml
of tunicamycin. Since the effect of the same concentrations on the wild-type strain
is also strong, it seems fair to assume that no significantly increased tunicamycin-
sensitivity is associated with the His- tag in the conditions tested.
To rule out any UPR induction caused by the tagging of Sec61, an HAC1 splicing
assay was done. In yeast, misfolded-protein accumulation in the ER activates the
UPR.This can be experimentally induced by treatment with inhibitors of ER protein
folding, like tunicamycin [24]. The UPR triggers an adaptive response to restore ER
homeostasis through the action of a transcription-factor, HAC1 [396, 343]. This tran-
scription factor is only active after alternative mRNA splicing [24, 364, 191]. By quan-
tifying the amount of spliced versus the unspliced forms of the HAC1 mRNA I could
determine, at the RNA level, whether the UPR was or not induced.
To this end, wild-type and mutant strains were grown in minimal medium to a maxi-
mum OD of 1 at 30ºC, 220 rpm and incubated for 3h in either the presence or ab-
sence of 200 µg/ml of tunicamycin (30ºC, 220 rpm), point at which total RNA was
isolated, and retrotranscripted into cDNA that was used afterwards for a quantitative
PCR reaction using HAC1 specific primer as well as ACT1 specific primers. The am-
plified ACT1 worked as internal control while the amplified HAC1 informed about the
UPR induction state of the cells.
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Figure 2.18: UPR activation in the 14His-taggedmutants. To this end, wild-type andmutant strains were grown inminimal medium
to amaximumOD of 1 at 30ºC, 220rpm and incubated for 3 h in either the presence (+) or absence (-) of 200 µg/ml of tuni-
camycin (30ºC, 220rpm). Total RNA (0.1 µg) retrotranscribed to cDNA by RT-PCR usingMaximaRT and aOligo(dT18)-dT primer.
The resulting cDNA (1 µg) was subjected to quantitative PCRwith a set of primers targetingHAC1 to monitor the UPR. PCR frag-
ments derived fromHAC1V mRNA (HAC1V = uninduced;∼ 720 bp) andHAC1J mRNA ((HAC1J = induced;∼ 470 bp) are indicated.
Primer for ACT1were also usedwith same cDNA to serve as a loading control. Samples were resolved on a 1% agarose gel.
As can be seen in Figure 2.18, for each strain, two sets of reactions are shown:
one was grown in the absence of tunicamycin (-), the other set was grown in the pres-
ence of tunicamycin (+). It can be observed that in both tagged-mutants, even in the
absence of tunicamycin, some spliced form of the HAC mRNA can be detected, un-
like what happens in the wild-type strain (black bars). This induction, however, is very
slight. Although this was not the optimal scenario, this level of induction did not seem
significant enough to compromise results obtained in the generated backgrounds,
since such induction did not seem to cause any growth defect (Figure 2.16) or signif-
icant tunicamycin sensitivity (Figure 2.17 B), pointing to an almost normal ER protein
homeostasis.
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Figure 2.19: 14His-tagged Sec61 forms half life determination. wild-type, 14His-SEC61 and 14His-sec61S353C cells were grown
to amaximumOD of 1, washed in LabelingMedium, and concentrated to 6OD/ml in the samemedium. Samples were then
starved for 30min and labeled with 6.5MBq of [S]-cys/met for 30min at 30 ºC, 220 rpm. After labeling, the zero time point was
taken (1.5 OD) and cells immediately killed with sodium-azide, pellet collected and ﬂash frozen in liquid nitrogen. To the remain-
ing culture ChaseMix was added, and the culture was kept growing at 30 ºC, 220 rpm. At the designated time points, samples
were collected (1.5 ODs) and treated as the zero time point. After all time points had been collected, samples were thawed on
ice, lysed by bead-beating (BeadBeatter 16), pre-cleared for 30min with Protein A Sepharose, and incubated overnight with Protein
A Sepharose and 10 µl of a Sec61N-terminal speciﬁc antibody. Samples were then resolved by SDS-PAGE on 4-12%Bis-Tris gels
(NuPAGE®Novex® Pre-Cast gels, Invitrogen). Gels were dried, the signal detected in phosphorplates and acquired in the Typhoon
Phosphorimager. Bands were also quantiﬁed using ImageQuant software and the relative band intensities (against the zero time
point intensity) were plotted. On the left panels the acquired signals for each strain and each time point are shown. On the left, the
plotted averaged intensities of each time point when comparedwith the zero. Sec61: Blue; His-Sec61: Green; His-secS353C61:
Red.
Even though no significant growth impairment had been detected in the constructed
mutants, I decided to verify whether the His-tag affected the half-life of Sec61.
To this end, I did 24h pulse chases with cells from wild-type, 14His-SEC61 and
14His-sec61S353C backgrounds. Each culture was pulse-labeled with [S]-cys/met
for 30 min, the indicated time points samples were taken (1.5 OD), lysed, and Sec61
immunoprecipitated. After SDS-PAGE, the signal was acquired by phosphoimaging
(Typhoon Phosphoimager) and band intensities were quantified (ImageQuant). The
relative band intensities (against the zero time point intensity) were then plotted (Fig-
ure 2.19).
As can be seen in Figure 2.19, Sec61 shows an half life of approximately 7h (up-
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per slice; blue line). From the analysis of both the band intensities as from the band
quantitations, one can see that Sec61 suffers a steady degradation at a constant
pace, with ∼ 20 % of the initial amount present after 24h. The His-tagged forms,
are degraded faster with t/ of ∼ 2 h (His-Sec61 - bottom slice, green line; His-
Sec61S353C - bottom slice, green line). It should be noted, however, that in both
cases after this initial plummet, the degradation slows down, becoming at least as
slow as that of the wild-type protein. Although the absolute amounts of the tagged
forms at the zero time points seem much higher than that of the wild-type form, the
amounts after this initial decline are very similar to that of Sec61, and keep being so
to the end of the experiment.
After studying the growth behavior and temperature sensitivity of the generated
strains, it was obvious that no significant growth defect was caused by N-terminally
tagging Sec61. It was also obvious that neither the ER protein homeostasis was com-
promised nor the UPR significantly activated. Although the tagged Sec61-forms showed
a shorter half life than the wild-type, I have shown that the steady state levels of the
14His-tagged Sec61 forms were similar to the wild-type strain (Section 2.4.1, Figure
2.15). Faced with this set of results, the 14His tagged constructs were deemed appro-
priate for further characterization of Sec61 interactions.
2.4.3 Crosslink to His-tagged Sec61 and Sec61S353C
After successfully tagging Sec61 and Sec61S353C and verifying that such tagging
does not cause significant defects in the mutants in question, I could proceed to the
purification setup. But, before going down that road, it was paramount to verify if this
tagged forms generated the same crosslink patterns as their untagged counterparts.
Also, since the idea was to analyze the purified complexes by mass spectrometry,
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and after discussing the subject with a mass spectrometry expert, it was deemed that
having a setup where the crosslinked complexes were separated (cleaved) before
analysis might increase protease access to both the interactor and Sec61, and con-
sequently, help in their detection. Since the sulfhydril-reactive crosslinker I had been
using was uncleavable, an alternative had to be found.
Figure 2.20: LC-SPDP structure. Scheme representing SPDP structure. Molecular formula, molecular weight, and spacer arm length
also shown in ﬁgure
In order to build a setup equivalent to the SMPH crosslink that allowed the cleav-
age of the crosslinked complexes before mass spectrometry, a suitable cleavable
alternative for SMPH needed to be chosen. After thorough crosslinker review, I chose
the crosslinker succinimidyl 6-[3´-(2-pyridyldithio)-propionamido] hexanoate (LC-SPDP)(Figure
2.20). As SMPH, LC-SPDP is water-insoluble, membrane permeable and possesses
both an amine- and a sulfhydryl-reactive group. Although the amine reactive group in
LC-SPDP is the same as in SMPH (NHS-ester), the sulfhydryl reactive group is differ-
ent: in SMPH this group is a maleimide, while in LC-SPDP it’s a 2-pyridyldithiol group.
Despite their different chemical identity, the reactivity of both groups is equivalent
[287]. Since LC-SPDP was the only crosslinker with the desired reactivities, cleav-
ability, and spacer-arm length, it looked like the most appropriate choice.
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Having settled on the cleavable alternative for SMPH, a comparison of the crosslink
pattern between SMPH and LC-SPDP was necessary, as well as the confirmation
that the crosslinked complexes could indeed be cleaved.
Figure 2.21: LC-SPDP crosslink pattern determination. Comparison of the crosslink pattern of both SMPH and LC-SPDP in a
sec61S353C background. Microsomes from sec61S353Cwere crosslinkedwith 1mMof either SMPH or LC-SPDP for 30min on
ice, quenched for 15min and solubilized in 2xLaemmli Buffer either with or without 200mMDTT. Samples were resolved by SDS-
PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen) and submitted toWestern Blotting. Signal acquired
in an Amersham Imager 680 blot and gel imager. Arrows represent crosslinked-complexes. Unspeciﬁc bands are labeled with an
asterisk (*). A) Proteins detected using a Sec61N-terminal antibody. B)Determination of the LC-SPDP crosslink pattern on a 14His-
sec61S353C background. Proteins detected using either a Sec61N-terminal (left panel) or Sec63 (right panel) antibody.
For this purpose, sec61S353C microsomes were crosslinked either with SMPH
or LC-SPDP (1 mM, for 30 min on ice, with 15 min of quenching) in the presence or
absence of DTT. Samples were then analyzed by immunoblotting using an anti-Sec61
antibody for protein detection.
As can be seen in Figure 2.21 A, in the sec61353C background, I could detect the
same crosslinked forms (arrows) in samples treated with either SMPH or LC-SPDP
(lane 1 versus lane 4), including the Sec61S353CxSss1 and Sec61S353CxSec63
crosslinked forms (at around 50 and 120 kD, respectively). It can also be seen that
upon sample reduction, the crosslinked bands disappear (lane 3 versus lane 5). In
153
this way it could be confirmed that LC-SPDP was an adequate cleavable counterpart
of SMPH for the purpose of this project.
Further confirmation that the crosslink behaviour observed in the sec61S353C
background was mirrored in the 14His-sec61S353C background was needed to en-
sure that this tagged form was a suitable tool for interaction identification in the es-
tablished setup. To confirm such adequacy, 14His-sec61S353C microsomes were
crosslinked with LC-SPDP (1 mM, for 30 min on ice, with 15 min of quenching), sam-
ple solubilized either in the presence or the absence of DTT, and analyzed by im-
munoblotting. Protein detection was done with either the Sec61 antibody or with the
Sec63 antibody. The Sec63 detection was meant not only to further confirm the crosslink
pattern of LC-SPDP, but also to evaluate the suitability of using Sec63 and Sec61S353CxSec63
as markers for crosslink and purification efficacy.
In Figure 2.21 B, it can be seen that not only the same Sec61 crosslink pattern
as the one obtained in the sec61S353C background can be detected in the 14His-
sec61S353C background upon LC-SPDP treatment (left panel, lane 2 and 3) but also
that, as established before, the crosslinks are DTT-sensitive (left panel, lane 5 and
6). Also, when using an anti-Sec63 antibody for detection, it can be observed that
the crosslinked band at around 130 kD not only has Sec63 in its composition (right
panel, lane 2 and 3) but is also DTT sensitive (right panel, lane 5 and 6), as the 120
kD counterpart in the sec61S353C background (Figure 2.7).
Being assured that the 14His-tagged strains behaved similarly to the untagged
ones regarding the interactions detected by crosslink, the establishment of the pu-
rification setup could be undertaken.
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2.4.4 14His-tagged Crosslink Purification Setup
Having successfully tagged the different forms of Sec61, a choice of purification method
had to be made. Since the tag to be used was a polyhistine one, the choice of Immo-
bilized Metal Affinity Chromatography (IMAC) as the purification system was a given.
In this type of chromatography, a matrix charged with a transition metal (usually Ni+)
can selectively bind with good selectivity strongly positively charged peptides, as the
polyhistidine tags. This binding can be reversed upon addition of a competing and in
excess binding molecule, such as imidazole [31].
Before starting with the establishment of the purification setup, a solubilization strat-
egy that was compatible with downstream purification had to be settled upon. I had
to maximize Sec61 solubilization, while keeping it from aggregating and maintain-
ing working conditions that did not compromise subsequent matrix-binding of the tag.
Since I knew from previous experience that Sec61 solubilization in IP Buffer (150 mM
NaCl / 1 % (v/v) Triton X-100 / 15 mM Tris-HCl, pH 7.5 / 2 mM Sodium Azide / 0.1 %
(w/v) SDS) was adequate, I tested solubilization in said buffer under different condi-
tions: 4ºC for 30 min, 42ºC for 20 min or 65 ºC for 10 min. As can be seen in Figure
2.22, the best condition for solubilization of Sec61 was the 4ºC incubation (lane 2).
To be noted that, even in the best condition tested, the solubilization yield it is not as
high as the one obtained in Laemmli Buffer.
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Figure 2.22: His-Sec61 solubilization test.Microsomes (17eq) from 14His-SEC61were resuspended in 50 µl of IP Buffer and in-
cubated either at 4 ºC for 30min, 42 ºC for 20min or 65 ºC for 10min. Sample was was centrifuged for 1min at 16.000 x g, half the
volumewasmixedwith 2xLaemmli Buffer, and samples were resolved by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex®
Pre-Cast gels, Invitrogen). Proteins were detected byWestern Blot using a Sec61N-terminal antibody. Control sample was resus-
pended in 50 µl of 2xLaemmli Buffer (SB) and denatured for 10min at 65 ºC.
Solubilization in similar or derived buffer, however, would have proven difficult,
since the characteristic that caused the increased solubility in Laemmli Buffer was
most probably the high amount of SDS. Unfortunately, most IMAC appropriate matri-
ces have low SDS compatibility [336]. SDS is also prone to precipitate at low temper-
atures, which were necessary in my purification setup to minimize protein degradation
during purification process. Also, I deemed that higher concentration of SDS would
contribute to a more thorough sample denaturation that might cause aggregation is-
sues during purification. Therefore, I opted for the use of a milder, less precipitation
prone detergent in the purification buffers (TritonX-100).
As shown in Supplemental Figure A.12 A and B, different buffers were tested. Start-
ing with a basic buffer for Niquel based IMAC inspired by the buffer used in the work
described in a publication where a similar construct was used (B1 - 50 mM Tris-HCl,
pH 7.4 / 300 mM KCl / 40 mM Imidazole) [380], I tried different buffer compositions
(Table 2.1). In Figure A.12 A, the effect of the addition of 0.5 % TritonX-100 (either by
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itself or in combination with 4 M urea) to the buffer was evaluated. It became obvious
that the purification buffer must have TritonX-100 in its composition, as only in sam-
ples where it was present was I able to detect any purified Sec61 (B2). The presence
of urea (B3), however, prevented column retention, when compared to the yields ob-
tained when TritonX-100 was used by it self. The same effect was seen when either
the same amount of urea was used in combination with 1 % SDS (B5) or where it was
increased to 8M (B6), while reducing, in both cases, the amount of KCl to 150 mM
(Figure A.12 B,bottom two panels). However, addition of SDS seemed to improve
column retention when compared with the same conditions in its absence (B4 and
B5 versus B2 and B6, respectively). Nevertheless, I noticed that, besides resulting
in lower yield than Buffer B2, these buffers were also very prone to precipitate and to
cause column clogging .
Table 2.1: Tested puriﬁcation Buffers. Composition of the buffers that were tested during IMAC puriﬁcation setup.
Composition
Buffer
Name
Tris-HCl, pH 7.4
(mM)
KCl
(mM)
Imidazole
(mM)
TritonX-100
(%)
Urea
(mM)
SDS
(%)
B1 50 300 40 - - -
B2 50 300 40 0.5 - -
B3 50 300 40 0.5 4 -
B4 50 150 40 0.5 - 1
B5 50 150 40 0.5 4 1
B6 50 150 40 0.5 8 -
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Based on the information above, I decided to settle on using Buffer B2 (50 mM Tris-
HCl, pH 7.4 / 300 mM KCl / 40 mM Imidazole / 0.5 % TritonX-100) as the purification
buffer for the remaining of the project.
Due to the intrinsic difficulties of purifying multi-spanning transmembrane proteins
like Sec61 (10 TMs), several purification approaches were tested. Not only the buffer
composition and native vs denaturing conditions were tested, but also batch vs col-
umn purification, manual vs automatic setup, and Ni+ vs Co+ charging of the matrix.
All data from the optimization process can be seen in Figure A.13. Shortly, it was de-
termined, that while batch purification worked (Supplemental Figure A.13 A), nickel
functioned as a better charging element for the purification matrix than cobalt (lane 5
vesus 6) since both generated the same level of background, but a better yield was
obtained from the the nickel-charged one (Supplemental Figure A.13 A). Also, upon
crosslink and upscaling, the efficiency of purification dropped drastically (Supplemen-
tal Figure A.13 B, upper panel) while the amount of background increased (lower
panel). Variations of the batch system were made where the sample was either de-
natured or not prior to purification, and where a gradient of imidazole was used for
elution. In all these cases I observed significant loss of His-Sec61 along the several
steps (Supplemental Figure A.13 C, lane 1 to 26). As can be seen, conversely, the
usage of an automated purification system in association to a pre-packed HisTrap FF
crude column, resulted in a proper column retention of His-Sec61 (Supplemental
Figure A.13 C). This was true for both native and denaturing condition (Supplemen-
tal Figure A.12 C). Although the yield of the purification in native conditions seemed
to be higher, it also seemed to generate a much greater background, on top of caus-
ing elution at slighly lower concentrations of imidazole. Also, since the level of pro-
teolysis in the sample until it could be properly stored for mass spectrometry analy-
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sis was a serious concern, I deemed better to denature samples prior to purification,
and doing all purification steps at 4ºC. The imidazole gradient also seemed to work
well for protein elution (Supplemental Figure A.13 C, lane 27 to 40) in this setup. This
method also allowed me to follow the purification in real time either by following the
absorbance (at 280 nm) or by following the conductance.
After this test phase, all purification conditions had been established. Purification
programs were also optimized to allow a more convenient elution pattern and fraction-
ing. A scheme of the final setup can be seen in Figure 2.23.
Figure 2.23: Puriﬁcation system scheme.Microsomes (500 eq) were treated either DMSO (Control), SMPH or LC-SPDP (1mM),
solubilized in 1ml of IP for 30min on ice, followed by 10minat 65ºC. Samples were then diluted with 4ml of cold Puriﬁcation Buffer,
and injected into a Histrap FF (1ml) pre-packed columns associated to a BioLegend LP puriﬁcation system. Columns was washed
with Binding Buffer (10ml ; 50mMTris-HCl, pH 7.4 / 300mMKCl / 0.5 % TritonX-100 / 40mM Imidazole) andwith Puriﬁcation
Buffer/ 100mM Imidazole(10ml). Elution was done along an imidazole gradient (150-500mM) in 15ml-long steps. Fraction of 7.5
ml were collected along the imidazole gradient, and DTT (100mM)were added. Each sample was TCA precipitated, resuspended in
2xLaemmli buffer, and resolved by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen).
Briefly, samples were crosslinked (1 ml reactions, using 500 eq of microsomes),
solubilized in IP Buffer on ice for 30 min, followed by a 10 min denaturing step at
65 ºC. After pre-clearing, sample was diluted with 4 ml of cold Binding Buffer (50
mM Tris-HCl, pH 7.4 / 300 mM KCl / 0.5 % TritonX-100 / 40 mM Imidazole). Sam-
ple was then injected into the system. The purification was set on an automatic gra-
dient program. A description of the purification program can be seen in Table 2.2 .
Collected fractions were then incubated with DTT, TCA precipitated, resuspended in
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50 µl 2XLaemmli Buffer, and resolved by SDS-PAGE. Each fraction was loaded (10
µl) in two different acrylamide gels. Detection was done by Western Blot, using the
N-Terminal Sec61 antibody for one replica of each purification set, and the Sec63 an-
tibody for the other replica. The remaining sample was resolved on a third gel, which
was stained with Coomassie G-250 (Supplemental Figure A.11).
Table 2.2: Puriﬁcation programDescription of the steps programmed into the automatic puriﬁcation system.
Phase Amount
Imidazole (mM)
Start
(ml)
End
(ml)
Length
(ml)
Fraction
Sample injection 40 0 10 10 Flowthrough
Column Wash 40 10 20 10 Wash
Imidazole gradient
100 20 35 15 F1-2
150 35 50 15 F3-4
200 50 65 15 F5-6
400 65 80 15 F7-8
500 80 95 15 F9-10
Column Wash 40 95 110 15 F11-12
As can be seen in Figure 2.24 A, independently of the treatment, elution of His-
Sec61S353C was achieved in an acceptably narrow interval of the elution gradient
and in easily detectable amounts (upper panels). Loss of protein in the flowthrough
was negligible (Figure 2.24 A; upper panel, Flow and Wash). In the lower panels,
the results of the Sec63 detection can be seen. Here, it can be observed that there
are no overlapping of Sec63 and Sec61 elution from the column in the control condi-
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tions ( i.e absence of crosslinker), while in crosslinked samples, Sec63 elution over-
laps, at least partly, with the Sec61 elution (Figure 2.24 A; compare lanes 4-8 in both
upper and lower panels). In sample treated with SMPH, this elution is detected as
Sec61S353CxSec63 complex ( Figure 2.24 A; bottom central panel, lanes 18 to 20),
while in the LC-SPDP treated sample, since the sample was reduced, and the crosslinker
cleaved, Sec63 elution is detected in its free form (Figure 2.24 A; bottom right panel,
lanes 31 to 33). To further confirm the quality of the purified samples and also as a
way of roughly estimating the total amount of purified protein, fractions 3 to 10 from a
different set of purifications were pooled, TCA precipitated, resuspended in 2xLaemmli
Buffer and resolved by SDS-PAGE. In the same acrylamide gel were also loaded
different amounts of BSA to serve as loading control. The gel was then stained with
G-250 and the intensity of total amount of protein estimated based on the BSA load-
ing controls used. An example of one of these stainings is showed in Figure 2.24 B.
Here, it can be seen that I was able to purify, roughly, around 2 µg of protein from
each sample, and that the amount of background was acceptably low.
After data analysis, I deemed that the full crosslink/purification setup was indeed
suitable for crosslinked Sec61 complex enrichment, and also suitable for a potentially
successful mass spectrometry analysis.
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Figure 2.24: Immunoblot and gel staining analysis of puriﬁed fractionsMicrosomes (500 eq) were treated either DMSO (Control),
SMPH or LC-SPDP (1mM), solubilized in 1ml of IP for 30min on ice, followed by 10min at 65 ºC. Samples were then diluted with
4ml of cold Puriﬁcation Buffer, and injected into a Histrap FF (1ml) pre-packed columns associated to a BioLegend LP puriﬁcation
system. Columns was washedwith Binding Buffer (10ml; 50mMTris-HCl, pH 7.4 / 300mMKCl / 0.5 % TritonX-100 / 40mM Im-
idazole) andwith Puriﬁcation Buffer/ 100mM Imidazole(10ml). Elution was done along an imidazole gradient (150-500mM) in
15ml-long steps. Fraction of 7.5ml were collected along the imidazole gradient, and DTT (100mM)was added. Each sample was
TCA precipitated, fraction of interest (3 to 10) were all resuspended in the same 50 µl of 2xLaemmli Buffer, and resolved by SDS-
PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen). A) Immunoblot analysis of the elution pattern when
both a Sec61 and a Sec63 antibodywas used for protein detection. BComassie G-25 stained gel of the pooled His-Sec61S353C-
containing fractions (3-10) to ascertain both puriﬁcation yield and co-puriﬁcation levels.
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2.5 Liquid Chromatography-tandem Mass Spectrometry and Statistical Analysis
With a successful scheme for crosslink followed by target-form purification estab-
lished, I was in position of proceeding with the mass spectrometry analysis. My first
attempt at mass spectrometry analysis was done in collaboration with Klaus Hollen-
meyer in the Chemistry department of the Saarland University using an AB Sciex
4800 Plus MALDI tandem TOF mass spectrometer. Sample was crosslinked, puri-
fied, and resolved by SDS-PAGE. After Coomassie staining, visible bands present in
the crosslinked samples were excised from the gel, as were the same gel positions
of the non-crosslinked sample. Proteins were extracted from the gel slices, trypsin
digested and analyzed by mas spectrometry. This analysis was also limited to only
LC-SPDP samples, as Dr. Klaus Hollenmeyer did not feel confident on the probability
of a detection of Sec61 in the crosslinked form. Unfortunately this approach proved
to be unsuccessful, as I was only able to detect Sec61 itself (results supplied as Sup-
plement File MassSpecUds in the annexed virtual media - i.e USB-stick ”Dissertation
Supp.”).
A mass spectrometry analysis in collaboration with Dr. Rod Chalk, of the Structural
Genomics Consortium (SGC) Oxford wa also attempted. To this end, affinity purified
samples and crosslinked samples solubilized with a range of different detergents (n-
Dodecyl-ȿ-D-Maltoside - DDM, Octyl Glucose Neopentyl Glycol - OGNG, digitonin,
and TritonX-100) were separated by reverse phase chromatography and analyzed by
mass spectrometry The reasoning behind using different detergents and concentra-
tions was that these detergents have different strengths and chemistry, preferentially
solubilizing different classes of proteins. In using them, I might be able to solubilize
only a sub-population in which Sec61 was included, serving as a rough purification
step. Analysis showed that the differential solubilizations were unsuccessful in enrich-
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ing Sec61 (data not shown). Analysis of the affinity purified samples returned no hits,
not even Sec61 being detected (data not shown). At the time, I thought that such lack
of signal was due to a co-precipitation of KCl during TCA precipitation, which inhib-
ited trypsin digestion and compromised the full analysis. Because a lot more effort
was necessary for the optimization of this setup, the collaborator lost interest in the
project.
I was then given access to the EMBL Core Proteomics facility as my supervisor is
an EMBL alumna. The head of the facility, Dr. Mikhail Savitski, and Mandy Rettel, a
PhD student, agreed to work with me. They suggested a new approach to analyze
my crosslinked samples.
Table 2.3: List of samples analysed by LC-MS/MS
Sample name Description Nº of
samples
Control Purification from non-crosslinked
14His-sec61S353C microsomes
3
Sec61_SMPH Purification from SMPH crosslinked
14His-Sec61 microsomes
3
Sec61_LC-SPDP Purification from LC-SPDP
crosslinked 14His-Sec61 microsomes
3
sec61S353C_SMPH Purification from SMPH crosslinked
14His-sec61S353C microsomes
3
sec61S353C_LC-
SPDP
Purification from LC-SPDP
crosslinked 14His-sec61S353C
microsomes
3
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For this new approach, samples were purified as described in Section 2.4.4, re-
suspended in 50 µl of 2xLaemmli buffer and resolved for 5 cm on an acrylamide gel.
Gels were then shipped to EMBL for analysis. Purifications were done sequentially,
making sure to purify the Control samples first, using a dedicated column for each
treatment type, and including extensive system washing steps in between samples
and sets. On site, each lane was cut into multiple bands, these were subjected to in-
gel trypsin digestion, the peptides were recovered and analysed by Liquid Chromatography-
tandem Mass Spectrometry (LC-MS/MS). In total, 12 samples were analyzed, as
listed in Table 2.3.
Peptides were then separated by liquid chromatography (nanoAcquity UPLC sys-
tem; Waters), and analyzed in a state-of-the-art mass spectrometer (LTQ Orbitrap
Velos Pro; Thermo Fisher Scientific).
The raw mass spectrometry data was processed with MaxQuant (v1.5.2.8) [65]
and searched against an Uniprot Saccharomyces cerevisiae proteome database.
For protein identification a minimum of one unique peptide with a peptide length of at
least seven amino acids and a false discovery rate (fdr) below 0.01 were required on
the peptide and protein level. Label-free quantification was selected using intensity-
based absolute quantification (iBAQ - calculated as the sum of the intensities of the
identified peptides and divided by the number of observable peptides of a protein)
[347] with the log fit function enabled. The raw mass spectrometry data can be found
in the Supplement File RawData (MassSpecEMBL/MassSpecData/RawData) in the
annexed virtual media (i.e USB-stick ”Dissertation Supp.”), as well as the excel file
Fulldata.xlsx (MassSpecEMBL/MassSpecData/Fulldata.xlsx) with the iBAQ quantita-
tions that resulted from the above described analysis.
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Frank Stein, a biostatistician from the EMBL Proteomics Core Facility, analyzed
these samples looking for enriched hits in the crosslinked samples (SMPH and LC-
SPDP) when compared to the non-crosslinked ones (Control). He processed the raw
output data of MaxQuant (proteinGroups.txt file) using the R programming language
(ISBN 3-900051-07-0). As a quality filter, a threshold of 2 unique peptides was set
for protein identification. Potential batch-effects were removed from the log2 of the
iBAQ values using the Limma package [316]. Batch-cleaned data were normalized
with the variance stabilization (vsn) package [166]. Missing values were imputed us-
ing the MSNbase package [110]. Finally, limma was used again to identify differen-
tially expressed proteins. A protein was called a ”hit” with a fdr smaller than 5 % and
a fold change of at least 3, and a ”candidate” with an fdr smaller than 20 % and a fold
change of at least 3. The MA plot (which reflects significant differences between sam-
ples) generated during analysis can be seen in Figure A.14.
In Figure 2.25, the general enrichment pattern can be seen in the volcano plots,
where hits are plotted by means of their level of enrichment versus their p-values.
Due to the large number of enriched proteins, this group was divided into two cat-
egories: ”hits” and ”candidates”. Both show log2FC values (i.e enrichment factor)
higher then 1,58 (which represents a minimal fold-change of 3), but ”hits” have a fdr
below 5% while ”candidates” present an fdr below 20%, but higher than 5%. This
threshold is visible in the graphical representation by a vertical purple line. ”Hits” and
”candidates” are shape-coded in the graph; ”hits” are represented as circles and ”can-
didates” as triangles. All non-enriched proteins (i.e below threshold line) are repre-
sented by a small, gray circles. The hits of potential interest were colored red, Sec
complex subunits were colored green, and other reported interactors (either by on-
line databases, literature, or personal communication with other researchers) were
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colored blue. These hits were resumed in Table 2.4, where the same color code was
used.
Figure 2.25: Volcano PlotVolcano plots based on the statistically determined protein enrichment in the crosslinked samples (His14-
Sec61 andHis14-Sec61S353C) when compared to the non-crosslinked samples. The horizontal axis represents log2 fold change
(log2FC) reﬂecting level of enrichment. The vertical axis plots the -Log10(pValue) of enrichment, reﬂecting signiﬁcance. Both hits
and candidates have a fold change of at least 3. Hits have a false discovery rate (fdr) < 5% and candidates an FDR < 20%. Purple line
is at fold-change of 3. Hits shown as colored dots and candidates as triangles. Elements of Sec61 complex in green; known interac-
tors or translationmachinery in blue; and shortlisted hits in red and points labeled on graph. Not signiﬁcant hits below reference
line and non-interesting hits above reference line in light grey.
From this protein-enrichment study, a total of 361 enriched proteins were found
(204 hits and 155 candidates). The highlighted ”hits”, with their respective log2FC val-
ues and sample representation can be seen in Table 2.4. Some of the ”hits” resumed
in this table were enriched in more than one treatment/sample (as can be seen in the
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”Sample” field for each hit). In those cases, the shown log2FC values are an average
of the log2FC values obtained in each sample/treatment. An excel file with the full sta-
tistical analysis and resulting data can be found in Supplement File TreatedData.xlsx
(MassSpecEMBL/StatisticalAnalysis/TreatedData.xlsx) in the annexed virtual media
(i.e USB-stick ”Dissertation Supp.”). The individual, per sample log2FC values can be
consulted there (sheet 3 to 6). Consultation of said list is advisable, since individual
log2FC, p-values, and fdr values can be of extreme interest.
Table 2.4: Shortlisted Hits. Listing of shortlisted hits. Presented hits are color coded tomatch coloring used for volcano plot label-
ing.
Besides the enrichment pattern of crosslinked samples when compared to the con-
trol samples, other combinations of comparison were made (e.g Sec61_SMPH ver-
sus Sec61_LC-SPDP, Sec61_SMPH versus sec61S353C_SMP, etc.). Although these
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comparisons were not the main objective of the analysis, they might contain some
useful information. Therefore a graphical analysis is annexed to this document for fu-
ture reference (Supplemental Figure A.15 and A.16) and the full data sets (LimmaRe-
sults.xlsx) and intermediary graphical analysis are supplied in the Supplement File
FullData (MassSpecEMBL/StatisticalAnalysis/FullData) in the annexed virtual media
(i.e USB-stick ”Dissertation Supp.”). There, the file Report.pdf, with a step-by-step
description of the data analysis can be consulted.
To have a graphical representation of a possible interaction grid present in this en-
riched fraction, I tried using network-prediction software and potentially see some
pattern. To this end the list of 361 enriched hits (plus Sec61) was fed into the on-
line protein-protein interaction network prediction tool STRING [386]. STRING is a
database of known and predicted protein-protein interactions. The interactions in-
clude direct (physical) and indirect (functional) associations; they stem from computa-
tional prediction, from knowledge transfer between organisms, and from interactions
aggregated from other (primary) databases. Before the final graphical representation
was obtained, I changed the following settings: network hedges (connecting lines)
reflect strength of data support; minimum score to 0.7 required for interaction vali-
dation; remove disconnected nodes in the network. All three settings were changed
to increase figure clarity and accuracy. I also applied a kmean clustering, where the
network was clustered to 7 clusters. The number of clusters was chosen randomly,
as it just defines the exact number of clusters the software returns from my network,
and only with the intent of highlighting a Sec61-containing cluster. After such setting
changes, the following grid was obtained (Figure 2.26).
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Figure 2.26: Interaction Grid. 361 enriched hits (plus Sec61) were fed into the online protein-protein interaction network predic-
tion tool STRING (database of known and predicted protein-protein interactions). Default settings changed as follow: network
hedges (connecting lines) reﬂect strength of data support; minimum score to 0.7 required for interaction validation; remove discon-
nected nodes in the network. A kmean clustering, where the network was clustered to 7 clusters was also applied. Sec61 containing
cluster in green. Sec61 itself highlited by a red circle. Non clustered hits shown in red. Other clusters in blue, light green, purple,
yellow, andmarine blue.
The Sec61-containing cluster is colored green and Sec61 is highlighted by a red
circle. It can be seen that in this particular cluster, which represents proteins with
close interaction relationship with Sec61, not only other Sec complex elements are
present, but also hits like Mpd1, Ubc7, Ubc7, Cue1, Ydj1, among others. It should
also be noticed that the EMC complex seems to show close proximity with the Sec61
cluster, which confirms recent data that Sec61 and the EMC complex can cooperate
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in protein integration into the ER membrane [362], as well as a cluster that seems
of mainly transcription elements (in marine blue). Several other clusters are high-
lighted (yellow, light green, blue, purple, and the unclustered background in red). The
software itself, as soon as the grid was rendered, generated the automatic warning
message ”your network has significantly more interactions than expected”. This was
taken as a sign of high probability of a meaningful interaction/graphical representation.
The tool allowed also for an analysis of the functional enrichments on our network.
The reported results can be seen Supplemental file Functional Analysis. Note that
the location of the hits in the grid is not meaningful, the connections between hits and
their thickness are.
Figure 2.27: Protein abundance/EnrichmentGraphical representation of the enrichment level (i.e logFC) of the Sec61 interactors
as function of their respective cellular abundance as in [209]. Known interactors blue, Sec61 complex subunits green, interesting
interactors red and labeled on the graph. Note absence of correlation between cellular abundance and interaction with Sec61.
While the enrichment pattern was sample- and crosslinker-dependent as can be
seen in Figure 2.25, there was the possibility that the detected enrichments might sim-
ply reflect the absolute abundance of proteins in the cell. To test this hypothesis, each
hit enrichment level was plotted as function of its cellular abundance. The reason-
ing was that if the enrichments detected reflected the cellular amount of each protein,
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then the probability of this representing true interactions was low. In Figure 2.27 we
can see that cellular amounts did not correlate with the enrichment levels seen in the
mass spectrometric analysis, suggesting that the detected interactions with Sec61
were specific. Files with the data that originated shown figure can be consulted in
Supplemental File Kulak cell amounts.xlsx (MassSpecEMBL/StatisticalAnalysis/Kulak
cell amounts.xlsx) in the annexed virtual media (i.e USB-stick ”Dissertation Supp.”).
2.5.1 Crosslinked Peptide Analysis
Figure 2.28: xQuest/xProphet pipeline analysis scheme.Workﬂow of the xQuest/xProphet software pipeline for the identiﬁcation
and statistical validation of cross-linked peptides fromXL-MS experiments. The ﬁrst step includes the conversion of rawMS data to
themzXML format and the preparation of the folder structure for the xQuest search. The second step includes the xQuest search
and the identiﬁcation of cross-linked peptides. The third step describes the statistical validation of the xQuest search results by
xProphet, and the fourth step illustrates the web server–based data and result visualization. UI, user interface. Scheme adapted
from [217].
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Knowing, or even having some hints, of the potential crosslink locations between two
crosslinked interactors would be invaluable, so I strived to find a way to infer some in-
formation on that from the data. In my search for methods to achieve this end, I came
across the xQuest/xProphet software [217]. This software identifies and statistically
validates crosslinked peptides from XL-MS experiments. The software was not opti-
mized for our crosslink setup, but I came to understand, that in fact, none of the avail-
able software was. There are two main reason for the inadequacy of most software:
• the high complexity of the sample. A total of ∼ 1900 different proteins were
identified by mass spectrometry in the 12 samples analyzed. This represents
a very complex sample, which these softwares are not prepared to handle.
• the crosslinker used. Most software is optimized for the analysis of samples
treated with homobifunctional crosslinkers, specially DSS. So, although reac-
tivity with both lysine (K) and cystein (C) could be set, the software was no able
to exclude homocrosslinks (K-K or C-C), which meant I had to exclude these
manually.
A general schematic from Leitner et al. [217] can be seen in Figure 2.28. Meaning-
ful parameters are described in the Methods section (Section 1.2), and definition files
can be found in the Supplement File deffile.def (MassSpecEMBL/xQuest/deffile.def)
in the annexed virtual media (i.e USB-stick ”Dissertation Supp.”).
Since the software had been reported to behave better when small databases were
submitted, I always kept databases below a total number of 30 proteins. This restric-
tion was set not only due to the better behavior of the software with small datasets,
but also due to the big data load. For each analysis round I had to screen 12 raw
data files for possible combinations. Moreover, the software was used in a virtual
machine environment, as it needed to run under the Ubuntu operating system. This
caused too much stress on the computer memory, causing not only slow analysis (the
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full data set would, in average take 72h to complete the full analysis), but also some
crashes of the software during the run, as well as problems with the result loading
and export from the server where the data could be read. Since the machine showed
itself to be incapable of loading most the results into the server, for whatever reason
that neither I, nor the software developer (Alexander Leitner) or the in house IT sup-
port that was contacted to try to clarify the subject (Timo Scheller), could determine.
To circumvent this issue, data had to be loaded onto a server (ARMv8 system of the
HIZ department) that had enough capacity/speed to successfully load the data into
the results server. Both the long time needed for each run, as well as the difficulty
with the results acquisition, limited the amount of optimization that could be done. I
tried, nevertheless, to feed the software bigger databases (175 and 360 proteins).
In all the cases above mentioned, the software was able to identify several crosslinked
peptides, not only between Sec61 and interacting proteins, but also between combi-
nations of the other hits. Unfortunately, the maximum score of the hits found in any of
the attempts by varying database components and size, was never above 25, which
is a low score for a true hit (score should be 40 or higher). Even in the higher score
range, I found an even distribution of both hits and decoys. Decoys are random pep-
tides generated by the software based on the sequences on the protein database,
and serve as internal controls. This told me that the probability of a given hit being
true or false was even. I tried different approaches with the intention of sifting true
from false hits: screening for peptide identities and verifying that these were differ-
ent in control and treated samples, mapping the detected interaction and evaluating
the likelihood of it being real (e.g link of cytosolic domain to cytosolic or lumenal do-
main of another protein?, is detected crosslink present in decoy hits?, etc.). These
approaches allowed the exclusion of some potential false positives, but not enough.
174
Figure 2.29: xQuest/xProphet Sec61xMpd1 crosslink report. Example of the returned results after xQuest/xProphet analysis. A)
Detected Sec61xMpd1 crosslinked site. B)Resume of the detected crosslinked sites detected by the software in a given analysis. A
mapping of the detected crosslinked positions onto Sec61 can also be seen.
During these analyses, a specific interaction prediction appeared multiple times,
and not only that, but the reported crosslink seemed to be possible and to make sense.
This interaction was between Sec61 and Mpd1. The software reported with some reg-
ularity a specific crosslink between Mpd1 C59 and Sec61 K209 (K243 in the 14His-
Sec61S353C mutant). The reported result can be seen in Figure 2.29 A. The data
can be seen in Supplemental File Analysis.xlsx (MassSpecEMBL/xQuest/ Analy-
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sis.xlsx) in the annexed virtual media (i.e USB-stick ”Dissertation Supp.”). This par-
ticular analysis was done with a database comprising Sec61, Pbr1 (Yns1), Sec63,
YNL021W (Yn8b), Asi3, She2, Psg1 (Ykh7) and Mpd1. In this analysis, like in so
many others, several potential Sec63 crosslink sites were also detected, as well as
potential interactions with the others tested hits. Reported crosslinks can be seen in
Figure 2.29 B.
Another interesting detail is that no crosslink to the unique cystein introduced into
L7 was detected by the software, only crosslinked lysines were detected in Sec61.
It should also be said that the xProphet segment of the pipeline did not seem to run
properly in any of the analysis, and consequently, no fdr values were ever calculated.
With this approach, although some potential crosslink sites had been highlighted,
their validity was dubious.
2.6 Sec61 Interactors Analysis
Based on the obtained mass spectrometry data, I chose some Sec61 interactors
that seemed functionally interesting for further analysis. These were Asi3, YKL077w
(Psg1), YNR021w, She2 and Mpd1.
Asi3 was chosen, although being described as a nuclear protein, involved in In-
ner Nuclear Membrane (INM) protein quality control, because it not only was strongly
present in our samples, but it was also strongly enriched in the crosslinked samples.
Asi3, a transmembrane protein that forms the Asi complex with Asi1 and Asi2, is also
reported as interacting with Ssh1 in the nucleus, but not with Sec61 [102]. Psg1 and
YNR021w are both ER membrane proteins, which are still uncharacterized [115, 168].
Their potential interaction with Sec61 seemed to be of interest since they might rep-
resent new ERAD factors. She2 (an RNA binding protein) [264] was also chosen for
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further investigation because although it has been reported that She2 binds to the ER,
its receptor has never been identified. This has been a long-standing question in the
field of RNA-targeting, hence it seemed likely that I could make a valuable contribu-
tion here. Mpd1 was also chosen, due to its connection to ERAD [415] and because
of the potential crosslink site identified to a lumenal domain of Sec61 by the xQuest
analysis.
2.6.1 Characterization of Sec61 Interactor Mutants
After narrowing down my list of 361 potential interactors to 5 ( Asi3, Psg1, Ynr021w,
She2 and Mpd1), the first step was to characterize the strains with deletions in each
of the genes encoding Sec61 interactors. I wanted to verify whether they showed any
phenotypes that might indicate a role of the potential interaction with Sec61 in ER
protein translocation or ERAD. For this purpose, mutant strains were obtained from
the Euroscarf strain collection and characterized using basic yeast techniques.
Figure 2.30: Temperature and tunicamycin sensitivity test of∆asi3,∆ynr021w,∆psg1, and∆she2mutants. Cell were grown
overnight in YPD, counted using a Neubeur chamber and sequentially diluted ( 10−). Samples of each dilution (5 µl) were then
plated side by side, in solid YPD and grown for at least 3 days. Each set was replicated 4 times in different plates. Plates for tem-
perature sensitivity were incubated at 20, 30 or 37 ºC (one replica per temperature). For tunicamycin sensitivity, one plate was
supplementedwith 0.5 µg/ml of tunicamycin and grown at 30 ºC.
I started by characterizing these strains with respect to their temperature and tu-
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nicamycin sensitivity. Cells were grown overnight, counted and sequential dilutions
made (10-10). Dilutions were plated on solid YPD with tunicamycin (0.5 µg/ml) or
without tunicamycin. The plate with tunicamycin and one of the YPD plates were incu-
bated at 30ºC. The two other plates lacking tunicamycin were incubated at either 20
or 37 ºC. As shown in Figure 2.30, only the positive controls showed any sensitivity
in the tested conditions. The sec61-3 mutant shows reduced viability both at 20 and
37ºC (two right-most panels) and the sec61-32 at 20ºC (second panel from the right)
and in the presence of tunicamycin (left-most panel). The sec61-32 mutant was used
as positive control for tunicamycin sensitivity, as this mutant has, at the permissive
temperature, the strongest ERAD defect characterized in a sec61 mutant [289].
The next step was characterizing these strains regarding their ER-import capacity.
To that end, I evaluated the translocation of the following proteins:
• wild-type pre-pro-Ⱦ-factor (ppȾF; ∼18 kDa) which is imported post-translationally
into the ER where the signal sequence is cleaved off by signal peptidase [434].
The resulting pro-Ⱦ-factor (pȾF; ∼ 16 kDa) is triptly glycosylated upon entry into
the ER. The glycosylated form is rapidly transported to the Golgi where it is pro-
teolytically cleaved to release the 13 aminoacid long Ⱦ-factor. Hence the precur-
sor form is only detectable in cells with an ER import or ER-to-Golgi transport
defect [382].
• Vacuolar protease carboxypeptidase Y (CPY), a soluble, glycosylated secre-
tory protein is also translocated post-translationally into the ER [201, 258]. It
is synthesized as a cytosolic precursor (ppCPY ∼59 kDa), which has its signal
sequence cleaved in the ER, originating the pro CPY form (pCPY, ∼57 kDa).
It then gets N-glycosylated at four sites to p1CPY (67 kDa). CPY is then post-
translationally modified in the Golgi to p2CPY (69 kD), and proteolytically pro-
cessed to mature mCPY (61 kDa) in the vacuole. If cells have a post-translational
import defect, then accumulation of the cytosolic ppCPY form can be seen [397,
30]
• Diaminopeptidase B (DPAPB) is a type II membrane protein with an N-terminal
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transmembrane domain [288]. Upon co-translational integration into the ER
membrane, the precursor protein (pDPAPB - 96 kD) is core-glycosylated to
form the mature protein (DPAPB -120 kD) [319]. If DPAPB is efficiently inte-
grated, its precursor form is undetectable, making it a typical substrate to test
co-translationaltranslocation impairments.
To evaluate the translocation dynamics of the above mentioned substrates, two
approaches were applied: for ppȾF, an immunoblotting approach was used, while for
CPY and DPAPB, the analysis was done by pulse labeling.
Figure 2.31: Import dynamics in∆asi3,∆ynr021w,∆psg1, and∆she2. Analysis of teh import dynamics of multiple translocation
reportersA)Analysis of the ppαF translocation proﬁle. Cells were grown to anmaximumOD of 1, and incubated at either 20,
30 or 37ºC for a period of 3 hours. After incubation, 1 OD of cells were collected, washedwith Tris-Azide buffer, and an extract
prepared. For each sample 0.4 OD were resolved by SDS-PAGE, and protein detected by Immunoblotting using a pαF speciﬁc
antibody. Signal was acquired by chemiluminescence using an Amersham Imager 600. B)Analysis of the CPY translocation proﬁle.
Cells were labeled with [S]-met/cys for 5min, lysed and immunoprecipitated. For each time point 1.5 OD of cells were lysed and
proteins immunoprecipitated using speciﬁc antibodies against CPY. After SDS-PAGE, proteins were detected by phosphorimaging.
C)Analysis of the DPAPB translocation proﬁle. Cells were pulse-labeled with [S]-met/cys for 15min, lysed and immunoprecipi-
tated. For each time point 1.5 OD of cells were lysed and proteins immunoprecipitated using speciﬁc antibodies against CPY.
After SDS-PAGE, proteins were detected by phosphorimaging. For each experiment, at least three replicas weremade.
For the ppȾF accumulation, triplicates of the mutants to be analyzed, plus a posi-
tive control ( sec61-32; import defect mutant at 20ºC) were grown to an OD of 1 at
30ºC, 220rpm, then one replica of each culture was incubated either at 30, 30 or 37ºC
for 3 hours. After the incubation, samples were collected from each culture, extracts
were made, and resolved by SDS-PAGE. Detection was done by immunoblotting us-
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ing a ppȾF specific antibody. As can be seen in Figure 2.31 A, none of the mutants,
except the positive control sec61-32, accumulates ppaF, and so, none of the mutants
seems to display any post-translational import defect of soluble substrates.
For the ppCPY and pDPAPB accumulation assay, cells were grown to a maximum
OD of 1, pulse labeled with [S]-met/cys, cells lysed, and each one of the sub-
strates was immunoprecipitated using specific antibodies. Samples were then re-
solved by SDS-PAGE, gels dried, signal detected on phosphorimage plates and ac-
quired in a Typhoon phosphorimager. Results can be seen in Figure 2.31 B and C.
For CPY (Figure 2.31 B), which is a post-translational imported, soluble protein
only sec61-32 shows a strong accumulation of this precursor (lanes 1-4). The ∆she2
mutant (lanes 13-14) showed a curious phenotype, reproducibly expressing much
higher amounts of both CPY forms.
In the case of pDPAPB (Figure 2.31 C), we see that, besides the positive control
(sec61-32; lanes 1-4), only in mutant ∆ynr021w (lanes 11-12) is this form detect, in-
dicating that this mutant is import defective for the membranal, co-translationally im-
ported pDPAPB substrate. The intensities of the pDPAPB band, however, are very
weak in both sec61-32 and ∆ynr021w even though the sec61-32 had been shifted
to the restrictive temperature where the import defect is strongest (i.e 20 ºC). This
might have been due to a prolonged lab-cooling problem that could have caused a
quicker processing of this form in all backgrounds, including the sec61-32 mutant,
during sample manipulation.
To further characterize the potential translocation defects on the pertinent strains,
I did a reporter protein translocation assay using a plasmid encoding a protein sub-
strate for cotranslational ER import (pRS313-PHO8-URA3; HIS, 2µ) [262]. This con-
struct encodes a fusion of the sequence coding the first 70 amino acids of Pho8 and
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the whole open reading frame (ORF) of URA3 [262]. PHO8 encodes alkaline phos-
phatase, which is involved in the dephosphorylation of phosphotyrosyl peptides in
S. cerevisiae [81]. URA3 encodes the Orotidine-5’-phosphate (OMP) decarboxylase
which is involved in the de novo biosynthesis of pyrimidines in the cytosol [211]. This
fusion protein is co-translationally imported into the ER. Since Ura3 needs to be in
the cytosol to be used as the only source of Ura3, only in strains with an import defect
is this fusion protein able to support growth when no Ura3 is supplied exogenously
[262]. This construct has been used to select sec61 mutants with a co-translational
import defect [258].
Figure 2.32: Translocation defect assay. Indicatedmutants were transformedwith the pRS315-PHO8-URA3 reporter plasmid, cells
were grown overnight in liquidminimal medium ( 2% glucose, -His) at 30˚C and 220rpm. Cells were then counted using a Neubeuer
chamber and serial dilutions (10-10 cells) weremade. Serial dilutions were plated in both histidine and histine/uracil lacking solid
minimal medium and grown at 30 °C for 3 days.
Strains were transformed with the plasmid encoding the construct, and selected
on minimal solid medium lacking His. After selection, cells were grown overnight in
liquid minimal medium also lacking His (30ºC, 220rpm), counted using a Neubauer
counting chamber, successive dilutions were made (10-10) and plated on solid min-
imal medium lacking both His and Ura. As can be seen in Figure 2.32, only the im-
port defective sec61-32 mutant grows on -His/-Ura solid medium (first line of right
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panel) suggesting that none of the mutants deleted for Sec61 interactor genes had
a co-translational ER import defect.
I next set to characterize this mutants regarding their ERAD capacity. To that end
I analyzed the dynamic of two ERAD substrates: KWW and KHN. The ERAD sub-
strate KHN, consists of the signal sequence of S. cerevisiae Kar2 fused to the Simian
Virus 5 HA Neuraminidase ectodomain [224, 407]. It contains O-linked sugars that
are modified upon transport to the Golgi, making it possible to determine the proteins
localization. It further contains four N-linked glycosylation sites. This substrate has
also internal dissulfide bonds [224, 406, 407].
KWW consists of chimeric integral membrane protein in which the luminal domain
of Wsc1 was replaced with KHN [406, 407]. The integral membrane protein Wsc1,
forming the cytosolic and transmembrane domain of KWW, is a signaling protein
(nonessential) with one transmembrane domain [225, 406, 407]. KWW has a mis-
folded lumenal domain leading to its degradation via the ERAD-L pathway [407].
Prior to pulse-chase experiments, all strains were transformed either with the ex-
pression plasmid pRS316-KWW-HA (CEN, URA) or pRS316-KHN-HA (CEN, URA),
and selected on minimal sodium medium lacking Ura. Cells were then grown to a
maximum OD of 1, washed in labelling medium, starved for 30 min, and labeled for
15 min. Samples were chased for a total of 90 min, taking samples at the indicated
time points. Results can be seen in Figure 2.33.
As can be seen in Figure 2.33, none of the mutants showed any significant delay
in the degradation of either KHN or KWW. Thus, none of the tested Sec61 interactors
seem to have a role in ERAD of the tested substrates.
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Figure 2.33: Kww and Khn ERAD dynamics in∆asi3,∆ynr021w, and∆psg1 backgrounds. wild-type andmutant strains were pulse-
labeled with [S]-met/cys for 15min, followed by chase incubations for the indicated times. For each time point 1.5 OD of cells
were lysed and proteins immunoprecipitated using an anti-HA antibody (Biomol). After SDS-PAGE, proteins were detected by
phosphorimaging. Bands quantiﬁedwith ImageQuant (GEHealthcare) and averaged values plotted. At least three replicas were
made. A) Pulse-chase analysis of the KHNERAD dynamics. B) Pulse-chase analysis of the KHNERAD dynamics
2.6.1.1 She2
Since the data in the literature seemed to strongly suggest that She2 was a real Sec61
interactor, I tried applying the immunoblotting approach to detect such interaction.
For that purpose, Prof.Ralf Jansen (Biochemistry, University Tübingen), with whom
I collaborated to evaluate the veracity of this interaction, supplied She2 specific an-
tibody. I prepared SMPH crosslink reactions with microsomes from sec61S353C,
sec61S353C/∆she2, SEC61 and SEC61/∆she2 strains and the SMPH crosslink pat-
terns for both Sec61 and She2 were determined. The sec61S353C/∆she2 strain was
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generated by integration of the sec61S353C mutation into the ∆she2 strain obtained
from the Euroscarf strain collection using the pRS306-Trunc.sec61S353C construct
described in Kaiser & Römisch [186]. Integration was confirmed by sequencing of
the target gene after integration. The samples were SMPH crosslinked, resolved by
SDS-PAGE and signal detected by Western Blot using both the Sec61 and the She2
antibodies.
Figure 2.34: SMPH crosslink pattern determination in sec61S353C/∆she2Microsomes from SEC61/SHE2, SEC61/∆she2,
sec61S353C/SHE2, and sec61S353C/∆she2 (17eq) were crosslinkedwith 1mMSMPH for 30min on ice, quenched for 15min, and
analyzed by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen). Protein detection was done byWest-
ern Blotting using either Sec61 or She2 speciﬁc antibodies and signal acquired on ECL ﬁlm. Crosslinked bands are signaled by a
lateral arrow.
As seen in Figure 2.34, the SMPH crosslink pattern observed in both the sec61S353C
and sec61S353C/∆she2 (upper left panel, lanes 2 and 4) are similar to each other
and to the one observed before in a sec61S353C background (Section 2.3). How-
ever, the 120 kD band seems to have its intensity decreased in the sec61S353C/∆she2
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(upper left panel, lane 2 versus lane 4). When the She2 antibody was used for detec-
tion in the same background (upper right panel), She2 could be detected around 29
kD only in the SHE2 strain, and no band could be seen in the ∆she2 (lane 5 versus
lane8), as was expected. Also, upon crosslink, She2 presented several crosslinked
bands (right arrows). However, no correlation between detected bands (in both SEC61/SHE2
and SEC61/∆she2) and the bands seen when Sec61 was detected could be made.
Figure 2.35: Mid2 import andmaturation analysis. Cells were pulse-labeled with [S]-met/cys for 15min, lysed and immunopre-
cipitated. For each sample, 1.5 OD of cells were lysed and proteins immunoprecipitated using speciﬁc anti-HA antibody. After
SDS-PAGE, proteins were detected by phosphorimaging. Top and bottom panels differ only in the incubation temperature for both
starving and labeling of the sec61S353C cells. In the top panel, sec61S353C cells were incubated at 20˚C, while in the bottom they
were incubated at 30˚C .
Since no conclusive answer was obtained from the immunoblotting approach, an
alternative one was attempted. I reasoned that if indeed Sec61 and She2 interact,
and She2 is needed for targeting of mRNA to Sec61 for co-translational translocation,
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then a She2 dependent substrate should be translocation deficient in a ∆she2 strain.
I therefore used an HA-tagged form of Mid2: pRS425-MID2-HA (LEU, CEN). Mid2 is
a plasma membrane protein, whose RNA targeting depends, on She2 [384]. Mid2 is
extensively glycosylated, and when its maturation process is delayed anywhere along
the secretory pathway, different sized intermediates accumulate. The translated Mid2
has 28 kD, but its fully glycosylated and mannosylated form has a molecular weight
above 200 kD [285, 171]. Several intermediate forms have been detected previously
[171]. In this assay two controls were used: the sec61-32 and the ∆pmt2 mutants.
The sec61-32 mutant was used to assess the effect of an import-defect sec61 mutant
on the Mid2 molecular size. The O-manosyl transferase mutant ∆pmt2 was used as
negative control for Mid2 processing, as in this mutant, a total abolishment of matura-
tion had previously been reported [285].
As can be seen in Figure 2.35, in the wild-type strain, although some intermediate
forms seem to be detected, the major detected band is that of the fully mature Mid2
at 200 kD (lanes 1 and 2, bottom and top panel; Mature). As expected, in the sec61-
32 mutant, an accumulation of the fully unglycosylated form of Mid2 is detected at
around 30 kD (lanes 3 and 4, bottom and top panel; Cytosolic). In the bottom panel
a substantial amount of the fully maturated form of Mid2 can also be detected in the
sec61-32 lanes. This was also expected, since the restrictive temperature for sec61-
32 is 20ºC, whereas the sec61-32 samples of the bottom panel were incubated at the
permissive temperature (30ºC), as the remaining of the samples. I could also detect,
in the sec61-32 samples incubated at 20ºC, additional intermediates forms (around
65 kD; band B and C). These might result from the delay in the translocation of an-
other protein needed along the Mid2 maturation process. The maturation pattern in
the ∆pmt2 mutant is also what was to be expected, as there was no translocation
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delay, since the detected Mid2 form presents an higher molecular weight than the
untranslocated form (seen in lane 3 and 4, at around 30 kD), which indicates the pres-
ence of some post-translational modifications. However, it is still very far from its full
maturated weight, running at around 40 kD (lane 5 and 6; band F). In the ∆she2 mu-
tant, however, I could observe quite a different pattern (lanes 7 and 8). Although the
fully mature form of Mid2 is also detected with intensities comparable to those found
in the wild-type, at 20ºC I could also detect distinct bands from multiple intermediates
(bands B, C, D and E). Nevertheless, such maturation-intermediary pattern does not
show either an accumulation of the cytosolic Mid2 form or any other band seen in the
sec61-32 background. Therefore, no correlation between Sec61 and She2 interaction
and translocation can be established.
Although She2 presented itself as a strong candidate for Sec61-direct interaction
detection, none of the approaches used led to confirmation of a functional role of an
interaction. This analysis is being continued in Prof. Jansen’s lab, who are investigat-
ing the effects of a number of sec61 mutants on a She2-mediated mRNA targeting to
the bud.
2.6.1.2 Asi3
To further probe the potential interaction of Sec61 with Asi3, a functional assay was
established. Asi3 has been previously decribed as part of a nuclear complex (Asi
complex) involved in INM protein quality control, promoting the degradation of func-
tional regulators of sterol biosynthesis [102]. Its presence as a potential Sec61 inter-
actor was surprising, but interesting. Several substrates, as Erg11 and Nsg1, have
been described as Asi3-dependent for their degradation [102]. I thought that evalu-
ating the degradation dynamics of some of those substrates on the strongest known
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ERAD-defective sec61 mutant (sec61-32 when grown at 30ºC) might give some hints
about the overlapping of these two pathways. If any of the Asi3 substrates degrada-
tion was also Sec61 dependent, then the probability of the Asi3 interaction with Sec61
being functionally important was strong. I chose Asi3-dependent substrates Erg11
and Nsg1. I transformed constructs with the HA-tagged versions of both substrates
into SEC61 and sec61-32 backgrounds, and analyzed their degradation dynamic by
both cycloheximide chase and pulse-chase. Due to expression issues, evaluation of
the degradation process of Nsg1 was not possible, although some degradation delay
in the sec61-32 background seemed to be seen (Supplemental Figure A.17). Erg11
was well expressed and allowed evaluation of its degradation kinetics. Cells were
grown to a maximum OD of 1 and either pulse-labeled with [S]-met/cys or incu-
bated in the presence of cycloheximide (protein-biosynthesis inhibitor) [141].
Figure 2.36: Erg11 degradation dynamics analysis. wild-type andmutant strains were pulse-labeled with [S]-met/cys for 15min,
followed by chase incubations for the indicated times. For each time point 1.5 OD of cells were lysed and proteins immunopre-
cipitated using an anti-HA antibody (Biomol). After SDS-PAGE, proteins were detected by phosphorimaging. Bands were quantiﬁed
using ImageQuant (GEHealthcare) and averaged values plotted. At least three replicas weremade.
In Figure 2.36 the pulse-chase results are shown. As can be seen, in a sec61-32
background, Erg11 showed a considerable slower degradation. While in the SEC61
background, after 60 min, I could detect only ∼25 % of the initial Erg11, in the sec61-
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32 background, after the same period of time 55 % of the initial Erg11 amount was
still detected. Erg11 shows an half life of 35 min in the SEC61 background and an
half life of 90 min in the sec61-32 background.
The data obtained form cycloheximide chase corroborates the effect seen by pulse-
chase (Supplemental Figure A.18).
With this Erg11 degradation analysis, I could establish that Erg11 is indeed also
dependent on Sec61 for degradation, suggesting that either Sec61 is the exit channel
for nuclear proteins as well as for ERAD, or that Asi3-mediated degradation is not
restricted to the INM.
2.7 Sec61 Hinge Mutants to Evaluate Function of Sec61-Mpd1 Interaction
Figure 2.37: Structure of Sec61 channel in closed and opened state. Structure of the Sec61 channel in closed (grey helices, pink
hinge) versus open state (blue helices, green hinge, green signal sequence (SS) inserted in lateral gate) (Voorhees andHegde, 2016)
(PDB 3J7Q, PDB3J7R). Note conformational changes in hinge (pink vs green) during channel opening.
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My xQuest/xProphet analysis of crosslinked peptides suggested a direct interaction
of Mpd1 C59 with K209 in lumenal loop5 of Sec61 which constitutes the hinge region
around which the N-terminal half of Sec61 swings during channel opening (Figure
2.37) [217, 423]. Comparison of Sec61 loop5 with SecY loop5 of bacteria and ar-
chaea by my collaborator, Prof. Ian Collinson (School of Biochemistry, University of
Bristol) revealed a substantial extension of loop5 in eukaryotes, which in turn includes
the crosslink site of Mpd1 (Figure 2.38, upper panel).
Figure 2.38: Alignment of loop 5 hinge region Top: Alignment of loop5 hinge sequences of eukaryotes (Homo sapiens, Hs; Saccha-
romyces cerevisiae, Sc), prokaryotes (Escherichia coli, Ec; Thermotoga maritima, Tm) and archaea (Methanococcus jannaschii). Protein
sequences were obtained fromUniprot. Regions coded by deletions in our sec61mutants are shown in red. The sequence forming
the archaeal hinge region is highlighted in yellow, and the sequence corresponding to the vestigial (post-deletion) eukaryotic coun-
terpart is highlighted inmagenta. Bottom left: view of the hinge from the ER lumen (eukaryotic - PDB 3J7Q), showing the protein
channel lined by TMHs 5, along with 6 and the intervening hinge (pink) with deletions 1 and 2 in red. The deletions result a shorter
hinge akin to the archaeal structure shown in yellow (PDB 1RHZ) (also seemiddle). Bottom right: space !lling model of Sec61 chan-
nel (PDB 3J7Q) in ERmembrane indicating positions of deletions 1 and 2. Note that the region deleted in sec61del1 is accessible for
lumenal proteins in contrast to sec61del2 which faces themembrane (lower right). .
I hypothesized that the eukaryotic extensions in loop5 might serve as docking sites
for ERAD factors to facilitate opening of the Sec61 channel from the lumen for export
of ERAD substrates. To test this hypothesis I deleted sections of the Sec61 hinge in-
cluding the Mpd1 contact site to create a smaller vestigial hinge within Sec61, similar
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to the SecY counterpart (Figure 2.38, top and bottom), and investigated the effects on
protein transport into the ER and ERAD.
2.7.1 Sec61 Hinge Deletion Mutant Construction
To generate the Sec61 hinge mutant strains, the SEC61 gene had to be edited. To
this purpose a scheme was designed where PCR-driven overlap extension (SOE
PCR) was used to delete the target regions indicated in red in Figure 2.38 [3, 164].
During SOE-PCR, overlapping gene fragments are generated. These overlap-
ping fragments will, upon annealing of the homologous regions, generate a continu-
ous unit, that is used as template in a new PCR reaction, generating the fused (full-
length) product. By choosing appropriate internal primers that overlap and flank the
mutagenesis-targeted sequence, one can either delete, add or exchange a given se-
quence. The intermediate fragments can then be fused together in a final PCR using
flanking primers [164, 161].
The loop5 hinge sec61 mutants were generated as follow. For the initial SOE-PCR
reactions, SEC61 was amplified from pBW11 [397] (pRS315-SEC61;CEN; LEU ).
Deletion 1 and deletion 2 were made separately. Deletion 1/2 was made using dele-
tion 1 construct as template and same primers as used for the generation of dele-
tion 2. For SOE-PCR, the regions upstream and downstream of the deletion sites
were amplified using a mutagenic primer and a gene flanking primer. Each muta-
genic primer immediately flanks the deletion site and both upstream and downstream
deletion-flanking primers have a stretch of complementarity with each other (20 bp)
(Figure 2.39 A, bottom panel). After this first round of PCR, products were resolved
in a 1 % agarose gel, to both clean and confirm the size of the PCR products (Figure
2.39 B).
191
Figure 2.39: Hingemutants construction scheme. Scheme depicting the strategy used for deletion of the desired loop 5 stretches
in order to generate desired Sec61 hingemutants. Coding region shown in leaf-green. Upstream and downstream regions shown in
grey. A) Scheme illustrating the Sec61ORF, with the regions to be deleted highlighted (del1 dark green, del2 light green) as well
as the primers used for this purpose. Bottom representations shows a zoom-in of the interest region. B Scheme representing
the different fragments originated by SOE-PCR andwhich ligation originated the desired sec61del1 (top), sec61del2 (middle), and
sec61del1/2 (bottom)mutants.
After gel fragment isolation, equal amounts of complementary fragments were used
as template for the final amplification with the gene-flanking primer-pair (Primer 64
and 16). Product size was confirmed (Figure 2.40 A) and fragments were then di-
gested HindIII/BamHI, as was the pRS315 vector. Each mutant gene (sec61del1,
sec61del2, and sec61del1/2) was ligated into the digested pRS315 (Figure 2.40 B).
Positive clones were confirmed by sequencing.
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Figure 2.40: Hingemutants constructs scheme. Scheme depicting the generated sec61 hingemutants. sec61del1 (top), sec61del2
(middle), and sec61del1/2 (bottom). A Scheme of the fragments generated after ligation of the SOE-PCR generated fragments.
BMaps of the constructs obtained by cloning of the generated sec61mutants into pRS315. pRS315-sec61del1 (top), pRS315-
sec61del2 (middle), and pRS315-sec61del1/2 (bottom)
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Correct pRS315-sec61del1, pRS315-sec61del2, and prRS315-sec61del1/2 were
then transformed into KRY461 (SEC61::HIS pGAL-SEC61-URA3 ). Transformants
were first selected on SC -URA/-LEU medium containing 2% (w/v) galactose and
0.2% (w/v) glucose. The pGal-SEC61 plasmid shuffle was done on SC 5’-FOA plates
lacking leucine. Expression of the mutant proteins was confirmed by immunoblotting
(Figure 2.41).
Figure 2.41: Hingemutants correct expression test. Cells from all the generated hingemutants (sec61del1, sec61del2, and
sec61del1/2), in addition to cells from the sec61∆L7mutant (mutant lacking entire loop 7) [397] were grown in YPD ( 2%Glu) liquid
medium to amaximumOD of 1, and equal amounts (0.4 OD) were analyzed by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®
Novex® Pre-Cast gels, Invitrogen). Protein detection was done byWestern Blotting using the Sec61 speciﬁc antibody and signal
acquired by the Amersham Imager 600 (GEHealthcare).
In the immunoblot shown, the Sec61∆L7 form runs at around 35 kDa (lanes 1 and
2), being in accordance with previously seen gel mobility (Section 2.1). With approx-
imately the same mobility, the Sec61del1/2 form was also detected in lanes 7 and 8.
In lanes 3 and 4, the Sec61del1 form can be seen at around 37 kD and, showing a
slightly lower mobility in gel, the Sec61del2 form in lanes 5 and 6 at around 39kD. In
this fashion, I confirmed that the sec61 mutants forms were being expressed and that
their observed gel mobilities were congruent with what was expected from the hinge
mutants.
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2.7.2 Sec61 Hinge Deletion Mutant Characterization
To determine how the deletions in the loop 5 hinge region affected the cell, the hinge
mutants were submitted to a battery of tests.
Figure 2.42: Growth rate of sec61 hingemutants. Cells were grown overnight in YPD (Gal 2%, 0.2%Glu), diluted to andOD of
0.02 and 1ml of culture applied per well (5 x 1ml per strain) in a FlowerPlate. The plate was then incubated in themicroreactor
Biolector at 30ºC, with 1200rpm, 85% humidity and 20.95%O2, for 24h. Calibration was done at 320nm, and biomass detemination
at 620nm using Filter 15. Readings were done each 15min. In the ﬁgure, the plotted results (after averaging) are shown.
I started by evaluating the growth dynamics of the hinge deletion mutants. To this
end, overnight grown cultures (YPD, 2% Glu) of SEC61 (KRY897), sec61del1 (KRY1116),
sec61del2 (KRY1117) and sec61del1/2 (KRY1118) were diluted to an OD of 0.02
(also in YPD, 2% Glu), applied to a Biolector Flower plate (1 ml per well, 12 wells per
strain), and grown for 48h in the microbioreactor BioLector, monotoring the biomass
(measured at 620nm) at every 15 min (Growth at 30ºC, with a shaking of 1200 rpm,
85% humidity and 20.95% O2). The specific growth curve for each strain can be seen
in Figure 2.42.
As can be seen, the hinge mutants show a growth dynamic similar to the wild-type,
presenting a growth curve that overlaps almost completely with that of the SEC61
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background (Figure 2.42).
Figure 2.43: Temperature and tunicamycin sensitivity of sec61 hingemutants strains.. Cell were grown overnight in YPD, counted
using a Neubeur chamber and sequentially diluted ( 10−). Samples of each dilution (5 µl) were then plated side by side, in solid
YPD (2%Gal / 0.2%Glu) and grown for at least 3 days. Each set was replicated 3 times in different plates. A)Plates for temperature
sensitivity were incubated at 20, 30 or 37 ºC (one replica per temperature). B) For tunicamycin sensitivity, all plates were grown at
30 ºC, but three of the plates where supplementedwith either 0.25, 0.5, or 0.75 µg/ml of Tunicamycin, respectively.
I also screened these mutants for either cold, heat or tunicamycin sensitivities, as
done in previous strain characterizations (Section 2.4.2 and 2.6.1). Cells from wild-
type and hinge mutants (together with the appropriate control for each of the assays)
were grown overnight, cells counted using a Neubauer counting chamber, sequen-
tial dilutions (10-10) prepared and plated in either solid YPD, for temperature sensi-
tivity tests and control conditions of tunicamycin sensitivity test, or in solid YPD sup-
plemented with tunicamycin (0.25, 0.5 or 0.75 µg/ml) for the tunicamycin sensitivity
assay.
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As can be seen in Figure 2.43 A, while deletion1 caused temperature- (right panel)
and cold-sensitivity (middle panel) alone and in combination with deletion2, deletion 2
by itself did not affect growth at any of the tested temperatures. As for tunicamycin
sensitivity, both the deletion1 and deletion1/2 mutants were mildly affected by the
presence of tunicamycin (both 0.25 and 0.5 µg/ml) (Figure 2.43 B). At 0.75 µg/ml
the tunicamycin effect was more striking, despite its effect being also stronger in the
wild-type. Overall, the deletion1 mutant was more sensitive to tunicamycin than the
deletion1/2, suggesting that deletion 2 compensates for part of the defect observed in
deletion1.
Figure 2.44: UPR activation in the sec61 hingemutants. To this end, wild-type andmutant strains were grown inminimal medium to
amaximumOD of 1 at 30ºC, 220rpm and incubated for 3 h in either the presence (+) or absence (-) of 200 µg/ml of tunicamycin
(30ºC, 220rpm). Total RNA (0.1 ￿g) retrotranscribed to cDNA by RT-PCR usingMaximaRT and aOligo(dT18)-dT primer. The result-
ing cDNA (1 µg) was subjected to quantitative PCRwith a set of primers targetingHAC1 tomonitor the UPR. PCR fragments derived
fromHAC1V mRNA (HAC1V = uninduced;∼ 720 bp) andHAC1J mRNA ((HAC1J = induced;∼ 470 bp) are indicated. Primer for ACT1
were also usedwith same cDNA to serve as a loading control. Samples were resolved on a 1% agarose gel.
To probe the proteostasis in Sec61 hinge mutants, I also analyzed their UPR in-
duction by monotoring HAC1 mRNA splicing. Cells were grown in the presence and
absence of tunicamycin, total RNA was extracted, converted to cDNA, and the HAC1
mRNA splicing induction probed by quantitative PCR (Figure 2.44). The results of
this analysis were congruent with those from the tunicamycin sensitivity test, in which
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a mild UPR induction was seen in deletion1 and deletion1/2 mutants (Figure 2.44
versus Figure 2.43). Interestingly, the basal UPR induction (in the absence of tuni-
camycin) in the deletion1 mutant was stronger than the one observed in the dele-
tion1/2 mutant (grey columns), although the UPR induction in the presence of tuni-
camycin was weaker. It should also be noted that deletion2 mutant seems to display
a lower basal UPR induction than even the wildype. This is in congruence with the
slightly lower sensitivity shown by the deletion2 mutant in comparison to the wild-type
when in the presence of 0.75 µg/ml of tunicamycin (Figure 2.43 B).
Figure 2.45: Protein steady state levels. Determination of the steady state levels of Sec61, Hrd1 andHrd3 in the different sec61
hingemutants backgrounds. Cells were grown to amaximumOD of 1 in YPD (2%Glu) and 0.5 and 0.1 OD of each back-
groundwas loaded side by side on an acrylamide gel and resolved by electrophoresis. Protein was detected by Immunoblotting
using either Sec61, Hrd1 or Hrd3 speciﬁc antibodies. Rpn12was used as loading control .
Two important points in the characterization of the sec61 mutants are the expres-
sion level of the mutant proteins and, of course, whether they cause any defect on
protein import into the ER. To address the first point, I evaluated the steady state level
of Sec61 in all hinge mutants (Figure 2.45, bottom slice). In addition, to avoid criti-
cism about potential indirect effects of the hinge mutants on ERAD by affecting Hrd1
and Hrd3 biogenesis, the steady state levels of both Hrd1 and Hrd3 were determined
(Figure 2.45, top slice). I did both analysis by quantitative immunoblotting. Cells of
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the different backgrounds were grown to a maximum OD of 1 in YPD (2% Glu) and 2
different amounts (0.5 and 0.1 OD) of each strain (SEC61, sec61del1, sec61del2
and sec61del1/2) were resolved by SDS-PAGE and revealed using specific antibod-
ies against the target proteins (Sec61, Hrd1 and Hrd3). Rpn12 was used as loading
control.
As is shown by the results in Figure 2.45, steady-state expression levels of all Sec61
hinge mutants were like wild-type, as were the steady state levels of both Hrd1 and
Hrd3, showing that they were expressed equally in wild-type and mutant cells.
To evaluate the ER-import capability if these strains, two different translocation re-
porters were used, as done previously (Section 2.6.1): pDPAPB and ppȾF. Cytosolic
precursors can only be detected when an import defect is present. While pDPAPB is
co-translationally imported into the ER, ppȾF is imported post-translationally. As can
be seen in Figure 2.46, both pDPAPB and ppȾF can only be detected in the sec61-
32, which has a known import defect when grown at 20˚C. Thus none of the hinge
mutants displayed any defect in co- or post-translational protein import into the ER.
Figure 2.46: Analysis of ER import in sec61 hingemutants. Early log-phase cells were pulse labeled with [S]-met/cys, lysed, and
DPAPB (upper; cotranslational import) or prepro alpha-factor (ppαF) (lower; posttranslational import) immunoprecipitated. Starv-
ing and labeling were done at 30ºC for all strains, except for sec61-32, which was incubated at 20°C. Labelling was done for 5min
for ppαF and 15min for DPAPB. Proteins were detected by phosphorimaging.
As both the sec61del1 and sec61del1/2 showed only a moderate tunicamycin-
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sensitivity (Figure 2.43) and slightly induced UPR (Figure 2.44), ER-proteostasis was
not dramatically compromised in the mutants excluding gross ERAD defects.
Lastly, I set to evaluate the ERAD capacity of the characterized mutants. To do so,
I analysed the ERAD dynamics of several well established ERAD substrates: KWW,
KHN, p∆gȾF and CPY*.
The ERAD substrate KWW is, as described before, a chimeric integral membrane
protein [406, 407]. The lumenal domain of KWW, KHN, consists of the signal se-
quence of S. cerevisiae Kar2 fused to the Simian Virus 5 HA Neuraminidase ectodomain.
KWW is misfolded in the lumenal domain (KHN) leading to its degradation via the
ERAD-L pathway [407]. Both proteins are dissulfide-bonded. Prior to pulse-chase
experiments, the strains were transformed with either the plasmid containing the gene
encoding KHN (pSM70, CEN/URA) or KWW (pSM101, CEN/URA). Both forms have
a triple HA epitope tag [406].
To evaluate the dynamics of these substrates, cells of wild-type and hinge mu-
tants strains were grown to a maximum OD of 1, pulse-labeled for 15 min with [S]-
met/cys and chased for the indicated periods. Proteins were then immuoprecipitated
with an anti-HA antibody (Biomol), resolved by SDS-PAGE, and signal acquired by
phosporimaging. Band intensities were quantified using the ImageQuant software
(GE Healthcare) and relative intensities plotted (GraphPad Prism).
As is obvious in the results shown in Figure 2.47, neither KHN (A; soluble) nor
KWW (B; transmembranal) showed significant ERAD defects in any of the Sec61
hinge mutants.
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Figure 2.47: KWWandKHNERAD dynamics determination. The sec61 hingemutants were screened for ERAD defects for KWW
and KHN. wild-type andmutant strains were pulse-labeled with [S]-met/cys for 15min followed by chase incubations for the indi-
cated times. For each time point 1.5 OD of cells were lysed and proteins immunoprecipitated using speciﬁc antibodies against
anti-HA. After SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen), proteins were detected by phos-
phorimaging. Bands were quantiﬁed using ImageQuant (GEHealthcare) and averaged values plotted. For each experiment, at least
three replicas weremade. A)KHNERAD dynamics. B)KWWERAD dynamics.
Two additional ERAD substrates were also tested: ΔgpȾF and CPY*.
The ΔgpȾF is a soluble, unglycosylated ERAD substrate, that does not require
ubiquitylation for degradation [142, 326, 433]. As the wild-type pre-pro-Ⱦ-factor (ppȾF),
the mutant Ⱦ-factor precursor (pΔgpȾF, ∼18 kDa), is efficiently imported into the ER
and its signal sequence cleaved [240]. The resulting ΔgpȾF (∼ 16 kDa) is an ERAD
substrate [54, 238, 240, 437]
For pulse-chase experiments, the sec61 mutants (sec61del1, sec61del2 and sec61del1/2)
and the corresponding wild-type (SEC61) were transformed with the expression plas-
mid p416pΔgpȾF (CEN, URA3) carrying a gene encoding pΔgpȾF.
CPY*, a soluble, glycosylated secretory protein that is translocated posttranslation-
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ally into the ER [201, 258] was also analyzed. CPY* is a model ERAD (ERAD-L) sub-
strate, being retrotranslocated into the cytosol and degraded by the 26S proteasome
[158, 206]. It has multiple disulfide bonds and its ERAD is dependent on reduction of
these by Pdi1 [120]. In addition, its ERAD depends on Mpd1 [131], but its exact role
is unclear.
Figure 2.48: ∆gpαF and Cpy* ERAD dynamics determination. The sec61 hingemutants were screened for ERAD defects for ∆gpαF
and Cpy*. Wild-type andmutant strains were pulse-labeled with [S]-met/cys for 5min followed by chase incubations for the indi-
cated times. For each time point 1.5 OD of cells were lysed and proteins immunoprecipitated using speciﬁc antibodies against
either ppαF or CPY. After SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen), proteins were detected
by phosphorimaging. Bands were quantiﬁed using ImageQuant (GEHealthcare) and averaged values plotted. For each experiment,
at least three replicas weremade. A)∆gpαF ERAD dynamics. B)CPY* ERAD dynamics.
To analyse the ERAD dynamics of those two substrates, cells of wild-type and
Sec61 hinge mutants strains were grown to a maximum OD of 1, pulse-labeled
for 5 min min with [S]-met/cys and chased for the indicated periods. Proteins were
then immuoprecipitated with specific antibodies against either ppȾF or CPY, resolved
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by SDS-PAGE, and signal acquired by phosporimaging. Band intensities were quan-
tified using the ImageQuant software (GE Healthcare) and relative intensities plotted
(GraphPad Prism).
While the ERAD of ˵gpȾF was unaffected in all Sec61 hinge mutants (Figure 2.48
A), this was not true for the CPY* ERAD (Figure 2.48 B). In Figure 2.48 B, it can be
seen that CPY* degradation is compromised in sec61del1, which lacks the contact
site for Mpd1 (Figure 2.48 B, magenta). In contrast, sec61del2 barely affects CPY*
degradation (Figure 2.48 B, red). The sec61del1/2 mutant has an intermediate pheno-
type (Figure 2.48 B, green).
My data suggests that the Sec61 hinge mutants do not have a general ERAD de-
fect, but that the mutant lacking the Mpd1 contact site is specifically defective in ERAD
of the substrate whose degradation requires Mpd1 (CPY*).
2.8 Mpd1 interaction
To verify the direct interaction between Sec61 and Mpd1, and the influence of the
Sec61 hinge mutants on the interaction, I had to establish a setup that permitted the
crosslink and detection of such interaction. One of the problems was my ability to de-
tect Mpd1. Since no specific antibody against it was available, the option presented
was of tagging Mpd1 in an effort to have a detection method.
2.8.1 MPD1 HA tagging
For the purpose of tagging Mpd1, I decided to take advantage of a PCR-based tag-
ging setup described in Janke et al. [177], which permits a versatile way of editing
yeast genome. It allows easy C- or N-terminal tagging or even gene deletion.
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Figure 2.49:MPD1 gene scheme. Schematic representation of theMPD1 coding region, including 250bp downstream. The priming
regions of the primers used for the latter ampliﬁcation of the gene HA-tagging cassette and their nomenclature are also repre-
sented in the scheme.
I designed two primers (Primer 110 and Primer 111). Primer 111 had homology with
the final extension of the target gene (49 bp - excluding the STOP codon; Figure 2.49,
in orange) and with the tagging cassette’s upstream adaptamer. Primer 110 had ho-
mology with the STOP codon and downstream region of the target gene and with the
tagging cassettes’s downstream adaptamer (50 bp, Figure 2.49, in blue).
The tagging cassette was then amplified from the template plasmid pYM24 (kindly
supplied by Dr. Michael Knop) using the above described primers as is schematized
in 2.50 A. The adaptamer region of the primers is depicted in grey.
The PCR product was directly used for transformation (Figure 2.50 B). Since the
tagging cassette possessed the hphNT1 resistance marker, transformants could be
selected on hygromycin supplemented solid YPD. Transformants were then confirmed
both by gene amplification and sequencing and by expression test. I was able to
have integrants, but the endogenous expression of Mpd1 was so low that its detec-
tion was quite difficult (data not shown). Since I needed a setup with high sensitiv-
ity in order to allow the determination of an effective interaction of Sec61 and Mpd1,
such system was sub-optimal.
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Figure 2.50:MPD1HA-tagging cassette. Schematic representation of theMPD1HA-tagging process adapted from [177]. A) primers
110 (orange) and 111 (blue) were used in a PCR reactions using as template a plasmid containing the cassette with the HA-tag and a
selectionmarker (hph). These primers allow ampliﬁcation of the cassettes as well as the targeting of the respective PCR product to
the desired genomic location. (B) Integration of tagging cassette is possible due to the overhangs provided by the Primers 110 and
111 ( color-coded primers in the ﬁgure A). The same colors indicate homologous sequences as shown in the representation of the
genomic region to be altered. Upon transformation, an integration of the cassettes into the yeast genome occurs due to homologous
recombination.
Therefore I decided to subclone the tagged MPD1-HA from the genome into a 2µ
plasmid, and in doing so, increase its expression level, and consequently, my capac-
ity for Mpd1 detection.
For this purpose, gene flanking primers were designed (Primer 114 and 115), and
used for the amplification of the tagged Mpd1 from the genomic DNA extracted from
a genomically MPD1-HA tagged strain. These primers included, respectively, SalI
and EcoRI restriction site, which permitted a directed cloning into SalI/EcoRI digested
pRS426 (URA, 2µM). After confirming a correct cloning by sequencing, this construct
was used to transform a SEC61 strain (KRY897), and also the hinge mutants (KRY1116,
KRY1117, and KRY1118). After confirming Mpd1-HA expression and detectability, I
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had the conditions to proceed with functional studies.
Figure 2.51: Mpd1-HA expression testAnalysis of the expression of the tagged form ofMpd1 by Immunoblot. wild-type and hinge
mutant cells were grown to amaximumOD of 1, and equal ODs (0.5 and 0.1) were resolved by SDS-PAGE on 4-12%Bis-Tris gels
(NuPAGE®Novex® Pre-Cast gels, Invitrogen). A commercial anti-Ha antibody (Biomol) was used for theMpd1-HA. Rpl24was used
as loading control. A speciﬁc antibody against Pdi was also used.
In figure 2.51 it can be seen that all mutants were not only expressing Mpd1-HA,
but also that its steady state level is similar in all backgrounds.
2.8.2 Mpd1 interaction with Sec61
Having generated a background where Mpd1 could be detected, I was in condition to
design a setup that might allow the confirmation of a direct interaction between Sec61
and Mpd1.
To directly confirm that Mpd1 interacted with Sec61, and that this interaction was
compromised in the sec61 hinge mutants, I prepared radiolabelled microsomes from
wild-type, sec61S353C and sec61 hinge mutant strains expressing HA-tagged Mpd1
and performed sequential immunoprecipitations with Sec61 and HA-antibodies. Briefly,
cells were grown to a maximum OD of 1 in SC minimal medium (Glu 2% / -Leu / -
Ura), pulse labeled for 30 min and crosslinked with either SMPH (1 mM), LC-SPDP (1
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mM) or SDAD (1.5 mM). SMPH was chosen because the Sec61-Mpd1 crosslinked
peptide was first identified by SMPH crosslinking to Sec61S353C. LC-SPDP, like
SMPH, has one cysteine- and one NH2-reactive group, only LC-SPDP is cleavable.
Therefore, in this double immunoprecipitation experiment, and under reducing con-
ditions, the free forms of the Sec61 interactors could be detected. Consequently,
SMPH is the negative control for LC-SPDP, because there should be no release of
Mpd1 from Sec61 after the first precipitation. SDAD is also cleavable, but with one
NH2-reactive and one photoactivatable reactive group. It was used to efficiently crosslink
Mpd1 to Sec61 regardless of the cysteine in loop 7. After quenching, samples were
solubilized and submitted to two sequential immunoprecipitation. The first immunopre-
cipitation was done with an anti-Sec61 N-terminal antibody. Saturation of the immuno-
precipitations were confirmed (data not shown). After washing and sample reduction
with DTT, samples were submitted to a second immunoprecipitation using the anti-HA
antibody. Samples were then resolved by SDS-PAGE and signal acquired my phos-
phorimaging.
In Figure 2.52 it can be seen that no free Mpd1-HA could be detected in any of the
control samples (i.e lacking any crosslinker) (lanes 1, 5, 9, 13, and 17) or in any of
the SMPH (i.e non-cleavable) crosslinked samples (lanes 2, 6, 10, 14, and 18). Con-
versely, as seen in the mass spectrometric analysis, in the LC-SPDP crosslinked
sec61S353C, a band compatible with Mpd1-HA could be detected at around 45 kDa
(lane 19). None of the other backgrounds, however, generated such band (lane 3, 7,
11, and 14). Uppon SDAD crosslink, the Mpd1-HA compatible band can be detected
in all the tested backgrounds (lane 4 , 8, 12, 15, and 20). Nevertheless, its intensity
is much higher in the SEC61 and sec61S353C backgrounds (lanes 4 and 20), while
in the sec61 hinge mutants backgrounds its intensity is much weaker (lane 8, 12, and
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15).
Figure 2.52: Mpd1-Sec61 direct interaction determination. Interaction of Sec61withMpd1was determined by crosslink in [S]-
met/cys-labeledmicrosomes treated with SMPH (cysteine andNH-reactive, non-cleavable), LC-SPDP (cysteine andNH-reactive,
cleavable) or SDAD (NH-reactive and photoactivatable, cleavable) as indicated. For explanations of the crosslinker selection, see
Material&Methods. Sec61 and crosslinked proteins were precipitated with anti-Sec61N-terminal antibodies, followed by reduc-
tion of the crosslinker. Subsequently, Mpd1-HAwas precipitated using HA-antibodies. After gel electrophoresis, proteins were
detected by phosphorimaging. Equal amounts of cells were used for the preparation of eachmicrosome batch. Protein levels of both
Sec61 andMpd1-HAwere similar in all strains. Saturating amounts of antibodies were used for each precipitation.
Collectively, the data suggest that Mpd1 does indeed interact directly with Sec61,
and that this interaction is through Sec61 loop 5, since the loop 5 mutations impairs
such interaction.
2.9 Genomic Integration of sec61∆L7
In previous work sec61∆L7 (the sec61 mutant lacking the full lumenal loop 7), was
shown to have an ERAD impairment, but it also showed some import defects [397].
To understand if the lack of such prominent lumenal loop might affect any Sec61 lu-
menal interaction, potentially with ERAD factors, I decided to compare the crosslink
pattern of Sec61 versus Sec61∆L7 in my initial work. At the time, the only available
mutant strains carrying this mutation were strains where sec61∆L7 was being ex-
pressed from a plasmid. I though that, for future work, the integration of this mutation
into the chromosomal DNA of S.cerevisiae might contribute to a tighter background.
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Therefore I set to generate the above mentioned strain.
For that purpose, I subcloned the sec61∆L7 gene from pRS315-sec61∆L7 by first
digesting the plasmid with BglI. This restriction enzyme cut the vector in three dif-
ferent places: 688 bp upstream of the sec61∆L7 ORF, 208 bp downstream of the
sec61∆L7 START codon, and 2074 bp down stream of the sec61∆L7 ORF. This gen-
erated three different fragments including a 3144 bp fragment that contained the trun-
cated (lacking the initial -208 bp) sec61∆L7 gene. Since the pRS305 (plasmid into
which I subcloned sec61∆L7) does not have an available BglI restriction site, an ex-
tra blunting step was necessary. To this end, I submitted the BglI digested pRS315-
sec61∆L7 to an incubation with T4 DNA ligase in the absence of ATP, which resulted
in a blunting of the overhang end generated by the BglI digestion. After blunting, I fur-
ther digested the sample using SalI. The SalI restriction enzyme cuts downstream
of the sec61∆L7 sequence cloned into pRS315 (including 634 bp of the downstream
region of sec61∆L7 and 8 bp from the pRS315 plasmid). With this final digestion, I
generated a 1705 bp, truncated sec61∆L7 gene (trunc.sec61∆L7), with a blunt end
and a SalI overhang. Taking advantage of this two ends, I cloned the trunc.sec61∆L7
fragment into a SmaI/SalI digested pRS305. After ligation and DH5Ⱦ transformation,
positive clones were screened by colony PCR and further confirmed by sequencing.
I first tried to integrate the sec61∆L7 mutation into an haploid S.cerevisiae strain
(KRY47). Unfortunately, although many tries were made, I was never able to isolate
an integrant. Faced with this challenge, I changed my approach, and tried the inte-
gration into a diploid S.cerevisiae strain (KRY486), followed by sporulation and tetrad
dissection using a MSM Tetrad Dissector (SINGER), with a subsequent characteriza-
tion of the obtained haploid strains (Figure 2.53).
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Figure 2.53: Chromosomal integration of sec61∆L7. Schematic illustrating the A) trunc.sec61∆L7 integration. B) Sporulation and
tetrad dissection process. Figure fromwww.singerinstruments.com/resource/what-is-yeast-genetics/.
Briefly, integrative vector was linearized, transformed into KRY486 (Figure 2.53 A),
and cells selected in solid SC minimal medium (2 % Glu/-LEU). Transformants were
then incubated in Sporulation Medium (1% Potassium Acetate / 0.1% Yeast Extract /
0.05% Glucose) for 5 days, tetrads were collected and digested with ß-Glucoronidase
from Helix pomatia. Using a tetrad dissecting microscope (MSM Tetrad Dissector;
SINGER) tetrads were dissected and spores gridded as schematized in Figure 2.53
B. To confirm correct integration and expression of our mutant gene, resultant hap-
loid strains were grown overnight in minimal medium, extracts were made and re-
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solved by SDS-PAGE. Protein detection was done by Western Blot using a Sec61-
specific antibody. Using this approach I was able to isolate one sec61∆L7 integrant,
as can be seen in Figure 2.54. Here it can be observed that the wild-type Sec61 runs
at around 40 kD, as is customary. Sec61 from spores 1-5 and 7 show the same gel
migration pattern, showing that all these spores also contain the SEC61 copy of the
gene. Spore 6, however, shows a Sec61-specific band at a lower molecular weight,
at around 35 kDa, characteristic of Sec61∆L7 (Section 2.1, Figure 2.1 A)
Figure 2.54: Chromosomal integration of sec61∆L7. Immunoblot of spore screen. Thewild-type Sec61 can be seenmigrating at 40
kD in the wild-type strain, as well as in spore 1-5 and 7. On spore 6, an increasedmigration of the Sec61 speciﬁc band (35 kD) can be
easily seen.
It must also be said that to further confirm the correct integration of the sec61∆L7
mutation, genomic DNA was isolated, the sec61∆L7 was amplified and the fragment
sequenced.
This strain was filed and can be used in the future for either crosslink assays or any
other purpose (KRY956).
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Discussion
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In the present work I aimed to characterize new Sec61 interactors, both cytosolic and
lumenal, with special interest in the latter. Sec61 is the pore forming subunit of the
ER protein translocation complex. In this role Sec61 interacts closely with Sbh1 and
Sss1, the two other components of the Sec61 complex, and is responsible for co-
translational tranlocation [278, 442, 188, 153] (Section 0.2.1). For post-translational
translocation to the Sec61 complex joins the Sec63-complex (Sec62, Sec63, Sec71,
and Sec72), forming thus the Sec complex [79, 44] (Section 0.2.1). Besides its role in
ER protein translocation, Sec61 has also long been one of the candidate retrotranslo-
cons, responsible for transport of ERAD substrates from the ER to the cytosol [289,
288, 120] (Section 0.4.6). Various mutations in the Sec61 protein were reported to im-
pair retrotranslocation and degradation of ERAD substrates like pαF [289, 288, 120],
CPY* and Deg1:Sec62ProtA [333], while their anterograde transport into the ER was
unaffected [293, 289, 28, 443]. Moreover, blockade of the Sec61 channels with ribo-
some nascent chain complexes abrogated the retrotranslocation of cholera toxin and
amyloid beta-peptide [339, 340]. Also, SEC61 over-expression alleviates protein im-
port defect during CPY* over-expression in cells unable to induce SEC61 expression,
suggesting Sec61 becomes limiting for import during high export demand [261].
Also supporting the hypothesis of Sec61 involvement on ERAD is the direct in-
teraction of Sec61 with the proteasome [262, 187]. In these studies, a direct inter-
action between Sec61 and the 19S RP was seen, as well as an impaired ERAD of
19S RP-dependent substrates in sec61 mutants with decreased affinity for 19S RP
[262, 187, 186].
The true identity of the retrotranslocon, however, remains controversial, with Sec61,
Hrd1 and Der1 as the three main candidates. All accumulated data seems to suggest
that in reality, depending on the substrate and cell conditions, a combination of dif-
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ferent elements might work together to form differently structured export complexes
[380, 113, 11].
Considerable work has been done before in the effort to identify Sec61 interac-
tors. Thanks to this work we know now of many other Sec61 interactors (Sbh1, Sss1,
Sec63, ribosome, SRP, OST complex, etc.) which helped clarify not only Sec61 func-
tion and mechanistic action, but also those of other pathways that converge or brush
with that of Sec61 [361, 195, 398, 422, 180] . Overall, Sec61 interactors for import
are well described. Work in the past, however, has mainly focused on Sec61 cytoso-
lic interactions, or interactions in the protein anterograde import pathway [361, 195,
398, 422, 180]. Here, I undertook an approach that, while not disregarding cytosolic
interactions, was focused on new lumenal interactions of the Sec61 channel.
In the present work I established a Sec61 chemical crosslink setup (Section 2.1 to
2.3) associated with an affinity purification step (Section 2.4) and mass spectrometry
analysis. This setup allowed the identification of several Sec61 interactors as well as
multiple candidate interactors (Figure 2.25 and Table 2.4). With data harvested from
this setup, I generated specific sec61 mutants that allowed the identification and char-
acterization of a new lumenal Sec61 interaction with Mpd1 (Figure 2.52). Moreover,
this interaction seems to be an ERAD-related one, at least for the ERAD substrate
CPY* (Figure 2.48 B).
Another interesting interaction reported in this work is the Sec61xAsi3 interaction,
that I here established by Erg11 (an Asi3 substrate) ERAD dependency on Sec61.
3.1 Crosslinking Setup
With the objective of identifying Sec61 new interactors I established a crosslinking
setup with different crosslinkers. I used DSS (Section 2.1), SDAD (Section 2.2), SMPH
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(Section 2.3) and LC-SPDP (Section 2.4.3) to crosslink Sec61 in microsomes in vitro
and analyzed the resulting Sec61 crosslink pattern. These four different crosslinkers
were tested in three different backgrounds: wild-type, sec61∆L7 and sec61S353C.
Sec61∆L7 is a Sec61 mutant form that lacks the full lumenal loop 7 and part of
adjacent TMDs (7 and 8) [397]. This mutation causes both ER import and export
defects, and a channel distortion that causes Sec61 complex instability [397]. The
Sec61S353C point mutation, in turn, has a unique lumenal cysteine in loop 7. This
point mutation induces a conformational change by unfolding the short Ⱦ-helix of the
lumenal loop 7, increasing the rigidity of the region [186]. This mutant has no ER im-
port defects, but has a decreased affinity for the 19S regulatory particle of the 26S
proteasome, resulting in a specific ∆gpαF ERAD defect, whose export from the ER is
dependent on the 19S RP-Sec61 interaction [186].
My initial approach was to crosslink the ER membranes with the above mentioned
crosslinkers and detect Sec61-containing complexes by immunoblotting using anti-
Sec61 antibodies for protein detection. In all variations of the setup, shifted Sec61-
containing bands were detected (DSS:Figure 2.2; SDAD:Figure 2.4; SMPH: Figure
2.8; LC-SPDP:Figure 2.21). By comparing crosslinking patterns obtained when using
either a Sec61-specific antibody or antibodies against ER proteins whose molecular
weight could account for the detected Sec61-shift, I was able to identify Sec61 inter-
actions with Sss1 (Figure 2.2 B), Sec71 (Figure 2.6) and Sec63 (Figure 2.10 B).
The Sss1 interaction was the most stable of all as it could be detected with all crosslink-
ers (Figure 2.2 B, 2.4 A, 2.8, 2.21). This interaction was carbonate sensitive (Figure
2.5), which is in accordance to the literature [90]. Moreover, I observed that in the
sec61∆L7 background, the Sss1 interaction was impaired. This impairment was ob-
served when crosslinking with DSS (Figure 2.2 A, lanes 2 and 3 versus 5 and 6) or
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SDAD (Supplemental Figure A.1 B, lane 3 versus lane 9), but not when SMPH was
used (Figure 2.8, lanes 2 and 3). This means that loop 7 deletion either causes an
absence or a shift of the amino acids crosslinked by DSS and SDAD. Since loop 7
has no lysines, we know that the DSS crosslinking couldn’t be through loop 7, which
supported the idea of a distortion. Since SMPH crosslinking of Sec61∆L7 to Sss1 is
not affected, the amino acids crosslinked here are either in domains that do not move
enough to impair crosslinking, or are available for crosslinking due to the conforma-
tional change (e.g any of the three natural TMD cysteins of Sec61). Another, simpler,
explanation is that SMPH is still able to crosslink to Sss1 despite the distortion just
because it is slightly longer than the other two crosslinkers (14.2Å versus 11.4Å and
13.6Å of DSS and SDAD). Nevertheless, this data supports the idea that loop 7 dele-
tion causes a channel distortion that might cause the reported Sec61 complex insta-
bility [397].
Interaction of Sec61 with Sec71 was detected when using SDAD (Figure 2.6, lanes
2 and 3 versus lanes 11 and 12). Sec71 identity was supported by Concanavalin A
(ConA) complex precipitation (Figure A.3 A, lanes 2 and 3 versus 5), since Sec71 is
glycosylated and ConA is a lectin for molecules containing mannose. As Sec71 is an
element of the post-translational complex, in which Sec61 is the translocon, such in-
teraction might not be surprising. Before the work of Wu et al. [450] and Itskanov &
Park [173], however, very little was known about the interaction of Sec71 with Sec61,
or any of other of the elements of the Sec complex. In these works, the authors pro-
vided cryo-electron microscopy (cryo-EM) structures of the Sec complex. Although
neither of the structures present a perfect coverage of Sec71 and Sec72, when both
Sec complex structures are aligned, an almost complete structure of Sec71 and Sec72
can be obtained (Figure 3.1, Sec71 in cyan and teal and Sec71 in bright and dark
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green; PyMOL files supplied as Supplement File in the annexed virtual media - i.e
USB-stick ”Dissertation Supp”- for 3D visualization). As can also be seen in Figure
3.1, both the Sec71 TMD and a cytosolic loop (around amino acid 115-130) are quite
close to the TMD4 and the N-terminus (respectively) of Sec61.
Figure 3.1: Structure of Sec61, Sec71 and Sec72when in complex. Structures of Sec61, Sec71 and Sec72 reported byWu et al.
[450] (PDB ﬁle 6ND1) and by Itskanov & Park [173] (PDB ﬁle 6N3Q) where aligned using PyMOL. Sss1, Sbh1 and Sec63 structures
were removed for clarity. The structures (i.e Sec61, Sec71, and Sec72) are colored orange, cyan and green in the structure fromWu
et al. [450] and yellow, teal and dark green in the structure from Itskanov & Park [173].
This data shows that a crosslink to Sec61 would indeed be possible. Since this in-
formation was not available at the time of the experiments, and without other clues to
a potential interaction point, I could not pursue this line of research. With the present
knowledge, point mutants of both Sec61 and Sec71 could be design and their crosslink-
ing pattern evaluated using my crosslinking setup.
Sec63 also belongs to the Sec complex, where it participates in post-translational
translocation. An interaction with Sec61 is therefore, not surprising, perhaps even
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less so than Sec71, as Sec61 interaction with Sec63 is known, if not well character-
ized, for some time [94, 248]. Information about the points of contact between the
two proteins were still mainly unknown until recently [450, 173]. Sec63 possesses a
lumenal J-domain which interacts with Kar2 and it is involved in post-translational im-
port and ERAD [235, 349]. Sec63 interaction was detected in the sec61S353C back-
ground (Figure 2.8, lanes 8 and 9), but not in SEC61 (Figure 2.8 lanes 5 and 6) when
using a cysteine reactive crosslinker (e.g SMPH). Both Sec61 and Sec63, however,
possess other cysteines that could potentially be crosslinked. Sec61 has three nat-
ural cysteines (C121, C150 and C373) and Sec63 has seven (C226, C329, C341,
C358, C369, C514 , C515). Although all of Sec63 cysteines are cytosolical, Sec61
cysteines are localized in TMDs, and consequently, harder to access for crosslinking.
The absence of a Sec63 crosslink in the wild-type, suggests that the crosslink is loop
7-cysteine dependent, or at the very least, enhanced, as it could only be strongly de-
tected in the sec61S353C background. To further characterize this interaction, differ-
ent populations of proteins (cytosolic or lumenal) were extracted prior to crosslinking
by the use of urea or sodium carbonate. The interaction between Sec61 and Sec63
turned out to be carbonate sensitive (Figure 2.9, lanes 2 and 3 versus lanes 10 and
11), indicating that it is either through a lumenal partner (since Sec63 is a membrane-
protein) or through a extra membrane domain that gets denatured upon carbonate
treatment. Since the only lumenal loop of Sec63 represents its J-domain, it could
be that the interaction detected was through it. We also know that loop 7 cysteine
causes an impairment of the affinity of the proteasome for the Sec61 channel [186].
Therefore, it can also be that the enhanced crosslink of Sec61S353C to Sec63 is an
indirect effect of its impaired 19S RP interaction. If the detected Sec61S353CxSec63
interaction happens in an ERAD-related role, it could be stabilized or even enhanced
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by the accumulation of 19S RP-dependent ERAD substrates. If this would be so, this
interaction, as well as this setup, could prove informative. More studies would have to
be made to clarify the subject, like screening Sec63 mutants, specifically, J-domains
mutants, for Sec61-interaction impairments. Without further data on more precise
points of contact, however, I deemed this hard at the time of these experiments. In
light of the recent publications [450, 173], however, this could present an alternative
line of research.
In further attempt to identify the Sec61 interactors, I applied different immunoblot-
ting approaches. I proceeded with the detection of Sec62, Pdi1, and Kar2 (Figure 2.6
and Figure 2.10 A) but non of these were found crosslinked to Sec61.
I also tried to detect a Hrd3 and Yos9 interaction. This was done by the immunoblot-
ting with specific antibodies (Figure 2.10 A, lanes 3 and 4 versus 15), and by crosslink-
ing in an ∆hrd3 or ∆yos9 background (Figure 2.11 A, lanes 3 and 4 versus 7 and 8). I
was unable to detect Hrd3 or Yos9 amongst the Sec61 crosslinked bands.
Lack of an interaction detection however, might not necessarily indicate a lack of
interaction. The sensitivity of the immunoblot approach might just not be enough to
detect transient or low abundancy interactions.
All characterized interactions using this methods represented known and relatively
stable Sec61 interactions. This bode well for the quality of my crosslinking setup, and
on my capacity of crosslinking Sec61 to its interactors. The crosslink setup I estab-
lished is robust, and could be used in the future to structurally characterize the de-
tected interactions, and perhaps other that were not pursued, after some optimization
aiming for a specific target.
For more transient and low abundancy interactions, however, this setup was sub-
optimal, needing to be associated with downstream steps of enrichment and higher
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sensitivity detection for optimization. This can allow detection of more transient and
low abundant interactions, that might represent finer steps of Sec61 function and gat-
ing control.
From the several variations of the crosslink setup I established, the one that was
better targeted for lumenal interactions was the SMPH/LC-SPDP based crosslink in
the sec61S353C background, since the lumenal cysteine in this mutant conjugated
with the cysteine reactivity of the crosslinker, increased the chances of lumenal crosslinks.
Consequently, this was the setup that was chosen for Sec61 enrichment and analysis
of interactors by mass spectrometry.
3.2 Sec61 Purification
Aiming to achieve sample complexity reduction and Sec61-interactor complexes en-
richment, I established a setup for crosslinked-sample purification. This setup re-
quired: tagging of Sec61 and Sec61S353C with a 14His-tag; establishment of the
crosslink setup in both backgrounds; establishment of a purification setup that al-
lowed Sec61-interactor complex purification.
The SEC61 and sec61S353C genes were tagged by cloning into a plasmid (sup-
plied by Rapaport’s lab [380]) that allowed 14His N-terminal-tagging (Figure 2.12).
Tagging of the Sec61 N-terminus had already been shown to be possible [289]. The
increased size of the tag was used aiming to reduce purification background, as the
yeast proteome is rich in histidines. These 14His-tagged constructs were subcloned
to a new CEN plasmid (pRS315) (Figure 2.14) and construct expression was con-
firmed (Figure 2.15).
Before proceeding with Sec61 interaction analysis in these backgrounds, the ef-
fect of the tagging had to be assessed. These backgrounds displayed doubling times
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similar to wild-type (Figure 2.16) and presented no significant temperature nor tuni-
camycin sensitivity (Figure 2.17 A and B), although a slight UPR induction was de-
tected (Figure 2.18). I also determined the half-life of the 14His-tagged Sec61 forms,
which revealed to be much shorter than the wild-type (Figure 2.19). These forms
showed a higher initial protein amount when compared to the untagged wild-type
form (Figure 2.19, 0 time point), and a quick degradation to levels similar to the ob-
served in the untagged wild-type form (Figure 2.19, 0 to 2h time points). At this point
the speed of degradation decreased dramatically, becoming similar to the one ob-
served in the control background (Figure 2.19, 2 to 24h time points). This effect might
be due to an higher expression of the tagged constructs, potentially generating a sub-
population of Sec61 that does not reach correct membrane topology or does not as-
semble with Sss1, and suffers quick degradation. Supporting this idea is the fact that
steady state levels of the tagged forms are similar to the untagged wild-type form (Fig-
ure 2.15).
Besides no significant growth defect or ER protein homeostasis defect being de-
tected, the crosslinking pattern obtained in these backgrounds showed a good over-
lap with the one obtained in the untagged backgrounds (Figure 2.21 A versus B).
Both Sss1 and Sec63 interactions could be detected (Figure 2.21 B, lanes 2, 3, 8
and 9), vouching for the function and stability similarity of the constructs to the un-
tagged counterparts. This showed that this system had potential for the purification of
Sec61-crosslinked interactors. Moreover, by resorting to LC-SPDP crosslink, I had a
setup in which the crosslinked complexes could be cleaved and the components ana-
lyzed individually (Figure 2.21 B, lanes 2 and 3 versus 5 and 6). It must be mentioned
that crosslink tests in the 14His-SEC61 background revealed that, unlike the SEC61
background, some crosslink of Sec63 with His-Sec61 could be detected (data not
221
shown), although weaker than in sec61S353C or 14His-sec61S353C. This might in-
dicate that the 14His-tag somehow stabilizes Sec63 interaction. A nonspecific band
could also be detected during immunoblotting (Figure 2.21 B, marked with *). This is
truly an nonspecific band, obtained with the Sec61 N-terminal antibody, as it appears
in blots of both pGal-SEC61 (Figure 2.4 A , left panel) and SEC61 backgrounds (Fig-
ure 2.4 A, right panel).
The purification process was optimized through a long process, in which different
approaches were attempted (Section 2.4.4). In its final version, the setup consisted
of solubilizing crosslinked 14His-SEC61 and 14His-sec61353C ER-vesicles (as well
as crosslinker-free samples) and injecting them into an HisTrap column incorporated
onto an automated protein purification system (BioLegend LP, Biorad) (Figure 2.23).
Sec61 was then eluted along an imidazole gradient (Figure 2.24 A). With this setup
I was able to successfully purify Sec61 and its crosslinked interactors in an efficient
and clean form (Figure 2.24 B).
This setup could be used in the future, after further optimization, for Sec61 purifi-
cation in either native or denaturing conditions. If in native conditions, a more bio-
compatible buffer, like Hepes, should be used instead of Tris, as well as a different
pH range. The use of glycerol (instead or in addition to a mild detergent) would also
be advisable. For denaturing conditions, the use of minimal amounts of SDS in the
buffer may proof beneficial.
Since there is a TEV protease recognition site between the N-terminal His tag and
Sec61, an elution by TEV protease digestion might be interesting as it might result in
a more specific and clean elution. Size exclusion chromatography (SEC) after IMAC
elution might be beneficial for background reduction, since proteins/complexes with
molecular weight below 50 kD could be purged, potentially resulting in reduced back-
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ground, or even allow an analysis by size range.
Overall, the setup resulted in efficient purification of crosslinked Sec61-containing
complexes, with close to maximal Sec61 column binding and a conveniently narrow
elution interval. Moreover, Sec63 can be used as marker for process quality control
check (i.e crosslink+purification and/or crosslink+purification+cleavage).
3.3 Mass Spectrometry Analysis
Taking advantage of this setup and of the interactions that I was able to character-
ize by immunoblotting, I crosslinked and purified 14His-tagged Sec61 and 14His-
Sec61S353C (Table 2.3), that were then trypsin digested and analyzed by label-free
Liquid Cromatography associated high resolution Mass Spectrometry (LC-MS/MS) by
Mandy Rettel of the EMBL Core Proteomics Department. The raw mass spectrometry
data was processed with MaxQuant (v1.5.2.8) [65] and searched against an Uniprot
Saccharomyces cerevisiae proteome database. Label free quantitation was used us-
ing iBAQ (calculated as the sum of the intensities of the identified peptides and di-
vided by the number of observable peptides of a protein) [347].
For statistical analysis, the raw output data of MaxQuant was processed by Frank
Stein, potential batch-effects were removed, the batch-cleaned data was normalized
and missing values were imputed. Finally, differentially represented proteins when
comparing control conditions (absence of crosslinker) to crosslink conditions (pres-
ence of either SMPH or LC-SPDP) were identified. A protein was considered to be
enriched if it showed a fold change of at least 3 (log2FC ≥ 1.58). If its false discovery
rate (fdr) was smaller than 5 % it was labeled as ”hit”. If its fdr was lower than 20 %
but higher than 5 %, it was labeled as ”candidate”.
After statistical analysis of the enriched hits on the crosslinked samples, I was able
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to identify 361 protein hits that were enriched in the crosslinked samples by at least 3
fold (Figure 2.25; Supplemental File Treated Data.xlsx). After analysis of the enriched
hits, I was able to identify a significant number of already reported Sec61 interactors
(Figure 2.25 and Table 2.4, blue), including a number of the Sec61 complex subunits
(Figure 2.25 and Table 2.4, green).
The variation of patterns between treatments might be due to either the structural
differences of SMPH and LC-SPDP or to the structural changes in the loop 7 hinge
region, described above. Regarding the structure, SMPH is 1.5 Å shorter than LC-
SPDP. This could enable the binding of proteins that experience steric hindrance
when using the longer crosslinker, causing a change in the type and number of pro-
teins interacting with Sec61. It could further result in an altered angle at which pro-
teins bind during interaction.
Validating the setup, I found multiple Sec61 known interactors, like the Sec com-
plex subunits (Sec62, Sec71, Sec72, Sss1, but not Sbh1), OST complex subunits
(Ost3 and 6, Stt3, Swp1) [226, 428, 334], and almost the full EMC complex. Indeed,
recent work has shown that Sec61xEMC interaction is needed for correct topology
and insertion of the first transmembrane domain of transmembrane proteins [61].
Moreover, translation and translocation related interactions, like those with Pho88
(or SND3)[9], Srp21, Srp68, Srp101 and Srp102 [180], RPL1B, 22A and 30 were also
found. Also vouching for data validity is the fact that the found enrichments did not
correlate, in their great majority, with reported cell amounts (Figure 2.27). This indi-
cates that detected enrichments have a high probability of being specific.
When screening the hits for ERAD factors, either reported or postulated, a number
of hits stood out: Asi3, Sop4, Emc10, Cue1, Mpd1, Pbr1, Psg1, Rpt2, She2, Ubc6,
Ubc7, Ubp1, Ubx7, YNR021W (Figure 2.25 and Table 2.4, red). Among these are
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several ERAD-related proteins (e.g. Cue1, Mpd1, Rpt2, Ubc6, Ubc7, Ubx7, Ubp1,
Emc10, and Asi3) suggesting a close proximity of the Sec61 channel to the ERAD
machinery (Figure 2.26, Sec61 in green highlighted by red circle) and Rpt2, a 19S
RP subunit. The detected Ubc6 and Ubc7 interactions, however, might also be due
to targeting of Sec61 for degradation as as been reported previously [374, 28]. Rpt2,
however, which could also be associated with Sec61-degradation, is only enriched
in Sec61 samples, but not in Sec61S353C samples. This is in agreement with the
previously reported lower 19S RP affinity of this mutant [186], supporting the notion
that it is not a Sec61-degradation related interaction, but a ERAD-relevant interaction.
Upon closer look at gene ontology analysis retrieved by the STRING database of
known and predicted protein-protein interactions used to render the predicted inter-
action grid in Figure 2.26, some points worth discussion came to light. Of the the
detected enrichments, a good fraction are of cytosolic and mitochondrial proteins.
These might represent contaminant ubiquituous proteins, as is likely the case of Tpi1,
Fpr1, Cit1, Lys20 or Tom70, which are quite abundant in the cell (Figure 2.27; Supple-
mental File Kulak cell amounts.xlsx). Most of them, however, must be proteins that
cycle to the cytosolic face of the ER either for PTM acquisition or for membrane in-
sertion. Likewise, proteins with a high number of TMDs might also be crosslinked to
Sec61 due to slow translocation. This might be the case of hits like Vhc1, which has
12 TMDs according to Uniprot.
Especially striking were the following enrichments:
• Lipid metabolic process factors like Erg1, 24 and 29, Ayr1, Nsg1, Elo1, among
others. These might indicate a specific lipid environment for Sec61 which could
be interesting and may pose an interesting line of research.
• TOR signallig pathway with an enrichment of Tor1, Tor2, and almost all SEACAT
complex (Sea4, Rtc1, Sec13 and Seh1) [263]. This might reveal a connection
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between stress signaling and Sec61 availability for remediation.
• COPI subunits (e.g Sec21 and 27, Tip20) and Septin ring (CDC10,CDC11,CDC12,CDC3,SHS1).
This is unexpected, as there is no reported physical interaction between Sec61
and the vesicular system.
Although the study of the identity of the enriched hits might be of great interest and
usefulness, all projected interactions would have to be functionally confirmed and
characterized. Nevertheless, enriched hit analysis might proof extremely useful for
future research planning.
3.4 Functional Analysis
Based on the results of the mass spectrometry and its statistical analysis, I decided
to functionally characterize mutants of some of the potentially interesting hits. I chose
four potential interactors: Asi3, Ynr021w, Psg1 and She2.
Asi3 has been described as a nuclear protein involved in INM protein quality con-
trol, promoting the degradation of functional regulators of sterol biosynthesis [102].
It is a transmembrane protein that forms the Asi complex with Asi1 and Asi2, and
is reported as interacting with Ssh1 in the nucleus, but not with Sec61 [102]. Both
the nuclear localization and the Ssh1 interaction seem to not correlate with my data,
since Asi3 was not only strongly present in my samples (which originated from micro-
somes) (Figure 2.25 and 2.27), but it was also strongly enriched in the crosslinked
samples. The fact that Ssh1 was not enriched in my crosslinked samples (Supple-
mental File Full data set.xlsx), excludes the possibility of enrichment of Ssh1 inter-
actors. Therefore, a characterization of an interaction of Sec61 with Asi3 seemed of
high relevance.
Psg1 and Ynr021w are both ER membrane proteins, which are still uncharacter-
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ized [115, 168]. Psg1 has been described as interacting with all the Golgi gycosyla-
tion machinery including Hoc1 (also one of my enriched hits), and might be involved
in quality control of glycosylated proteins[115]. It interacts strongly with the gene prod-
uct of YKL063C [115], which is also uncharacterized and is also enriched in my anal-
ysis. Their potential interaction with Sec61 seemed to be of interest since they might
represent new ERAD factors.
She2 (an RNA binding protein) [264] was also chosen for further investigation be-
cause despite its known targeting to the ER and its genetic interaction with Sec61
(SGD), its ER receptor has never been identified. This has been a long-standing
question in the field of RNA-targeting, hence it seemed likely that I could make a valu-
able contribution.
I tested deletion mutants of all four genes for gross growth defects. They displayed
no temperature sensitivity (Figure 2.30, three rightmost panels), and no ER-homeostasis
impairment, as I did not detect tunicamycin sensitivity (Figure 2.30, left panel). More-
over, all mutants displayed a normal ER import of ppαF, ppCPY and pDPAPB (Figure
2.31). It must be said, however, that during pDPAPB pulse-chases, the air-conditionair
in the lab did not work and that resulted in sub-optimal conditions (as can be seen by
the low intensity of the positive control) that might have affected data quality. Since
this was the most sensitive import test done to the strains, and some pDPAPB seems
to be detected in the ∆psg1 background, I would suggest not disregarding a potential
role of Psg1 in co-translational substrate processing. My characterization, however,
excluded any gross import defects in the tested mutants.
To investigate a potential role of these proteins in ERAD, ERAD of of two substrates
(KHN and KWW) was characterized in ∆asi3, ∆psg1, and ∆ynr021w backgrounds,
with no significant effects detected (Figure 2.33), supporting the notion that none of
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the mutants displays a grossly impaired proteostasis. To rule out roles with higher
degree of specificity of these proteins on ERAD, one would have to screen more sub-
strates and rule out their ERAD impairment. Due to time restrictions I was unable to
follow this up during my thesis work.
Next, I decided to investigate the physical interaction between Sec61 and She2.
She2 targets RNA to the ER and the bud, but its receptor in the ER is still unknown.
If a direct interaction between She2 and Sec61 could be proven, it would support the
idea that Sec61 is its ER-receptor. To assess a direct interaction of Sec61 with She2,
two strains were generated: sec61S353C/SHE2 and sec61S353C/∆she2. I used
crosslinking to assess if the lack of She2 affected any of the detected shifted bands.
When using either the Sec61 or the She2 antibody to detect the interaction, no corre-
lation in the crosslinking pattern was observed (Figure 2.34). This indicated that the
interaction was either not a direct one, or I was lacking sufficient sensitivity to detect
the She2 interaction in the immunoblotting approach.
I reasoned that if indeed Sec61 and She2 interact, and She2 is needed for target-
ing of mRNA to Sec61 for co-translational translocation, then a She2 dependent sub-
strate should be translocation deficient in a ∆she2 strain. Mid2 is a She2 dependent
substrate. This means that if the targeting of Mid2 by She2 to the ER is done through
She2 interaction with Sec61, in a ∆she2 background I should be able to detect the
same Mid2 cytosolic percursor as in sec61-32 at restrictive temperature, where Sec61
displays an import defect. This was not the case. Although I detected several Mid2 in-
termediates in ∆she2 (Figure 2.35, lanes 7 and 8), none represented the fully unglyco-
sylated cytosolic form detected in sec61-32 (Figure 2.35, lanes 3 and 4). This might,
however, be due to a poor choice of substrate, since Mid2 was also shown to be de-
pendent on Khd1, another mRNA binding protein, for ER targeting [384], and more
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substrates should be screened. Due to time and substrate-expression limitations, this
was not possible within my study.
Presently, Prof. Prof. Jansen’s lab in Tübingen, who has been working on She2 for
the past 10 years, is continuing this line of research by investigating the effects of a
number of sec61 mutants on a She2-mediated mRNA targeting to the bud.
To further probe the role of a potential Sec61 interaction with Asi3, I devised a
more indirect assay. Several substrates, as Erg11 and Nsg1, have been described as
Asi3-dependent for their degradation [102]. I thought that evaluating the degradation
dynamics of some of those substrates on the strongest known ERAD-defective sec61
mutant (sec61-32 when grown at 30ºC) might indicate if an overlapping of these two
pathways occurs. If any of the Asi3-substrates degradation was also Sec61-dependent,
then the probability of the Asi3 interaction with Sec61 being functionally important
was strong. I chose Asi3-dependent substrates Erg11 and Nsg1. I could detect a
delay in Erg11 ERAD in a sec61-32 background grown at the permissive tempera-
ture when compared to its degradation in a SEC61 background (Figure 2.36). Nsg1
expression level, however, was so low that it remains unclear whether this result is
meaningful (Figure A.17).
I could establish that Erg11 is indeed also dependent on Sec61 for degradation,
suggesting that either Sec61 is the exit channel for nuclear proteins as well as for
ERAD, or that Asi3-mediated degradation is not restricted to the INM. Another inter-
esting point to be made is that the Asi complex is described as promoting the degra-
dation of functional regulators of sterol biosynthesis [102], with Erg11 and Nsg1 being
two of such regulators. As mentioned above, the enrichment analysis of my crosslinked
samples revealed an enrichment of lipid metabolic process factors, including Nsg1,
among others. The detected enrichments and interactions suggest that Sec61 might
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somehow be involved in this pathway. This result might be of extreme interest, and
future research should clarify this interaction.
3.5 Crosslinked Peptides Identification
In any protein-protein interaction study, the knowledge of the potential points of con-
tact between proteins is invaluable, as with this knowledge specific interaction-impairing
mutation can be designed. With this in mind, and although it was not the initial plan, I
used the xQuest crosslinked-peptide analysis software to identify inter-protein crosslinks
in my raw mass spectrometry data, specifically crosslinks to Sec61. In doing so, I at-
tempted to validate my enrichment analysis and gain knowledge for further experi-
mental setup.
There is a number of available software that identifies crosslinked-peptides from
raw mass spectrometry data. Among these, xQuest is the most powerful, and was
chosen as being the most suitable for analysis of my sample, as many of the other op-
tions were not compatible with my crosslinker or did not handle well samples with the
complexity of mine. xQuest is optimized for the use of isotopically labeled crosslink-
ers, but works also (albeit less efficiently) with only a light crosslinker, like the ones
used during this study. It is also not optimized for heterobifunctional crosslinkers, like
SMPH, thus the impossible homocrosslinks (i.e like K-K or C-C) had to be purged
manually. Another limitation is that only one variable amino acid modification (besides
of the reactive aminoacids) can be established in the analysis definition file. During
indentification of peptides by mass spectrometry, some amino acid modifications that
cause a shift of their isotopic mass have to be accounted for, as is the case of methio-
nine oxidation and N-terminal acetylation. For peptides identification in my samples,
these two modifications were set as variable modification, since they do not occur in
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100% of the cases. My samples were also alkylated with iodoacetamide to block cys-
teines, causing an increase of their isotopic mass. To account for this shift, cysteine
alkylation was set as a fixed modification. A high fraction of the peptides, however,
would have crosslinked cysteines, which should not be available for alkylation. Cys-
teines would, then, have two possible forms: alkylated or crosslinked. In this scenario
the optimal definition for the xQuest analysis would be setting up three variable modi-
fications: alkylation of cysteines, oxidation of methionines, and N-terminal acetylation.
Faced with this choice I opted to prioritize the definition that would conflict less with
correct identification of crosslinkable amino acids, and set as variable the alkylation of
cysteins.
Upon raw mass spectrometry data analysis with the xQuest software, many crosslinks
were detected in each run of the software. The results shown in Figure 2.29 are the
results obtained in one such analysis. As can be seen, several crosslinks could be de-
tected between Sec61 and other proteins of the database (Figure 2.29). In all of the
runs, however, low score for reported true hits were obtained (10 to 20 instead the 40
that usually indicate true hits) (Supplemental File Analysis.xlsx). Moreover, decoys
(nonsense sequence based on the protein database) were scored at same level as
hits. This indicates that all my hits were falling into a statistically grey area. This weak
statistical confidence should stem from all the software limitations mentioned before
and could not be improved despite my best and extensive efforts, as well as support
from the software developer (Dr. Alexander Leitner, Zürich)
A common characteristic of all the xQuest detected Sec61 crosslinked peptides
was that none represented a crosslink to a cysteine in Sec61, only to lysines. Sec61
has 3 natural cysteines: C121, C150 and C373. All of them are localized in TMDs, so
the lack of crosslink to the natural cysteines is not surprising. Even if they do crosslink,
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protease digestion might generate peptides that are too apolar, and therefore harder
to detect by mas spectrometry. Sec61S353, however, has a fourth cysteine in an ex-
tramembrane domain. If this loop 7 cysteine is in close proximity to the place of in-
teraction or sits too close to the membrane, it may happen that it is unavailable for
crosslinking as well. Similarly, if the trypsin digestion prior to mass spectrometry anal-
ysis generates too big of a peptide (40 amino acids-long in the loop 7 case, consider-
ing no miscleaves) software identification becomes also difficult. A double protease
digestion prior to the mass spectrometry analysis was considered, but the xQuest
software also does not tolerate double-protease digestion.
For individual hit validation one would have to compare some of the known interac-
tions with the described points of contact in the literature. In order to validate the de-
tected hits, a similar analysis would have to be done for each one of the interactions.
To be completely thorough, this analysis should be done not only by mapping inter-
action between Sec61 and its interactors, but also mapping the interactions detected
between the interactors, so as to have a multi-plane vision of the complexes. With the
obtained scores, that would mean mapping thousand of interactions. This would be
impossible in the time given for the present study. Also, not enough information was
available for such approach. Many interactions are not characterized and even the
structures of many of the detected proteins are not known. The structures of the Sec
complex that allow such analysis for Sec63, for example, were just recently available
[450, 173]. At the time of the analysis, available information was not enough to allow
hit validation.
In light of these new publications the crosslinks of Sec61 to Sec63 detected by the
software can now be evaluated. In these works the author set to determine the struc-
ture not only of Sec61, but of the entire Sec complex [450, 173]. Both structures re-
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ported by Rapoport’s (4.1 Å) and Park’s (3.7 Å) labs are very similar, as can be seen
by the alignment of both structures in Figure 3.2 A (PyMOL files supplied as Supple-
ment Files in the annexed virtual media - i.e USB-stick ”Dissertation Supp”- for 3D
visualization).
Figure 3.2: Sec61 and Sec63 structure. Structures reported byWu et al. [450] and Itskanov & Park [173]. Sss1, Sbh1, Sec71, and
Sec72were removed for clarityA)Alignment of structures fromWu et al. [450] (PDB ﬁle 6ND1) and Itskanov & Park [173] (PDB
ﬁle 6N3Q). In the structure fromWu et al. [450] Sec61 and Sec63 are in orange and dark blue, respectively. In the structure from
Sec61 and Sec63 are in yellow and light blue, respectively. B) Structure fromWu et al. [450]. Sec61 and Sec63 in orange and dark
blue, respectively. Detected crosslinked amino acids in red and labeled (both in Sec61 as in Sec63). Since structure does not cover
Sec61 K470, F465wasmarked instead for reference. Remaining Sec63 cysteines in magenta.
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Since no crosslinked Sec61 cysteines were identified, whichever true interaction
was detected by the software, it happened between a lysine in Sec61 and a cysteine
in the interactor. Of the crosslinks detected to Sec63, of its seven cysteines (all cy-
tosolical), three were reported to be crosslinked to Sec61: C341, C514 and C515. If
these results were random, crosslinks to any of the cysteines in Sec63 would have
been found, and not only crosslinks with the cysteines oriented towards Sec61 (Fig-
ure 3.2 B, cysteines in red versus cysteines in magenta). The lysines found to be
crosslinked in Sec61, are also in close proximity to the Sec63 cysteines to which they
were reported to be crosslinked (Figure 3.2 B, red). The exception might be K405
and K396 (loop 8) which seem somewhat further away from the Sec63 cysteines than
the space that the crosslinker was expected to bridge (Figure 3.2 B, red). This area,
however, seems flexible and is possible that these areas come closer together during
channel opening or closing. Overall, taking into consideration Sec63 cysteine localiza-
tion, it seems safe to say that the reported crosslinks were, in fact, the most probable
ones to occur.
Besides the structures, Rapoport reports also interactions between the Brl domain
(a.a 440-490) of Sec63 and loop 6 (a.a 261-290) and 8 (a.a 312-361) of Sec61, the
Sec63 TMD3 with TM1 of Sec61, and the N-terminus of Sec63 with the loop 5 of
Sec61. Park reports interactions of Sec61 TMD5 (just before loop 5) with Sec63 J-
domains (a.a 109-220) and TMD3 (a.a 208-210). Although these locations do not
overlap exactly with the detected crosslinks, this is to be expected, since the prerog-
ative for crosslinking is not only spatial closeness of both protein domains, but also
the availability of crosslinkable amino acids in a radius compatible with the crosslinker
size. The detected crosslinks, however, are close to the domains reported as interact-
ing (e.g K26 close to the begining of TM1, K405 and K396 close to loop 8). The inter-
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action of Sec61 with the Sec63 J-domain would also be in agreement with our data
regarding Sec61xSec63 being carbonate sensitive, although no J-domain peptide
was found to be crosslinked to a Sec61 peptide. For a more precise analysis, these
structures should be rendered in a software that allows drawing of the crosslinks in a
size-sensitive form, to verify if the crosslinks would be stereochemically possible.
Overall, as can be seen from the overlap of the crosslinks between Sec61 and
Sec63 detected by xQuest and the recently reported Sec complex structure, the re-
ported crosslinks make sense and are definitely possible. This indicates that the prob-
ability of the software detecting mainly true interactions is high. Nevertheless, indi-
vidual validation would be needed. Although time consuming for someone without a
bioinformatics background, if hit validation is possible, xQuest analysis may become
a powerful tool. Optimization of crosslink setup for analysis with this software, in a
machine running Ubuntu operating system natively, would yield quicker and poten-
tially interesting results.
A simple way of trying to validate some of the hits obtained would be to repeat the
analysis while crosslinking with an homobifunctional crosslinker. These might gener-
ate better scores and allow hit validation. Other variations of the analysis that might
yield interesting information would be comparing present results with those obtained
when using different crosslinker concentrations, crosslinkers with different character-
istics, or even when analyzing different IMAC elution fractions. Analysis of both the
enrichment pattern and the crosslinked peptides in Sec61∆L7 might also be quite in-
teresting. Hits that are enriched in the current setup but were not in a sec61∆L7 back-
ground might proof to be of particular interest. Unfortunately, access to an adequate
mass spectrometer was very expensive, and any re-analysis could not be supported
by my budget, which was already quite strained in consequence of the present anal-
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ysis. In any case, easy and cheap access to state-of-the art MS would be key. To
consider as well would be a collaboration with the Aebersold group, whose expertise
in this type of analysis would surely allow and quicken a fruitful crosslinked-peptide
identification.
3.6 Sec61, Mpd1 and ERAD
During xQuest analysis optimization, a specific crosslink of Sec61 with Mpd1 was es-
pecially recurrent (Sec61 K209 to Mpd1 C59; Figure 2.29). Mpd1 had been one of my
shortlisted hits, due to its connection to ERAD [415]. It belongs to the protein disul-
fide isomerase (PDI) family [415], whose members localize mainly to the ER, where
they form and isomerize disulfide bonds [269, 86, 401], but also act as chaperones
for ERAD relevant substrates [441]. Mpd1 is the only PDI family member that, when
under the control of the PDI promotor, can rescue strains deleted for all other PDI
homologs [415]. It had previously been shown that the cysteines in the catalytic do-
main of Pdi1 are essential for reducing the disulfide bonds in CPY* prior to export,
making Pdi1 essential for CPY* ERAD [229]. While Pdi1 has two thioredoxin domains
with CXXC motifs, Mpd1 contains one active thioredoxin domain with a CGHC motive
[269]. The study of Grubb et al. [131] demonstrated that besides Mpd1, the enzymatic
activity of Pdi1 is also required for CPY* ERAD, but the reason why both proteins are
essential for CPY* ERAD is still unclear.
Upon closer look into the Mpd1 and Sec61 crosslinked peptides I noticed that Mpd1
C59 is the first cysteine in its single redox-active CGHC motif, and Sec61 K209 is in
its lumenal loop5, which constitutes the hinge region around which the N-terminal half
of Sec61 swings during channel opening (Figure 2.37, pink versus green) [217, 423].
Comparison of Sec61 loop5 with SecY loop5 of bacteria and archaea revealed a sub-
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stantial extension of loop5 in eukaryotes including the crosslinking site of Mpd1 (Fig-
ure 2.38, upper panel). I hypothesized that the eukaryotic extensions in loop5 might
serve as docking sites for ERAD factors to facilitate opening of the Sec61 channel
from the lumen for export of ERAD substrates (Figure 3.4).
Encouraged by the xQuest detected Mpd1 crosslinking, the Mpd1 role in ERAD
[415], and by the structural analysis of Sec61 loop 5, I verified if the Sec61 hinge re-
gion was the point of contact for Mpd1, or at least of importance for the ERAD dynam-
ics in yeast.
To achieve this, I deleted the sections of the Sec61 hinge including the Mpd1 con-
tact site that were only present in the eukaryotic channel (Figure 2.38, bottom right).
These mutations (sec61del1, sec61del2, and sec61del1/2), as is visible in the topo-
logical model, cause a shortening of loop 5, making it similar to the bacterial and
archeal channel (Figure 2.38, top and bottom left). I then characterized these strains
and investigated the effects of these mutations on protein transport into the ER and
on ERAD.
While deletion1 caused temperature- and cold-sensitivity alone and in combina-
tion with deletion2 (Figure 2.43 A), steady-state expression levels of all hinge mutants
were like wild-type (Figure 2.45), and there was no effect on co- or post-translational
protein import into the ER (Figure 2.46). Only the double mutant sec61del1/2 showed
a moderate tunicamycin-sensitivity (Figure 2.43 B) and slightly induced UPR (Figure
2.44).
The temperature-sensitivity could be explained by a temperature dependent pro-
tein instability caused by the deleted region 1 and 2, although this was not verified.
Another possibility is a deletion-dependent conformational change of the loop 5 hinge
region, leading to a defect in the mechanism of the channel-opening. The tunicamycin-
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sensitivity points to some misfolded protein response defect, since cells show greater
difficulty to deal with misfolded protein clearing. The conclusion that ER-proteostasis
was not dramatically compromised in the mutants, excluding gross ERAD defects, is
supported by the normal ERAD kinetics for the KHN, KWW, and p˵gpȾF substrates
in these backgrounds (Figure 2.47 and 2.48 A) [289, 407].
CPY* degradation, however, was compromised in all Sec61 hinge deletion mu-
tants. Of the three mutants, sec61del1 (which lacks the contact site for Mpd1) caused
the primary defect in ERAD of CPY* (Figure 2.48 B, magenta). The double mutant
(sec61del1/2) showed an intermediate delay (Figure 2.48 B, green). If both deletions
would be responsible for the impact on ERAD, the double deletion should have a
higher ERAD impact. This may suggest that it is not just the absence of specific amino
acids deleted in sec61del1, but also the distortion of the hinge by the deletion that
caused the CPY* ERAD defect (Figure 2.38, lower). In sec61del1/2 this distortion is
partially compensated (Figure 2.38, lower), which may account for its weaker pheno-
type. Since the sec61del2 mutation is located on the opposite side of loop 5, near the
transmembrane domain, the combination of both deletions could thus result in a com-
pensation of the conformational change emanating from sec61del1, that translated in
a conformation similar to the wild-type.
I have also confirmed that the Mpd1 interaction with Sec61 was compromised in
the sec61 hinge mutants using sequential immunoprecipitations from wildtype, sec61S353C,
and sec61 hinge mutant radiolabelled microsomes over-expressing HA-tagged Mpd1.
In all hinge mutants less Mpd1 was associated with Sec61 compared to wild-type or
Sec61S353C (Figure2.52), but it was not possible to correlate the amount of Mpd1
bound to mutant Sec61 with the degree of the CPY* ERAD defect (compare Figures
2.52 and 2.48 B). The more dramatic effect of the sec61del2 mutant on Mpd1 crosslink-
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ing than on ERAD may be due to the fact that crosslinking is critically dependent on
steric proximity of few amino acids whereas protein-protein interaction is usually via
a larger surface area. I was, however, unable to co-precipitate sufficient amounts
of Mpd1 with Sec61 under native conditions which is why I resorted to crosslinking.
Indisputable, however, is that Mpd1 interaction is impaired in the Sec61 hinge mu-
tants, suggesting that loop 5 is important for it, and that these mutants display a CPY*
ERAD defect.
The doubling of the t/ of CPY* that I observed in sec61del1 (Figure 2.48 B, ma-
genta) is comparable to the effect of a complete deletion of MPD1 on CPY* degrada-
tion [131] suggesting that Mpd1 primarily promotes CPY* ERAD by its interaction with
the Sec61 hinge. It has been shown previously that while the oxidoreductase func-
tion of Pdi1 is critical for ERAD of disulfide-bonded CPY*, Pdi1’s chaperone function -
which is decisive for ERAD targeting of other substrates - is not [120, 131]. My data
indicates that for CPY*, this targeting role may be fulfilled by the Pdi1 homologue
Mpd1 (Figure 3.4).
Mpd1 consists of two thioredoxin modules, a and b [415]. The redox-inactive Mpd1
b module contains an extension similar to, but substantially longer than an extension
in the redox-inactive b’ module of Pdi1 which serves to bind substrate proteins when
it acts as an ERAD targeting chaperone (Figure 3.3) [415, 120]. The Mpd1 b domain
may therefore be responsible for substrate binding whereas the a domain - containing
C59 that I crosslinked to Sec61 loop5 - interacts with the Sec61 channel.
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Figure 3.3: Structure ofMdp1 compared to Pdi1. The approximate twofold rotation relating theMpd1 (blue) and Pdi1 (red) b do-
mains when the a domains are superposed. The rest of the a domain is omitted for clarity. Figure fromVitu et al. [415].
Other studies support the idea that the ubiquitin ligase Hrd1 is the retrograde translo-
cation channel for ERAD [380, 11, 451]. Schoebel et al. [341] solved the structure
of the Hrd1/Hrd3 complex by cryo-EM and proposed that it is the ERAD retrograde
translocation channel. Baldridge & Rapoport [11] also reconstituted in vitro the ERAD
pathway using proteoliposomes and purified Hrd1. They crosslinked CPY* with Hrd1
and observed its translocation. This setup was, however, sub-optimal and completly
non-physiological, since there was no Hrd3 present (which is necessary for Hrd1 ac-
tivity control) and CPY* was very aggregation-prone in it.
To exclude that the sec61 hinge mutants reduced biogenesis of the ER ubiquitin
ligase Hrd1 and its cofactor Hrd3 I performed quantitative immunoblots for both pro-
teins and found that they were expressed equally in wild-type and Sec61 hinge mu-
tant cells (Figure 2.45). Moreover, as can be seen in Figure 2.11 B, the ∆hrd1 and
∆hrd3 mutants displayed only a slight delay in ΔgpȾF degradation, which may or may
not be indirectly due to the accumulation of ubiquitin-dependent ERAD substrates
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in the mutants, but it definitely excludes the Hrd1/Hrd3 complex as ERAD channel
for ∆gpȾF. This fits with the description of ∆gpȾF being dependent on Sec61 for ex-
port [289] and strengthens the idea that at the very least, Hrd1 is not a general ERAD
channel.
Figure 3.4: Mpd1-Sec61 interactionmodel.Model for initiation of CPY* ERADmediated byMpd1 interaction with lumenal hinge of
Sec61. Mpd1 (green) binds CPY* and targets. Mpd1 then binds to Sec61 (yellow) through loop 5 and induces channel opening from
the lumenal side and promotes CPY* export. Sec61, in complex with Hrd3 (dark brown), Hrd1 (light brown) andDer1 (blue) promote
One possibility is that Sec61 and Hrd1 might operate together in retrograde translo-
cation of misfolded proteins to the cytosol. This hypothesis was also stated by Stein
et al. [380] and Gauss et al. [113], and Baldridge & Rapoport [11] do not exclude other
components to be involved in a physiologic system. Further crosslinking studies showed
that Der1 is also a part of the Hrd1/Hrd3 complex [243]. My data on the Mpd1 inter-
action with Sec61 together with the data from the literature may suggest that Sec61,
Der1, and Hrd1/Hrd3 act together in the protein export or form an export channel with
varying multiple subunits dependent on the substrate, as shown in Figure 3.4. This
assumption is supported by the fact that other known ERAD components, extensively
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characterized and which interaction with Hrd1/Hrd3, Der1 and Doa10 is well estab-
lished [391], were shown to be enriched in our crosslinked samples (Ubc6, Ubc7,
Ubx7, Ubp1, Cue1, Rpt2).
3.7 Concluding Remarks
In this study I have successfully established a crosslinking setup that allowed:
• chemical crosslinking of Sec61 to new and known interactors
• purification of Sec61-crosslinked complexes
• Identification of interactors by mass spectrometry.
This setup allowed chacteriziation of several Sec61 interactors, including several
newly discovered ones. Besides the enrichment analysis that will surely proof to be a
trove of information about Sec61 interactions, I have established interactions between
Sec61 and several of the Sec channels subunits (Sss1, Sec71 and Sec63), the nu-
clear envelope protein Asi3, described as being involved in inner nuclear membrane
(INM) protein quality control, and Mpd1, a Pdi1 homologue.
I have shown that Sec61 interacts with Mpd1 through its hinge region and that
such interaction is important for ERAD of a specific substrate. My results can now
serve as a basis for investigating the exact sequence of events of substrate binding
and a Sec61 mediated export.
Collectively, my data suggest that interaction of the CPY* ERAD factor Mpd1 with
the Sec61 hinge region in loop5 contributes to export and degradation of this sub-
strate. My results are consistent with the view that Sec61 forms part of an export com-
plex in the ER membrane for misfolded protein transport to the cytosol (Figure 3.4).
The extended hinge in Sec61 compared to SecY (Figure 2.38) may serve to activate
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and open the channel from the lumen for intercalation and subsequent transport of
CPY* to the cytosol (Figure 3.4).
I propose that Mpd1 targets CPY* to an export complex in the ER membrane that
likely consists of Sec61, the Hrd complex, and Der1 as shown in Figure 3.4, and that
these proteins cooperate in export of CPY* for degradation in the cytosol.
The results obtained during this work are consistent with the view that Sec61 forms
part of an export complex in the ER membrane for misfolded protein transport to the
cytosol (Figure 3.4).
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Figure A.1: Sec61 SDAD crosslinking pattern determination. Immunoblot analyisis of the SDAD crosslinking pattern after titrating
crosslinker concentration and UV irradiation distance. ER vesicles (17eq) were crosslinkedwith 1.5mMSDAD for 30min on ice,
quenched for 15min, UV-irradiated (356 nm) and analyzed by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels,
Invitrogen). Protein detection was done bywestern blotting and signal acquired in ECL ﬁlm. A) SDAD concentration titration in
wildtypemicrosomes (KRY461;GAL1-SEC61). Two different anti-Sec61 antibodies were used: an N-Terminal and an C-Terminal.
The UV irradiation distance usedwas 3.6 cm. B)Distance of UV irradiation test. Microsomes fromGAL1-SEC61 (left panel) sec61∆L7
(right panel) were used. Two different distances were used: 1.6cm and 3.6 cm.
Figure A.2: SDAD conditions titration. Immunoblot analyisis of the Sec61 SDAD crosslinking pattern versus the Yos9 one. ER
vesicles (17eq) were crosslinkedwith 1.5mMSDAD for 30min on ice, quenched for 15min, UV-irradiated (356 nm; 3.6 cm) and an-
alyzed by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen). Protein detection was done bywestern
blotting and signal acquired in ECL ﬁlm. A)Comparison of the SDAD crosslinking pattern when two different antibodies are used for
protein detection: anti-Sec61 and anti-Yos9. B)Comparison of the SDAD crosslinking pattern obtained in a SEC61 (Left panel) or
∆yos9 (left panel) background.
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Figure A.3: Sec61 SDAD crosslinking pattern determination. Immunoblot analyisis of the SDAD crosslinking pattern after different
treatments. ER vesicles (17eq) were crosslinkedwith 1.5mMSDAD for 30min on ice, quenched for 15min, UV-irradiated (356 nm;
3.6 cm) and analyzed by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen). Protein detection was
done bywestern blotting and signal acquired in ECL ﬁlm. A)Concanavalin-A precipitation of SDAD crosslinked samples. Samples
were solubilized in IP Buffer after crosslinking and incubated under rotation with 20 µl Concanavalin A for 2h at room temperature.
Supernatant was removed and TCA precipitated, and beads were washed and sample was eluted in 2xLaemmli Buffer. After dena-
turing teh samples were resolved in SDS-PAGE. Lanes 1 to 3 (right panel) show a control set of reactions were two samples were
crosslinkedwith SDAD (lanes 2 and 3) and onewhere the sample was treated only with DMSO (lane 1). Lanes 4 to 6 show a similar
set, but in which the samples were incubatedwith Concanavalin-A and proteins bound to it were eluted and resolved by SDS-PAGE.
The left panel (lanes 7 to 9) show the TCA precipitations of the supernatants of the Concanavalin A incubations. Sec61 antibody
was used for protein detection. B) SDAD crosslinking pattern in the presence of exogenous ATP (5mM) in SEC61 and sec61∆L7
backgrounds.
Figure A.4: Immunoprecipitation of SMPH crosslinking samples. Samples were crosslinked either with SDAD (1.5mM) or SMPH
(1mM) and immunoprecipitated with a range of antibodies (10µl): α-Sec61-N, α-Sec61-C and α-Hrd3. Protein was then detected
by immunobloting using a Sec61 speciﬁc antibody. Two exposures are shown (shorter: upper panel; longer: bottom panel). For each
different immunoprecipitation, two replicas weremade: one where the sample was reduced before SDS-PAGE (DTT) and another
where it was not.
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Figure A.5: Sec61 SMPH concentration titration. ER vesicles (17eq) were crosslinkedwith different amounts of SMPH for 30min
on ice, quenched for 15min, and analyzed by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen).
Protein detection was done bywestern blotting and signal acquired in ECL ﬁlm. A) SMPH concentration titration on a sec61S353C
background. B) SMPH concentration titration on a SEC61 (leftmost panels) and a sec61∆L7 (rightmost panels) background. Both top
and lower panels shows the same gel slices, just with different exposure times. Lower panels represents longer exposure.
Figure A.6: SMPH crosslinking pattern determination bymulti-antibody immunoprecipitation. ER vesicles (17eq) were crosslinked
with 1mMof SMPH for 30min on ice, and quenched for 15min. After solubilization, the samples were submitted to an immuno-
precipitation with one of the following antobodies: α-Sec61-N, α-Bip, α-Hrd3, α-Pdi, or α-Yos9. For this purpose, solubilizations
were incubated for either 2 h at room temperature or over night at 4 ˚C, under rotation, with 10 µL of the speciﬁc antibody and 60
µl of ProteinA-Sepharose. Sepharose beads were washed, sample eluted with 2xLaemmli Buffer, and analyzed by SDS-PAGE on
4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen). Protein detection was done bywestern blotting using the Sec61
antibody, and signal acquired in ECL ﬁlm.
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Figure A.7: Sec61 SMPH crosslinking pattern determination in permeated cells. Cells were permeabilized by liquid Nitrogen lysis,
and crosslinkedwith different amounts of SMPH, solubilized and resolved by SDS-PAGE SDS-PAGE on 4-12%Bis-Tris gels (Nu-
PAGE®Novex® Pre-Cast gels, Invitrogen). A)Crosslinking of semi-permeated cells. Reactions were done in a total volume of 100 µl
and 10, 20 or 50 µl of permeated cells were used. B) SMPH crosslinking of semi-permeated cells in the presence of EDTA.
Figure A.8: Constructs obtained by cloning into pRS426-GAL-His .Maps of the construct generated by cloning SBH1 and SSS1 into
pRS426-GAL-14His-TEV. pRS426-His-SEC61 on the left and pRS426-His-sec61S353C on the right.
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Figure A.9: Constructs obtained by subcloning 14His-tagged constructs into pRS315.Maps of the construct generated by sub-
cloningGAL1-14His-SBH1-CYC1 (left) andGAL1-14His-SSS1-CYC1 (right) into pRS315.
Figure A.10: Growth rate of 14His-taggedmutants inminimal medium. Cells were grown overnight in liquid SC -LEUmedium (Gal
2%, 0.2%Glu), diluted in the same type of medium to anOD of 0.02 and 1ml of culture applied per well (5 x 1ml per strain) in a
FlowerPlate. The plate was then incubated in themicroreactor Biolector at 30ºC, with 1200rpm, 85% humidity and 20.95%O , for
48h. Calibration was done at 320nm, and biomass determination at 620nm using Filter 15. Readings were done each 15min. In the
ﬁgure we can see the plotted results, after averaging. Shown biomass values are in the log scale. SEC61 in blue, sec61S353C in red,
14His-SEC61 in green, and 14His-sec61S353C in magenta.
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Figure A.11: Protein total amount after puriﬁcation. Puriﬁcation of His-sec61S353c after diferent treatments: Control (upper
panle), SMPH crosslinking (middle panel), and LC-SPDP (bottom panel). For each set, 500 eq of microsomes were treated either with
DMSO (control) or 1mM crosslinker (SMPH or LC-SPDP), quenched, solubilized and Puriﬁed using the bofere described system
(BioLogic; Biorad) along an imidazole gradient. The different fractions were TCA precipitated, incubatedwith DTT and resolved
by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-Cast gels, Invitrogen). For protein detection, gels were stainedwith
Coomassie G-250. Besides the different fraction a loading control of 2 µg of BSAwas also loaded in each gel (lane 15).
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Figure A.12: Puriﬁcation buffers test. On an automated puriﬁcations system, several buffer compositions (Binding Buffer/Elution
Buffer) were tested. The default 50mMTris-HCl, pH 7.4 / 300mMKCl / 40mM Imidazole (B1) buffer was used as the baseline
conditions. Samples were eluted along a imidazole gradient (100-500mM) using the same base-buffer as the correspondent Binding
Buffer being tested. Samples were TCA precipitated and resolved by SDS-PAGE on 4-12%Bis-Tris gels (NuPAGE®Novex® Pre-
Cast gels, Invitrogen). Protein detection was done using an anti-Sec61 antibody. A)Comparison of the puriﬁcation pattern obtained
when using either the default buffer (B1; upper panel), the same buffer supplementedwith 0.5% of TritonX-100 (B2;, middle panel),
or with 0.5% of TritonX-100 and 4MUrea (B3; bottom panel). B)Comparison of the puriﬁcation pattern obtainedwhen using
either the TritonX-100 supplemented buffer (0.5%)(B2; upper panel), a B2-based buffer further supplementedwith 1% (B4;
second panel from the top), and buffer based on B4 further supplementedwith 4M (B5; Second panel from the bottom) or 8M
(B6; bottom panel) of urea, while in both cases reducing the KCl to 150mM.CComparison of the puriﬁcation pattern obtained using
B2-like buffers for puriﬁcation either under denaturing (upper panel) or native (bottom panel) conditions.
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Figure A.13: Puriﬁcation system test. Several afﬁnity puriﬁcation systems and strategies were tested. A) Test of the better resin
charging cation in a batch setup. Two different cations were tested: Ni+ and Co + . Samples (microsomes; 50 eq) were solubilized
and incubatedwith either a Ni +(Ni Sepharose ) or Co + (Talon® Superﬂow) charged resins and eluted with Elution Buffer (50
mMTris-HCl, pH 7.4 / 300mMKCl / 0.5 % TritonX-100 / 500mM Imidazole ). B) The puriﬁcation efﬁciency of the batch setup in
crosslinking conditions was also tested. Microsomes (50 eq) were either treated with DMSO (control) or SDAD, and submited to
the batch puriﬁcation setup. Flow through (F.),Wash (W.), ﬁrst Elution (E1), and second Elution (E2) fractions were TCA precipitated
and resolved by SDS-PAGE. A set of standard SDAD crosslinking reactions (17 eq) were also solubilized and TCA precipitated (Mic.)
to serve as the baseline for sample complexity. The sample was either immunobloted against Sec61 (upper panel) or stainedwith
Coomassie Brilliant Blue (bottom panel). C) The use of denaturing or native conditions for sample preparation was also tested. For
the batch puriﬁcation setup (Batch), sample was puriﬁed using either deanturing (D) or native (N) conditions. Puriﬁcation was done
either by simple elution (500mM Imidazole (Elution) or along an Imidazole gradient (100-500mM). Each fraction was resolved by
SDS-PAGE and immubnobloted against Sec61. For the automated puriﬁcation setup (AKTA) only native conditions (N) were used
and elutions was doen only along an imidazole gradient (100-500mM; rightmost panels) An typical chromatogram obtained during
a automated puriﬁcation setup is shown bellow the immunoblot panel.
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Figure A.14: Mass spectrometry statistical analysisMA plot. AnMA plot (plot displaying a difference in expression patterns be-
tween the average intensities of two samples)was done by plotting each hit enrichment (log2 fold change) in function of its sample
absolute amounts in the sample (log2 average expression). The above plots represent the difference of enrichment when the differ-
ently crosslinked samples (Sec61 and sec61S353C) were compared to the control samples (uncrosslinked sec61S353C).
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Figure A.15: Secondary comparisons Volcano plots. Volcano plots based on the statistically determined protein enrichment in
the crosslinked samples (His14-Sec61 andHis14-Sec61S353C) when compared between each other. The horizontal axis repre-
sents log2 fold change (log2FC) reﬂecting level of enrichment. The vertical axis plots the -Log10(pValue) of enrichment, reﬂecting
signiﬁcance. Both hits (blue) and candidates (red) have a fold change of at least 3. Hits have a false discovery rate (fdr) < 5% and
candidates an FDR < 20%. Purple line is at fold-change of 3. Not signiﬁcant hits below threshold in green.
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Figure A.16: Secondary comparisonsMA plots. AnMA plot (plot displaying a difference in expression patterns between the average
intensities of two samples) was done by plotting each hit enrichment (log2 fold change) in function of its sample absolute amounts
in the sample (log2 average expression). The above plots represent the difference of enrichment when the differently crosslinked
samples (Sec61 and sec61S353C) were compared to each other in different combinations.
Figure A.17: Nsg1 degradation dynamics analysis.Wildtype andmutant strains were pulse-labeled with [S]-met/cys for 15min,
followed by chase incubations for the indicated times. For each time point 1.5 OD of cells were lysed and proteins immunoprecip-
itated using an anti-HA antibody (Biomol). After SDS-PAGE, proteins were detected by phosphorimaging.
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Figure A.18: Erg11 degradation dynamics analysis by cyclohexemide chase. Wildtype andmutant strains were grown to amax-
imumOD  of 1, cyclohexemide (100 µg/ml)was added, zero time point takenwashedwith Tri-Azide. Cultures were incubated
at 30ºC, 220 rpm and shown time point taken and treated as the zero time points. Each time point was lysed and resolved by SDS-
PAGE. Proteins were detected by immobloting using an anti-HA antibody (Biomol) and signal was acquired in ECL ﬁlm.
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